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Summary
Post-transcriptional regulation of gene expression relies on multiple mech-
anisms to elicit translational control and/or mRNA decay. RNA silencing
pathways operate at both stages, targeting a significant fraction of the tran-
scriptome, namely those mRNAs complementary to short interfering RNAs
(siRNAs) and microRNAs (miRNAs). Using Drosophila S2 cells, I have car-
ried out a genome-wide search for transcripts regulated by these pathways.
mRNA expression profiles were obtained for cells depleted of AGO1,
AGO2, PIWI or Aubergine, members of the Argonaute family of proteins
essential for RNA silencing, and analyzed alongside profiles from cells de-
pleted of the miRNA-processing enzyme Drosha. Changes in transcript levels
in Drosha-depleted cells correlated closely with those in the AGO1 knock-
down, demonstrating that miRNA targets change level following inhibition
of the miRNA pathway and supporting the idea that miRNAs can cause
degradation of the targeted transcripts, and do not just repress translation
as previously thought. Furthermore, it was found that a subset of miRNA
targets is also regulated by AGO2; together with evidence that AGO1 and
AGO2 silence the expression of a common set of mobile genetic elements,
this suggests a degree of functional overlap for AGO1 and AGO2 in the
Drosophila RNA silencing pathway.
I next focused on the Drosophila protein Belle, a member of the conserved
family of DEAD-box RNA helicases. Most members of this protein family
exhibit NTPase activity stimulated by or dependent on RNA binding and use
the energy derived from NTP hydrolysis to unwind double-stranded RNA
or disrupt RNA/protein interactions. Many DEAD-box proteins localize
to RNA granules such as maternal and neuronal transport mRNPs, polar
granules, and P bodies. Belle is a component of nuage within nurse cells and
polar granules within the oocyte. It is an essential protein required for larval
growth, as well as male and female fertility, and has a putative role in RNA
silencing.
I show that Belle is required for cell viability. In cells depleted of Belle,
general protein synthesis is inhibited. However, a luciferase mRNA reporter
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with Belle tethered to the 3′ UTR is translationally repressed without any
reduction in mRNA levels. Tethering of Belle to the reporter mRNA in-
duces the formation of heavy mRNP complexes. Translational repression
is abolished when Belle contains mutations disrupting the putative helicase
activity.
Using a biochemical and computational approaches, I found that in Dro-
sophila S2 cells, Belle is part of an interaction network consisting of pro-
teins implicated in general protein synthesis as well as selective translational
control mechanisms. Belle interacts with translation initiation factors and
ribosomal proteins, supporting the idea that Belle is required for general
translation efficiency. However it also associates with translationally reg-
ulated mRNAs and proteins involved in mRNA translational control and
localization, suggesting that Belle may be implicated in mRNP assembly
and transport as well as localized mRNA translation. Finally, I show that
Belle interacts with AGO2 and other components of the RISC, suggesting
that Belle may function as an auxiliary factor in the RNA silencing pathway.
Zusammenfassung
Bei der posttranskriptionellen Regulation der Genexpression wirken mehrere
Mechanismen um die Translation und/oder den mRNA Abbau zu kontrollie-
ren. RNA-Interferenz wirkt auf beiden Ebenen um einen erheblichen Anteil
des Transkriptoms zu regulieren; na¨mlich diejenigen mRNAs, zu welchen
es kleine komplementa¨re short interfering RNAs (siRNAs) und microRNAs
(miRNAs) gibt. Um die Transkripte, welche auf diese Art reguliert werden,
zu identifizieren, habe ich eine genomweite Suche in Drosophila S2 Zellen
durchgefu¨hrt.
Es wurden mRNA-Expressionsprofile von Zellen erstellt, in welchen An-
geho¨rige der fu¨r die RNA-Interferenz essentiellen Argonaut-Proteinfamilie
(AGO1, AGO2, PIWI oder Aubergine) depletiert waren. Diese wurden mit
dem Profil von Drosha-depletierten Zellen verglichen, einem Enzym das die
miRNAs prozessiert. Die Vera¨nderungen im Transkriptionsniveau von Drosha-
depletierten Zellen korrelierten eng mit jenen von AGO1-depletierten Zellen.
Dies zeigt, dass sich nach einer Blockade der miRNA Produktion die Menge
der jeweiligen Zieltranskripte a¨ndert, was wiederum die These stu¨tzt, dass
miRNAs zum Abbau des Zieltranskriptes beitragen, und nicht nur, wie bisher
angenommen, dessen Translation unterdru¨cken. Weiterhin konnten wir bele-
gen, dass eine Untergruppe von miRNA Zieltranskripten auch u¨ber AGO2
reguliert wird. Zusammen mit der Tatsache, dass AGO1 und AGO2 die Ex-
pression einer allgemeinen Gruppe genetisch mobiler Elemente unterdru¨cken,
deutet dies darauf hin, dass sich die Rollen von AGO1 und AGO2 bei der
RNA-Interferenz u¨berlappen.
Danach konzentrierten sich meine Untersuchungen auf die DEAD-box
RNA-Helikase Belle aus Drosophila. Die meisten Mitglieder dieser Protein-
familie zeigen NTPase-Aktivita¨t, die abha¨ngt oder stimuliert wird durch die
Bindung an RNA. Sie benutzen die durch die NTP-Hydrolyse frei werdende
Energie, um doppelstra¨ngige RNA aufzuwinden oder um Wechselwirkungen
zwischen RNA und Proteinen zu sto¨ren. Viele dieser DEAD-box Proteine
finden sich in so genannten RNA Ko¨rperchen (RNA granules), wie z.B. den
mu¨tterlichen und neuronalen Transporter-mRNPs, den polaren Ko¨rperchen
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(polar granules) und den prozessierenden Ko¨rperchen (P bodies). Belle ist
ein Bestandteil der “Nuage” Struktur in Ammenzellen, und der polaren
Ko¨rperchen in Oozyten. Es ist ein essentiell notwendiges Protein und er-
forderlich fu¨r das Larvenwachstum und fu¨r die Fruchtbarkeit bei ma¨nnlichen
sowie weiblichen Fliegen. Daru¨ber hinaus spielt es eine mutmaßliche Rolle in
der RNA-Interferenz.
Ich konnte zeigen, dass Belle fu¨r die Lebensfahigkeit der Zelle erforderlich
ist. In Zellen, in welchen Belle depletiert wurde, ist die allgemeine Proteinsyn-
these gehemmt. Ein Luziferase-mRNA Reporterkonstrukt hingegen, in wel-
chem Belle ku¨nstlich an das 3′ UTR Ende gebunden wird bleibt mengenma¨ßig
stabil, wa¨hrend die Translation gehemmt wird. Die Bindung von Belle an
die Reporter-RNA fu¨hrt zur Bildung von schweren mRNP-Komplexen. Belle
Proteine mit Mutationen, die die mutmaßliche Helikaseaktivita¨t sto¨ren, un-
terdru¨cken die Translation nicht.
Mit einem kombinierten biochemischen und rechnerischen Ansatz fand
ich Belle als Teil eines Interaktionsnetzwerkes, das sowohl Proteine der all-
gemeinen Proteinbiosynthese entha¨lt, also auch Proteine beinhaltet die an
speziellen translationellen Kontrollmechanismen mitwirken. Belle interagiert
dabei mit Translationsinitiationsfaktoren und ribosomalen Proteinen, was die
Theorie stu¨tzt, dass Belle fu¨r die Effizienz der allgemeinen Translation not-
wendig ist. Allerdings assoziiert es auch mit translational regulierten mRNAs
und mit Proteinen, welche eine Rolle in der Translationskontrolle und Loka-
lisation von mRNA spielen. Dies wiederum deutet auf ein Rolle von Belle
im Zusammensetzen und Transport von mRNPs und bei der lokalisierten
Translation von mRNA. Schlussendlich zeige ich, dass Belle mit AGO2 und
weiteren Bestandteilen des so genannten RISC Komplexes interagiert, was
darauf hindeutet, dass Belle als zusa¨tzlicher Faktor bei der RNA-Interferenz
fungieren ko¨nnte.
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1 Translational control in eukaryotes:
cis-regulatory sequences and trans-acting
factors
1.1 Origins of translational control
The main goal of the regulation of gene expression is to determine the levels
of proteins in the cell. A protein’s level is defined by its rate of synthesis and
its rate of degradation. It is also proportional to its mRNA’s level which in
turn depends on the transcriptional activity and rates of mRNA decay.
Protein synthesis is a sophisticated process that requires a lot of energy
(four high-energy bonds per peptide bond) and extensive molecular machin-
ery. It is not surprising that a process of such importance demands close
monitoring and control. Translational control can be defined as a way to
regulate gene expression by changing the efficiency of utilization of an mRNA
in specifying protein synthesis. One of the main features of translation as a
site of regulation of gene expression is that it offers the possibility of rapid
response to external stimuli without invoking nuclear pathways for mRNA
transcription, processing and export.
The idea of translational control emerged very soon after the articula-
tion of the messenger hypothesis. Even before the discovery of the double
helix, it was generally assumed that “DNA makes RNA makes Protein”, be-
cause DNA was in the nucleus and translation took place in the cytoplasm,
therefore something had to be a messenger between these two compartments.
Early on, ribosomal RNA was thought to carry out this role, until evidence
gradually accumulated suggesting that it did not have the characteristics of
the postulated messenger. In 1961 Jacob and Monod first coined the term
“messenger RNA” [189], and its existence was demonstrated by Brenner,
Jacob and Meselson [48], and by Gros and colleagues [154].
The discovery of cytoplasmic free mRNPs which are not bound with ribo-
somes put forward the idea of masked or blocked mRNA [389, 390]. Subse-
quent studies on developing embryos, reticulocytes, virus-infected cells, and
cells responding to different stimuli ranging from heat to hormones and star-
vation to mitosis had laid the firm foundation for the hypothesis that mRNA
could be subject to differential utilization depending on the circumstances
(reviewed in [279]).
The cytoplasm of eukaryotic cells is much more organized structurally
than that of prokaryotes. The lack of a nuclear barrier between the sites
of mRNA synthesis and translation, the greater speed of macromolecular
synthesis in bacteria and their lesser dependence on mRNA processing are
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the factors that allow a coupling of transcription and translation which almost
eliminates the need for translation control.
Both translation and transcription are critical biosynthetic steps in which
the cell makes large investments of energy. Multiple precise mechanisms
have evolved to control transcription. Why does translational control exist?
Probable reasons for the evolutionary success of translational control are
summarized below.
• Translational control is fast and direct. It is applied to the last step
of genetic information flow and therefore avoids the delay imposed by
mRNA transcription, nuclear processing and export.
• Translational control is reversible. Most mechanisms are brought about
by reversible modifications of translational factors (phosphorylation)
which can either stimulate or repress translation. Selective mechanisms
of translational repression do not require mRNA degradation, therefore
de-repressed mRNAs can be translated. The reversible nature of trans-
lational control is economical in terms of energy consumption.
• Translational control allows fine-tuning. The changes in transcrip-
tion efficiency are considerably greater in magnitude than changes in
translation efficiency. Thus, regulation of transcription is more coarse,
whereas translational control provides a means of fine-tuning gene ex-
pression.
• Translational control regulates gene expression in systems that lack
transcriptional control. These include e.g. reticulocytes, oocytes and
RNA viruses, all of which possess little or no opportunity for transcrip-
tional control and in which gene expression is modulated mostly at the
translational level. The fact that translational control is widely used
during development and by some RNA viruses suggests that this mode
of control is more ancient than transcriptional regulation, consistent
with the RNA World hypothesis [136].
• Translational control provides higher spatial resolution of regulation of
gene expression then transcriptional regulation. It is advantageous over
direct protein targeting and allows rapid response to local requirements.
Precise localization of protein synthesis within the cell is essential for
morphogen gradient establishment in the oocyte during development
[99, 107]. Local translation is also required for maintenance of cellular
asymmetry of polarized cells such as fibroblasts and endothelial cells
[75], as well as neurons, where it enables synaptic plasticity [44].
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• Translational control is flexible. A broad spectrum of mechanisms of
various specificity exist which allow the regulation of either single genes
or whole classes of mRNAs. Such flexibility affords the cell a powerful
and adaptable means of regulating gene expression.
Obviously, the outcome of translational control compensates for the the en-
ergetic penalties due to the exertion of regulation over a midstream reaction
in a long gene expression pathway.
1.2 General principles of translational control
All possible mechanisms of translational control can be divided into global
and selective controls. Global controls, such as those operating in oocytes or
in cells recovering from stress, affect almost the entire complement of mRNAs
within a cell, switching their translation on or off or modulating it in unison.
This kind of regulation is usually implemented by substantial alteration in
the activity of general components of the translational apparatus that act in
a nonspecific manner. Selective controls, on the other hand, affect a subset
of the mRNAs within a cell, in the extreme case a single species only. Se-
lective controls in cancer development, metabolic diseases, following stress,
and during apoptosis or viral infection utilize the differential sensitivity of
mRNAs to more subtle changes in the activity of general components of the
protein synthesis machinery, e.g., initiation factors eIF4E and eIF2 [280].
The most specific translational control is achieved through mechanisms rely-
ing on mRNA’s cis-regulatory sequences and trans-acting factors or ligands
(proteins, RNAs, small molecules) that target individual mRNAs or classes
of mRNAs.
This introduction focuses on selective translational control mechanisms in
Drosophila based on cis-regulatory sequences and trans-acting factors, since
these are most relevant to my work. The introduction leaves outside of its
scope other translational control mechanisms as well as regulatory effects on
protein degradation, and regulation at the levels of mRNA transcription and
decay. However, the relationship between translation and mRNA stability is
complex and it is not always possible to segregate one from another (as is
indicated, for example, by miRNA-mediated silencing, see § 1.8).
A major response of cells to growth stimuli or stress is to change the
availability and/or activity of general translation factors and thereby modu-
late global translation activity. It is thought that some mRNAs that harbor
special cis-regulatory sequences in their 5′ UTRs (IRES elements, uORF, sec-
ondary structure elements) are able to escape this regulation by bringing into
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play alternative mechanisms of translation initiation such as internal initia-
tion, although this view is subject to stark criticism [229, 233, 234, 236, 235].
1.3 Translation initiation in eukaryotes
The rate of translation is mainly controlled at the level of translation initi-
ation (see, e.g., [279]). Initiation efficiency in turn is dependent on the gen-
eral translational machinery (availability of free ribosomes and amino-acid-
charged tRNAs; availability and activity of translation factors) and structural
features of mRNAs (cis-elements) that influence ribosomal recruitment, scan-
ning to the initiation codon, and initiation codon recognition. Eukaryotic
mRNAs exist in cells as mRNPs rather than as free polynucleotides. The
mRNAs are dynamically associated with proteins that mediate nuclear ex-
port, stability, subcellular localization and translational control [97]. Some of
these trans-acting protein factors are able to augment or inhibit translation
initiation.
This section describes briefly the general translation initiation pathway,
given its importance for the majority of global and selective mechanisms of
translational control.
Standard translation initiation in eukaryotes is the process of assembly
of an 80S ribosome on an mRNA in which the start codon is base-paired to
the anticodon of aminoacylated initiator methionyl-tRNA (Met-tRNAMeti ) in
the ribosomal peptidyl (P) site. According to the current model (see Fig. 1),
the initiation pathway includes the steps which are listed below (reviewed in
[335, 170]).
• Ternary complex (TC) formation is the assembly of eIF2, GTP
and Met-tRNAMeti . The TC is responsible for delivering Met-tRNA
Met
i
to the 40S subunit and is essential for identification of the start codon
within the mRNA. After each round of initiation, eIF2·GDP is released
as an inactive complex. eIF2B is a guanine nucleotide exchange fac-
tor (GEF) for eIF2·GDP which accelerates the replacement of GDP
with GTP. eIF2·GTP is an active form that has high affinity for Met-
tRNAMeti .
• Assembly of the 43S preinitiation complex (PIC) from the TC
and a 40S ribosomal subunit is facilitated by eIF1, eIF1A, and eIF3 by
a mechanism which includes direct interaction of eIF2 and the 40S sub-
unit, interaction between factors, and induced conformational changes
in the 40S subunit.
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Figure 1. Schematic representation of the assembly of an 80S ribosomal translation
initiation complex on a 5′-capped and 3′-polyadenylated mRNA.
The model divides this process into different stages, showing initiation factors at the stage
at which they first participate in the process. After completion of initiation, Met-tRNAMeti
is base-paired with the start codon of mRNA in the P site of the 80S ribosome, and the
vacant A site is able to accept delivery of the elongator tRNA by eEF1A. Modified from
[335].
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• Recruitment of the 43S preinitiation complex to the mRNA
occurs at the 5′ end of the mRNA. The 43S PIC is intrinsically capa-
ble of 5′-end-dependent attachment to the mRNA. Most natural mR-
NAs have considerable secondary structure near the 5′ end. Binding of
the 43S complex is greatly stimulated by the cooperative activities of
eIF4F, eIF4B, and possibly PABP, which are thought to unwind the
5′-proximal secondary structures to prepare a binding site for the PIC.
The 5′ end of all cellular mRNAs is capped with 7-methylguanosine.
Via interaction with the eIF4E subunit of eIF4F, the m7G cap strongly
promotes 43S complex binding. eIF4F also contains eIF4A (a DEAD-
box RNA helicase) and a large modular protein eIF4G. During PIC
recruitment to mRNA, eIF4G enhances the RNA helicase activity of
eIF4A (which is also activated by eIF4B) and the cap-binding activ-
ity of eIF4E. eIF4G also binds directly to the mRNA and to the eIF3
component of the 43S complex. PABP which binds to eIF4G further
enhances the interaction of eIF4F with the cap.
• Ribosomal scanning on mRNA starts at the 5′ end of the mRNA
and continues linearly in the 5′ → 3′ direction until the 40S ribo-
some/factor complex encounters the first AUG codon, which is recog-
nized by base-pairing with the anticodon in the Met-tRNAMeti . The
question of if and when the relay of interactions among the cap, eIF4F,
and the PIC is disrupted during scanning has not been answered. Very
little is known about the mechanism that actually propels the 40S sub-
unit/factor complex. The 43S complex is capable of ATP-independent
scanning on mRNA lacking any secondary structure without eIF4E,
eIF4B, and eIF4F, but they are required for scanning if the 5′ UTR
contains even weak secondary structure.
• Recognition of the initiation codon is principally determined by its
complementarity with the anticodon of Met-tRNAMeti . eIF1 is critical
for destabilization of premature, partial base-pairing of triplets in the 5′
UTR with the Met-tRNAMeti anticodon and can also induce dissociation
of aberrantly preassembled ribosomal complexes. Experiments in yeast
have shown that eIF1A, eIF4G and eIF3 also influence initiation codon
recognition, probably via their interactions with eIF1, eIF2, or eIF5.
• Ribosomal subunit joining occurs after eIF5-induced hydrolysis of
eIF2-bound GTP, which leads to a reduction in eIF2’s affinity for Met-
tRNAMeti . The combined action of eIF5B and the 60S subunit displace
eIF2·GDP and other factors (eIF1, eIF1A, and eIF3) from the 40S
subunit surface which contacts the 60S subunit in the 80S ribosome,
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during the actual subunit joining event. eIF5 activates GTP hydrol-
ysis by eIF2 only when there is a sufficiently long pause in scanning.
That allows the initiation complex to distinguish an authentic AUG start
codon (long pause) from other contenders (e.g., short pause at UUG).
Virtually all these steps of the translation initiation pathway can be tar-
geted by global and selective control mechanisms. Availability of transla-
tional machinery, modulation of the activity of translation initiation factors
by phosphorylation and other post-translational modifications greatly affect
translation initiation efficiency. The mRNA structural features (such as 5′-
cap, 3′-poly(A), and UTRs) are other key factors that define the translation
initiation efficiency.
1.4 Global mechanisms of translational control
1.4.1 Phosphorylation of eIF2
Phosphorylation of the translation initiation factor eIF2 is one of the best
characterized mechanisms of general translational control in eukaryotes. eIF2
is a heterotrimer comprised of a large γ subunit and smaller α and β subunits.
eIF2γ binds GTP and Met-tRNAMeti and delivers them to the 40S ribosomal
subunit. The assembly of the ternary complex (eIF2·GTP·Met-tRNAMeti ) is
the first step in translation initiation. The interaction of the ternary complex
with the 40S subunit forms the preinitiation complex.
eIF2γ cycles between its GTP-bound (active) state and its GDP-bound
(inactive) state. The recycling of inactive eIF2·GDP to active eIF2·GTP is
catalyzed by eIF2B which is a guanine nucleotide exchange factor (GEF).
Phosphorylation of eIF2α converts eIF2 from a substrate to a competitive
inhibitor of eIF2B. The amount of eIF2B is limiting compared to the amount
of eIF2. Thus, phosphorylation of a small percentage of eIF2α results in the
sequestration of eIF2B in inactive phosphorylated eIF2·eIF2B complexes and
in the inhibition of protein synthesis [88].
The phosphorylation event is purely regulatory; it has no direct effect
on the function of eIF2 as an initiation factor. Phosphorylation is highly
dynamic and regulated by kinases and phosphatases. There are four known
eIF2α kinases in vertebrates: GCN2 (responds to amino acid deprivation),
PERK (responds to an imbalance between the load of ER client proteins and
chaperons, so called ER stress); HRI (responds to unbalanced synthesis of
heme and globin); and PKR (responds to the presence of dsRNA in cells).
The orthologs of GCN2 and PERK have been identified in Drosophila [367,
320, 387, 342].
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There are two known phosphatases that dephosphorylate eIF2(αP). One
contributes to the high basal eIF2(αP)-directed phosphatase activity, the
other ensures recovery of protein synthesis during the later phases of stress
responses. It is not known whether these kinases and phosphatases account
for all eIF2α phosphorylation and eIF2(αP) dephosphorylation activities of
cells [359].
Diverse stress-induced signals are channeled to a single downstream eIF2α
phosphorylation step, which is followed by a cascade of translational and
transcriptional activation events which are required for the recovery from
the stress (Fig. 2).
1.4.2 Phosphorylation of other translation factors
It is now clear that phosphorylation status can regulate the activity not only
of eIF2 but also many other translation factors. Recent studies have provided
compelling evidence that two signaling cascades in particular have critical
roles in this process: the target of rapamycin (TOR) and mitogen-activated
protein kinase (MAPK) signaling modules.
The TOR proteins are evolutionarily conserved protein kinases that have
key roles in cell growth, proliferation and survival. They are thought to
act as a checkpoint for translation, accepting signaling input both from hor-
mone/growth factor receptors and nutrient sensors, and in this way allows
translation to occur only in the presence of sufficient nutrients to fuel pro-
tein synthesis [349]. In Drosophila, the TOR pathway is involved in body
size assessment and growth control, and in adaptation to hypoxia (reviewed
in [289, 358]).
It has been demonstrated that phosphorylation of the RpS6 kinase (S6K),
several translation factors (eIF4B, eIF4G, eEF2), and the eIF4E-binding
proteins (4E-BPs) is all mediated by TOR signaling (reviewed in [345]).
The classical MAP kinase signaling pathway is an evolutionarily con-
served pathway that is involved in the control of many fundamental cellular
processes that include cell proliferation, survival, differentiation, apoptosis,
motility and metabolism [222]. Several downstream kinases of the MAPK
pathway appear to be important for translational control transducing signals
emanating from both growth factor stimulation and stress. These kinases
phosphorylate eIF4E, 4E-BP and eIF4B [345].
Although not as well characterized, other signaling modules (calmodulin-
dependent protein kinase CaMKI implicated in Ca2+/CaM signaling, casein
kinase 2, and cell-cycle-regulated kinase Cdk11) have also been implicated
in translational control. It is clear that even more intracellular signaling
modules will be implicated in translational control as this process is studied
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Figure 2. Schematic overview of the eIF2α-phosphorylation-dependent integrated
stress response. Modified from [359].
The four kinases—PERK, GCN2, HRI, and PKR—are activated by distinct stress sig-
nals, which in turn are dependent on protein synthesis. Stress conditions that lead to
eIF2α phosphorylation and inhibition of ternary complex formation derepress translation
of mRNAs that contain uORFs by a mechanism of regulated translation reinitiation. It
results in expression of some transcription factors (GCN4 in yeast, ATF4 in mammals,
and probably some others) that activate transcription of downstream genes. The latter
encode transcription factors, chaperons, ER enzymes, enzymes involved in lipid and amino
acid metabolism, and also include anti-oxidative stress response genes. Also included is
the gene which encodes an eIF2(αP)-specific regulatory subunit of a phosphatase that
inhibits the stress-induced cascade [359]. Grey dashed arrows correspond to activating
signals; red blunted lines correspond to inhibitory signals.
1.4 Global mechanisms of translational control 11
in more cell types and under other types of physiological conditions.
The phosphorylation state of individual residues in translation initiation
factors and the biological function of phosphorylation events have been char-
acterized in many direct studies. The best characterized mechanism is the
control of eIF4F formation by the eIF4E-binding protein (4E-BP) family
of translational repressors. 4E-BP and eIF4G binding to eIF4E are mutu-
ally exclusive, thus 4E-BP binding to eIF4E abrogates eIF4F formation and
inhibits cap-dependent translation initiation. Phosphorylation of 4E-BPs
affects their ability to interact with eIF4E; hypophosphorylated 4E-BPs effi-
ciently bind to eIF4E, hyperphosphorylated 4E-BPs do not. In the presence
of adequate nutrients, mammalian 4E-BP1 is phosphorylated downstream of
TOR, resulting in a sufficient pool of eIF4E for incorporation into eIF4F.
Under starvation conditions, 4E-BP1 is dephosphorylated and sequesters a
proportion of eIF4E to decrease the abundance of active eIF4F and inhibits
general protein synthesis [345].
Several extracellular stimuli activate phosphorylation of eIF4E via the
MAP kinase pathway, which might be important for regulation of the rate
of protein synthesis during certain physiological conditions.
Other translation initiation factors were also found to be phosphorylated
(eIF4G, eIF4B, eIF3, eIF2B, eIF5, and eIF5B), but it is not clear yet how
these modifications affect translation factor activity and how these changes
in activity relate to the control of global translation rates or the translation
of the specific mRNAs or mRNA classes [345].
Even though translation is most frequently controlled during the initia-
tion step, accumulating evidence points to the elongation step as a target
for control under defined circumstances. The phosphorylation state of eEF2
changes in a way consistent with its having a role in regulating protein syn-
thesis. It becomeshypophosphorylated in response to a wide range of stimuli
that activate protein synthesis and hyperphosphorylated under conditions of
low cellular energy status.
eEF2 mediates the translocation step of elongation where, following the
addition of an amino acid to the growing protein chain, the tRNA attached to
the polypeptide translocates from the A site into the P site on the ribosome
and the ribosome moves by one codon along the mRNA. This is accompanied
by hydrolysis of a GTP molecule bound to eEF2.
The phosphorylation of eEF2 by eEF2 kinase results in a drastic inhibi-
tion of polyphenylalanine synthesis in poly(U)-directed translation [364]. It
also inhibits eEF2 activity in reticulocyte lysates [346]. Mammalian eEF2
undergoes phosphorylation within its GTP-binding domain, which prevents
its binding to ribosomes and thus inactivates eEF2 [53].
Although these and several other studies have reported that eEF2 phos-
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phorylation correlates with inhibition of elongation in vitro, evidence that
that the changes in eEF2 phosphorylation are responsible for the alterations
in protein synthesis rates in vivo still remains limited [167].
1.5 Principles of selective translational control
In contrast to global translational control mechanisms, selective mechanisms
have evolved to target specific mRNAs or mRNA classes. The most “primi-
tive” and efficient mechanisms of this kind preceded more sophisticated reg-
ulatory schemes which appeared later during the course of evolution and rely
solely on structural features of the mRNA such as the 5′-leader sequence
(secondary structures, upstream ORFs or, more correctly, uAUG codons) and
the context of the initiation codon. These mechanisms interfere with trans-
lation initiation in as much as it is the rate-limiting step and because doing
so prevents the cell from wasting the energy required for protein synthesis.
Other mechanisms of selective translational control are dependent on
mRNA-specific cis-sequence elements which on its own have no capability to
affect translation. In this case, the recruitment of additional factors (RNA-
binding proteins or non-coding small RNAs) is required. Such factors not
only directly and stably interact with the aforementioned sequence elements
(acting in trans to the mRNA) but also with the translational apparatus
thereby augmenting or decreasing translation efficiency. Although most of
these primary and secondary structure elements lie in the non-coding regions
of the mRNA (preferentially in the 3′ UTR), some reside in the coding region.
The scanning mechanism of translation initiation [230] accounts easily
for regulation by unusual sequences (uAUGs or uORFs, secondary structure
elements) or proteins that bind near the 5′ end of the mRNA [232]. In light
of the scanning model, it is less clear how sequences located at the 3′ end can
affect translation. To explain regulation via the 3′ UTR one has to invoke
the closed-loop model (reviewed in [203]), which is based on the discovery
that eIF4G can bind simultaneously to eIF4E, at the capped 5′ end of the
mRNA, and to the poly(A) binding protein (PABP) at the 3′ end [419].
The 3′ UTR regulatory elements affect gene expression in a variety of ways
[237]. Nevertheless, it has proved to be difficult to demonstrate unequivo-
cally that one of these ways involves direct participation of the 3′ UTR in
translation initiation or any subsequent step [231, 236].
Different possible cis-regulatory elements are shown in Fig. 3. A single
mRNA can harbour several regulatory elements, which determine the mRNP
association and mode of post-transcriptional regulation. Thus, trans-acting
factors can regulate the same mRNA by cooperating or competing for a
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Figure 3. mRNA-specific cis-acting regulatory sequences which participate in
translational control.
The 5′ end of all cellular mRNAs is protected from exonucleases by the 7-methylguanosine
cap structure which also strongly promotes ribosome binding via interaction with eIF4E.
Poly(A) tail which is bound by PABP protects the 3′ end of all cellular mRNAs (except
histone mRNAs which have a stem loop at the 3′ end) and stimulates translation via
the interaction between PABP and eIF4G. Most mRNAs have considerable secondary
structures near the 5′ end. A cap-proximal stem loop in the ferritin mRNA, termed iron
responsive element (IRE) interacts with IRP, iron regulatory protein, which sterically
blocks the binding of the 43S PIC. Upstream open reading frames (uORFs, or uAUGs)
reduce the translation of downstream ORFs due to the inefficient reinitiation mode. Cer-
tain structure elements in the 5′ UTR can not only inhibit cap-dependent initiation, but
also serve as internal ribosome entry sites (IRESs) which promote cap-independent in-
ternal initiation. A similar role was recently attributed to polypurine (A)-rich sequences
(PARSs). Some IRESs require IRES trans-acting factors (ITAFs) to function efficiently.
The optimal context of the initiation codon—Pu (A or G) at the −3 position and G at
the +4 position—greatly augments translation initiation efficiency. The 3′ UTR often
contains several cis-regulatory elements: binding sites for proteins and miRNAs, as well
as structure elements that govern the spatial and temporal translation and stability of an
mRNA. These include: zipcode, AU-rich element (ARE), Nanos responsive element (NRE),
and cytoplasmic polyadenylation element (CPE).
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regulatory outcome at more than one cis-element. Moreover, a single trans-
acting factor can target multiple mRNAs.
In a broad perspective of post-transcriptional regulation of gene expres-
sion, such cis-elements and trans-factors confer the possibility of precise co-
ordination of mRNA splicing, export, localization, translation and stability.
1.5.1 RNA operon
These views have recently coalesced into the post-transcriptional “RNA-
operon” theory, according to which trans-acting factors combinatorially reg-
ulate multiple functionally related mRNAs along a coordinated pathway of
mRNA metabolism, allowing cells to respond better to environmental cues
[211, 210, 209]. The RNA operon regulates mRNA stability and translation,
guaranteeing the co-regulated expression of a set of proteins that function
in the same pathway or form a macromolecular complex. Each mRNA can
join different RNA operons as determined by a “cis-element code” that gov-
erns its fate. Because each mRNA can be a member of more that one RNA
operon, if the protein encoded by the mRNA evolves more than one func-
tion, it can be dynamically co-regulated with other mRNAs independently
to serve a different functional role [209, 210]. Therefore, the genetic infor-
mation that is represented by multiple copies of each mRNA species, rather
than by the gene itself, can be used combinatorially at several levels, and
can be regulated as part of multiple mRNPs, simultaneously or sequentially
(Fig. 4).
1.6 Selective control: mechanisms that affect initiation
of translation
The scanning mechanism of translation initiation postulates that the 40S
ribosomal subunit enters at the 5′ end of the mRNA and migrates linearly
(scans) downstream along the 5′ UTR. The model predicts that translation
should start at the AUG codon nearest the 5′ end of the mRNA. The distance
from the 5′ end to the first AUG codon is irrelevant. The scanning mechanism
was shown to operate with no measurable reduction in efficiency even when
the first AUG codon was more than 1000 nt from the 5′ end of the mRNA [36].
Scanning may be difficult when a long 5′ UTR sequence contains sec-
ondary structures. Base-paired structures are most inhibitory when their
proximity to the 5′ end blocks ribosome entry. Once bound to mRNA, the
43S PIC has some ability to disrupt base-pairing, although this has limits.
Thus, secondary structure can greatly reduce translation efficiency but does
not completely block scanning [232].
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Figure 4. Post-transcriptional RNA operons. Modified from [209].
Coordination os subsets of mRNAs from transcription to translation. Transcription factors
activate transcription of a set of genes (Gene 1-4). While they are still being transcribed,
the mRNAs are processed, spliced, and exported to the cytoplasm. The four mRNAs
shown, when grouped in different combinations, form three different operons, labeled as
mRNP 2-3-4, mRNP 2-3, and mRNP 1-2-3. The make-up of each operon is determined
by the binding of trans-acting factors (labeled F1, F2, and F3) to specific cis-regulatory
elements, which lead to both co-regulation within each RNA operon and overall coordi-
nation of all three operons as high-order combinatorial “regulons”. The four transcripts
contain different sets of cis-elements. Therefore, an mRNA that contains more than one
element can be a member of more than one mRNP complex [209].
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1.6.1 Upstream AUGs and leaky scanning
If the first AUG codon lies in a poor context, this allows some ribosomes to
bypass it and thus reach a start codon further downstream. There are also
instances of skipping of the first AUG despite a good context which can happen
when it is located too close to the 5′ end to be recognized efficiently. This is
called leaky scanning (reviewed in [230, 232]). It enables the production of
two separately initiated proteins from one mRNA. Some examples in which
two proteins are produced from one mRNA via leaky scanning are listed in
the review [230]. The large number of genes that employ leaky scanning
indicate the considerable biological significance of this mechanism and of the
proteins thereby produced (Fig. 5).
Secondary structures located downstream of a weak initiating codon slow
scanning and thus provide more time for codon/anticodon base-pairing. Sup-
pression of leaky scanning by this mechanism requires a critical distance (13-
15 nt, which corresponds to half the diameter of the ribosome) between the
AUG codon and the downstream structure element. Proteins that stabilize
such structure elements might regulate the dual initiation via leaky scanning
to achieve for example tissue specific expression of one or the other isoform
[230].
1.6.2 Upstream ORFs and reinitiation
Reinitiation occurs with mRNAs that have small ORFs near the 5′ end. The
ribosome initiates in the normal way at the first AUG codon, producing
the peptide encoded in the small upstream ORF (the term “5′ UTR” in
this case is not appropriate, in as much as small ORFs located within “5′
untranslated region” do get translated). When the 80S ribosome reaches
the stop codon of the uORF, the 60S subunit is though to be released while
the 40S subunit remains bound to the mRNA, resumes scanning and may
initiate another round of translation at a downstream start codon. For this
to occur, the 40S subunit must reacquire Met-tRNAMeti . Reacquisition of
Met-tRNAMeti appears to be an important point of control and is promoted
by lengthening the intercistronic distance, which provides more time for Met-
tRNAMeti to bind, or by increasing the eIF2 ternary complex concentration.
Genetic experiments also implicate eIF3 in the Met-tRNAMeti rebinding step
[230]. Another potential point of control is at the termination site of the
uORF, where secondary structure might prevent the resumption of scanning
or, in some other way, prevent reinitiation.
Although little is known about the molecular mechanisms underlying
reinitiation, working rules can be formulated given that certain changes in
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Figure 5. Examples of leaky scanning. Modified from [230].
(A) An example of “maximally” leaky scanning wherein one murine c-Myc mRNA pro-
duces three independently initiated proteins. Optimizing the context around the first AUG
codon suppressed production of the 50 kDa isoform, while changing the upstream CUG
codon to AUG suppressed production of both the 65 and 50 kDa isoforms. (B) An example
of “minimally” leaky scanning in which a strong, but not quite perfect, context at the first
AUG causes most ribosomes to initiate there while allowing a low level of initiation down-
stream. The first AUG codon in the rat histone mRNA initiates translation of a full-length
protein. The second AUG, 85 codons downstream and in the same reading frame, initiates
production of a peptide which has growth-regulatory properties. Mutation of aggaagAUGu
to gccaccAUGg suppresses OGP production. Major (three polypeptide chains) and mi-
nor (one polypeptide chain) translation products are shown below their respective start
codons. Sequences that cause the initiation to be weak, and thus promote leaky scanning,
are highlighted in red. The mRNAs are not drawn to scale.
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mRNA structure affect reinitiation.
(1) Eukaryotic ribosomes can reinitiate following the translation of a small
ORF but not following the translation of a full-length protein-coding
ORF. Naturally occurring uORFs are usually only a few codons long.
Reinitiation was found to be barely detectable for an experimental con-
struct in which the uORF was 35 codons long [228, 343]. Moreover, it
is abolished if an uORF that would otherwise be short enough to allow
a reasonable level of reinitiation includes a pseudoknot structure that
would be expected to cause the ribosomes translating the uORF to
pause [228, 226]. The critical parameter is not the length of the uORF
per se, but the time taken to complete its translation. This might be
explained if reinitiation depends on retention of certain initiation fac-
tors which gradually dissociate from 80S ribosomes during the course
of elongation [232].
The only apparent exception occurs with cauliflower mosaic virus, where a
protein encoded by the virus appears to promote reinitiation following the
translation of a full-length first cistron [329]. The translation of polycistronic
mRNAs by what are likely to be termination-reinitiation events requires the
immediate-early virus-encoded protein TAV. It has been suggested that TAV
interacts with the eIF3g subunit, leading to stabilization of the eIF3-ribosome
interaction, so that it persists throughout the elongation phase of translation
and thereby facilitates reinitiation [363].
(2) Eukaryotic ribosomes cannot reverse to reinitiate at an AUG codon po-
sitioned far upstream from the termination site. An extremely low
frequency of reinitiation, too low for accurate quantification, was seen
when there were four nucleotide residues between the stop and restart
codons, but no reinitiation whatsoever with a ten-residue spacer [228].
Many other studies have shown that the strongest inhibition is caused
by an uORF that overlaps the start of the downstream cistron [230].
The inefficient reinitiation mode of translation can regulate gene expres-
sion in eukaryotes in several ways (Fig. 6). The simplest effect is a reduction
in protein synthesis from the major ORF. Small uORFs which force transla-
tion to occur by reinitiation are used to limit expression of potent proteins
which are required in small amounts. When eIF2 ternary complex levels
are low, the slow reacquisition of Met-tRNAMeti might cause 40S subunits to
bypass the closest downstream AUG codon and advance farther before reiniti-
ating. Thus, the site where translation reinitiates can be manipulated by the
availability of the ternary complex, and this can be manipulated by kinases
(§ 1.4.1).
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Figure 6. Small uORFs function in various ways to modulate translation. Modified
from [230].
(A) The presence of an uORF forces translation of the major ORF to occur by a reini-
tiation mechanism, which is usually inefficient. The extent of inhibition depends on the
number and arrangement of uORFs and whether the context flanking the upstream start
codon(s) allows some escape via leaky scanning. Modulation of eIF2 ternary complex
levels can affect selection of reinitiation sites. (B) Because reinitiation can occur only
in the 5′ → 3′ direction, an overlapping uORF strongly impairs translation of the major
ORF which is translated by low-level leaky scanning allowed by a not-quite-perfect context
at start of the uORF. (C) This mRNA initiates from two start codons; initiation from
the first AUG codon of the major ORF occurs by leaky scanning. The uORF serves to
divert some ribosomes to the downstream start site of the major ORF. (D) Because the
uORF start codon is close to the 5′ end or has suboptimal context, the uORF captures
only a fraction of the 43S PICs, leaving the rest able to access the major ORF AUG codon
by leaky scanning. The ribosomes that translate uORF undergo a prolonged pause or
stall at its termination codon, because the peptide encoded by the uORF seems to block
the ribosomal nascent peptide tunnel, or interferes with the translation termination pro-
cess. Stalling prevents any following 43S PICs from reaching the major ORF by leaky
scanning and abrogate subsequent resumption of scanning by ribosomes that eventually
overcome the stall. Grey dashed arrows correspond to activating signals; red blunted lines
correspond to inhibitory signals.
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The best studied example involves the yeast GCN4 gene (Fig. 6A). GCN4
is a transcription factor which turns on expression of genes involved in amino
acid biosynthesis. Translation of GCN4 itself is regulated by amino acid
availability because the 5′ UTR has four small uORFs, forcing translation to
occur via reinitiation; reinitiation is in turn controlled by a kinase activated
by uncharged tRNAs for which levels increase during amino acid starvation.
The kinase (GCN2) inactivates eIF2α by phosphorylation, and the level of the
eIF2 ternary complex drops. This extends the time of reacquisition of Met-
tRNAMeti by the scanning 40S subunit and allows translation to reinitiate
from the major ORF (Fig. 6A and [171, 172]).
Stress-induced eukaryotic eIF2α phosphorylation increases translation of
the metazoan activating transcription factor 4 (ATF4), activating the inte-
grated stress response, a pro-survival gene expression program. The 5′ UTR
of the ATF4 mRNA contains two conserved upstream ORFs. Scanning ri-
bosomes initiate translation efficiently at both uORFs and ribosomes that
had translated uORF1 efficiently reinitiate translation at downstream AUGs.
In unstressed cells, low levels of eIF2α phosphorylation favor early capacita-
tion of such reinitiating ribosomes, directing them to the inhibitory uORF2,
which precludes subsequent translation of the ATF4 major ORF. In stressed
cells, high levels of eIF2α phosphorylation delays ribosome capacitation and
favors reinitiation at the major ATF4 ORF over the inhibitory uORF2 [265].
In the special case of sequence-specific uORFs, the peptide produced from
translation of a small uORF has regulatory effects (Fig. 6D and [3, 114, 243]).
1.6.3 Internal translation initiation: IRESs
In some instances, mRNAs utilize an alternative initiation mechanism of in-
ternal ribosome binding in which the 5′ UTR of the mRNA has an active
role in 40S subunit recruitment. The 5′ untranslated RNA segments respon-
sible for such internal initiation are known as internal ribosome entry sites
(IRESs).
The first IRESs were discovered after the analysis of the complete se-
quences of picornavirus RNAs (reviewed in [193]). The 5′ end of the pi-
cornavirus RNA genome is covalently linked to a small protein called VPg.
When a newly synthesized viral RNA is destined to engage in protein syn-
thesis, the VPg is removed to yield a viral mRNA with a 5′-terminal pU
residue, instead of a cap structure [311]. The initiation codon of the viral
mRNA is located several hundred nt downstream of the 5′ end, and the in-
tervening sequence may harbor multiple unused AUG codons and very stable
stem-loop structures, which would greatly decrease, if not completely abol-
ish, scanning of the ribosomal subunit. Nevertheless, such a 5′ UTR from
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the encephalomyocarditis virus (EMCV) was shown to very efficiently direct
translation of reporter genes in a rabbit reticulocyte lysate. Moreover, inser-
tion of the 5′ UTRs of the poliovirus or EMCV genome RNA between two ad-
jacent coding regions in a bicistronic mRNA construct enabled translation of
the downstream cistron independent of the upstream cistron [195, 194, 332].
These findings suggested that cap-independent translation of picornavirus
mRNA proceeds by a mechanism whereby ribosomes are recruited to mRNA
sequence elements that function as IRESs. Internal initiation was later con-
firmed by translation of a circular mRNA containing the EMCV IRES el-
ement [62], whereas it was shown that RNA circles lacking IRES elements
could not be translated [227, 224]. Viral IRES elements possess structures
that must be maintained, because small deletion, insertions and point muta-
tions within the IRES elements dramatically reduce their activities (reviewed
in [193, 192]). However, there are few similarities in sequence, size, or sec-
ondary structure among different viral IRES elements [96].
The minimum set of canonical initiation factors that are required to re-
cruit 40S subunits to the EMCV IRES has been identified. Factors eIF2,
eIF3, eIF4G, eIF4A, eIF4B, and Met-tRNAMeti were sufficient to recruit and
to position 43S complexes at the authentic start codon in an ATP-dependent
reaction [338, 336]. Other noncanonical translation factors—IRES trans-
acting factors (ITAFs)—have been implemented in internal translation initi-
ation via IRESs. The hepatitis C virus (HCV) IRES can bind directly to 40S
subunits and only requires eIF3 and the eIF2 ternary complex to properly
position the ribosome at the AUG start codon [337]. Following 40S recruit-
ment, a number of initiation factors such as eIF5 and eIF5B, as well as GTP
hydrolysis are required for 60S subunits to join and generate 80S ribosomes
(§ 1.3).
The cricket paralysis virus (CrPV) intergenic region (IGR) IRES mediates
translation initiation by a mechanism that is very distinct from the canonical
model of translation initiation and other IRES-mediated models. Remark-
ably, 80S ribosomes can assemble on the CrPV IGR IRES using purified 40S
and 60S subunits in the absence of initiation factors and GTP hydrolysis, all
of which indicate a novel pathway for 80S assembly [428].
Structural studies of HCV and CrPV IRESs in complex with the ribosome
support the idea that despite different sequences, structures, and host-factor
requirements, these IRESs stabilize the same conformational state of the 40S
ribosomal subunit [96].
EMCV infection leads to dephosphorylation of 4E-BP1, an eIF4E bind-
ing protein. In EMCV-infected cells, hypophosphorylated 4EBP1 binds to
eIF4E and prevents the interaction between eIF4E and the cap structure,
leading to inhibition of cap-dependent translation [139]. This selective in-
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hibition of cellular mRNA translation allows almost exclusive utilization of
the host’s translational resources for production of viral proteins and RNAs,
likely contributing to the rapid proliferation of picornaviruses [193].
Numerous RNA viruses and at least two DNA viruses as well as a va-
riety of cellular mRNAs have been shown to utilize IRES mechanisms for
translation initiation [193, 165, 223]. Among these are genes involved in cell
proliferation, differentiation, and cell death. It is noteworthy that these pro-
teins are biologically effective at rather small concentrations and thus do not
need to be expressed at high levels.
Global cap-dependent translation is subjected to transient inhibition un-
der specific physiological conditions, in keeping with cellular requirements
(§§ 1.4.1, 1.4.2). The induction of apoptosis is also associated with sub-
stantial inhibition of cap-dependent protein synthesis. A number of IRES-
containing mRNAs appear to be resistant to reduced levels of the eIF2
ternary complex during stress. It is thought that IRES-mediated transla-
tion provides a means for escaping the global decline in protein synthesis
and allows the selective translation of specific IRES-containing mRNAs be-
cause both apoptosis and survival as well as recovery from stress require de
novo protein synthesis [174].
It is not understood how the translation machinery binds internally to
cellular mRNAs. As with viral IRESs, there are no obvious primary struc-
ture similarities that define a consensus sequence. There is no convincing
evidence that high-ordered structures are significant or required for cellular
IRES function [104].
As with viral IRESs, additional proteins (beyond the canonical initiation
factors) are often required for optimal expression from cellular IRES ele-
ments. ITAFs may remodel IRES structures by stabilizing a conformation
that is active for ribosome recruitment, or may function as a bridge between
the RNA and the ribosomes. Examples include La, Unr, hnRNP-C1/C2,
and PTB (hnRNP I). At present, the observed effect of the putative ITAFs
on IRES activity is usually a 1.5- to 3-fold activation, suggesting that their
effect is not the major one [104].
The difficulty in characterizing cellular IRESs that confer very low ef-
ficiency of expression and the fact that eukaryotic cells produce no nat-
ural bicistronic mRNAs (other than those explicable by leaky scanning)
have contributed to scepticism about the credibility of many reported IRESs
[233, 235, 236]. Not a single cellular IRES has been rigorously tested em-
ploying the circular mRNA test which was used to confirm the function of
the viral IRES [62].
However, the discovery of IRES elements has led to important new in-
sights into the biology of viruses and regulation of translation initiation as
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an additional level of control of gene expression in response to physiological
and environmental signals. Protein synthesis from IRES-containing mRNAs
frequently occurs at times when there is a global reduction in cap-dependent
translation. The potential utility of cellular IRES-mediated translation as
an alternative way to modulate gene expression clearly warrants further in-
vestigation.
1.6.4 Translation initiation via PARS
Eukaryotic mRNAs containing polypurine (A)-rich sequence (PARS) or ho-
mopolymeric poly-(A) sequence preceding the initiation codon are known to
exhibit enhanced cap-independent translation, both in vivo and in vitro. An
example of this is provided by highly expressed poxvirus late mRNAs, which
carry an unusual modification. This consists of poly(A) sequences (30-40 nt
long, but sometimes shorter) placed at the 5′ ends of these mRNAs, immedi-
ately before the initiation AUG codon [37, 372, 330, 430]. In vivo translation
of poxvirus mRNAs with a poly(A) leader was shown to be at most weakly
dependent on the cap-binding complex eIF4F and may be cap-independent
[20, 298].
Direct in vitro experiments that used uncapped poly(A) sequences (5, 12,
and 25 nt long) as the 5′ UTR resulted in an efficient translation of such
mRNAs in an eukaryotic cell-free system [157]. A subsequent study has
shown that 48S preinitiation complex (PIC) formation at the cognate AUG
initiation codon on the mRNA with poly(A) leader does not require eIF3,
eIF4A, and eIF4F [379]. This fact implies that ATP-dependent unidirectional
scanning of a poly(A) leader is not strictly required for finding the correct
initiation codon. It is likely that the poly(A) leader sequence can effectively
bind preinitiation 40S ribosomal subunits at random internal sites within
the poly(A) sequence and may thus allow the particles to perform energy-
independent diffusional movement (“phaseless wandering”) along the 5′ UTR
until the particle is fixed at the initiation codon [379].
The 48S PIC formed in the absence of eIF3 and eIF4F can join the 60S
ribosomal subunit and form the 80S initiation complex. Moreover, such an
mRNA has been shown to outcompete a capped mRNA with a 5′ UTR
derived from the β-globin mRNA, in a direct competition assay [379].
The factors required for translation initiation on poxvirus poly(A) mRNA
leaders are analogous (and in some cases homologous) to prokaryotic IF1,
IF1A, and IF2. This implies that poxviruses use the most basic (most an-
cient) elements of translation initiation machinery that are present in both
prokaryotes and eukaryotes.
IRES-like polypurine (A)-rich sequences (PARSs) discovered in crucifer-
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infecting tobamovirus (crTMV) may represent another manifestation of the
same mechanism [94]. It was shown that the PARSs placed as an inter-
cistronic insert in a bicistronic mRNA exhibit a high frequency of initiation
at the second cistron in both in vivo and in vitro plant and animal trans-
lation systems. Remarkably, the activities of crTMV IRES-derived PARSs
appeared to be even somewhat higher than that of EMCV IRES in plant and
human cells [94].
Typical viral IRESs are characterized by relatively stable tertiary struc-
tures and represent compact modules that are capable of specifically binding
and positioning the preinitiation 40S ribosomal subunits on the mRNA [96].
The situation with poly(A) leaders or poly(A) internal inserts seem to be
quite different: these have no fixed tertiary structure and do not position the
ribosomal particle at a strictly determined site in the mRNA. It would be
therefore appropriate to consider such enhancers of cap-independent initia-
tion of translation as a special case [379].
Recently it has also been reported that a “minimal” 60 nt IRES that
contains an internal poly(A) tract preceding the AUG initiation codon allows
a cap-independent translation of mRNAs that are required for starvation-
induced differentiation in yeast [138]. This activity requires specific binding
of Pab1 (the yeast ortholog of PABP) to the 5′ UTR and the presence of
eIF4G [138].
It is possible that the mechanism of the 48S initiation complex formation
in the case of an internal poly(A) tract is different from that of a poly(A)
leader. Another possibility that was proposed by Shirokikh and Spirin in
[379] is that Pab1 and eIF4G are required at later stages of cap-independent
translation of mRNAs than is required for the invasive growth in yeast. Such
a late eIF4F/eIF4G-dependent stage was suggested by a study of the trans-
lation acceleration effect during translation of uncapped mRNAs and may
result from a noncovalent circularization of polysomes in the course of their
formation[4].
1.6.5 Proteins targeted to the 5′ UTR
Iron-response proteins Ferritin is the major iron-binding protein whose
function is to sequester excess intracellular iron, thereby protecting cells from
the generation of reactive oxygen and nitrogen free radicals which can damage
DNA. Translation of ferritin heavy- and light-chain mRNAs is turned on and
off by the iron-response proteins (IRP1 and IRP2). Under conditions of low
iron, IRP binds a combined sequence/structure motif (iron-response element,
IRE) near the 5′ end of the mRNA (Fig. 7A). Binding of IRP does not affect
the association of the cap-binding complex eIF4F to the mRNA but blocks
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entry of the 43S ribosomal subunit [297]. The repression is relieved when
the IRE is moved away from the cap-proximal position, suggesting that the
IRE/IRP complex sterically prevents 43S binding [145].
In addition to controlling translation of ferritin, the IRE/IRP mechanism
regulates other genes involved in iron uptake and utilization. In the case of
ferroportin, the IRE is near the 5′ end of the mRNA and regulation is at the
level of translation. In the case of the transferrin receptor, the IRE is in the
3′ UTR and regulation is at the level of mRNA stability [166].
This steric hindrance mechanism is simple and efficient, and it is not only
specific to IRP. It has been shown that other RNA-binding proteins with no
role in translational control can repress translation when bound to structures
located within ca. 40 nt of the cap [398]. It seems surprising that there are
not more such examples similar to the IRE/IRP interaction in translational
control.
1.6.6 Proteins targeted to the 3′ UTR
The binding sites for many regulatory proteins are located in the target
transcript’s 3′ UTR. Thus any proposed mechanism must explain how a
protein bound to the 3′ end of a mRNA is able to interact with the translation
machinery. The idea that interaction between 5′- and 3′-bound proteins
might circularize an mRNA (closed-loop model) can be helpful in explaining
repression of translation. Inability to translate an mRNA circularized via
a protein bridge (wherein one of the proteins is bound very close to the
cap) would be expected from the earlier demonstration that 40S ribosomal
subunits cannot bind to mRNAs circularized enzymatically by RNA ligase
[227]. Alternatively, a protein bound to the 3′ UTR of a circularized mRNA
may interact with translation initiation factors bound to the 5′-end and make
them unaccessible for their partners.
CPEB and Maskin Many translationally dormant maternal mRNAs be-
come cytoplasmically polyadenylated and translationally activated during
oocyte maturation and early embryonic development in Xenopus. These
mRNAs share the presence of a cis-acting regulatory motif in their 3′ UTR
called the cytoplasmic polyadenylation element (CPE), with the consensus
sequence UUUUUAU. The CPE is the binding platform for CPE-binding pro-
tein (CPEB), which mediates repression of the translation of CPE-containing
mRNAs prior to maturation. CPEB is an RRM- and zinc-finger-containing
sequence-specific RNA-binding protein that is found in a wide range of ver-
tebrates and invertebrates [352]. By virtue of its recognition of CPE, CPEB
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Figure 7. Inhibition of translation initiation by 5′- and 3′-UTR-binding proteins.
(A) IRP binds to IRE, a 5′-proximal stem loop in the 5′ UTR of ferritin mRNA, and
sterically blocks the association of 43S PIC to eIF4F. (B) The CPEB/Maskin complex
binds to the cis-regulatory cytoplasmic polyadenylation element (CPE) in the 3′ UTR of
cyclin B1 mRNA and competitively inhibits the interaction of eIF4G with eIF4E. (C)
Bicoid binds to the Bicoid-binding region (BBR) in the 3′ UTR of caudal mRNA and
recruits the cap-binding d4EHP which blocks the association of eIF4F to the 5′ cap.
is indirectly responsible for both translational repression and translational
activation by polyadenylation.
CPEB was found to be associated with Maskin [396]. Maskin also binds
eIF4E in the region normally occupied by eIF4G. Thus, Maskin competes
with eIF4G for binding to eIF4E and this can inhibit translation by prevent-
ing the formation of the cap-binding complex [396, 52], although this has not
yet been shown directly (Fig. 7B).
While the poly(A) tail is short, Maskin remains associated with both
CPEB and eIF4E. Upon the induction of oocyte maturation, the kinase Au-
rora A phosphorylates CPEB which stimulates poly(A) tail elongation. The
elongated poly(A) tail recruits PABP. PABP, in turn, binds eIF4G and helps
it to displace Maskin from eIF4E, the result of which is translation initiation
[352].
Although CPEB and Maskin are the key factors for the repression of
maternal mRNA in late Xenopus oocytes, another mechanism must exist,
since Maskin is absent earlier in oogenesis. It was found that in the early
Xenopus oocyte, CPEB functions in a very large RNP complex with Xp54
(Me31B/DDX6), PAT1, RAP55B (CAR-1/Tral), FRGY2 (Yps/YB-1), 4E-
T, and eIF4E1b, an ovary-specific eIF4E which binds the cap weakly [288]. It
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was proposed that the repression of CPE mRNAs in Xenopus oocytes by the
CPEB complex may rely upon the combination of conserved P body compo-
nents, including Xp54 and 4E-T, alongside a weak cap-binding eIF4E1b pro-
tein, which can act as a co-repressor when tethered to the 3′ UTR [288, 392].
CPEs within the 3′ UTR appear to link mRNA translational control and
localization through their interaction with CPEB. In neurons, inserting the
CPE into an unlocalized message is sufficient to cause the message and CPEB
to be transported into dendrites. Overexpression of a truncated CPEB that
only contains the RNA-binding domains dominantly interferes with the trans-
port of endogenous messages into dendrites. GFP-tagged CPEB forms parti-
cles containing RNA and motor proteins that exhibit microtubule-dependent
transport in cultured hippocampal neurons [176]. These particles also contain
Maskin, suggesting that CPEB and Maskin can both participate in maintain-
ing localized mRNAs in a translationally quiescent state during transport and
in microtubule association of transport particles containing these mRNAs
[176]. It is likely that the large CPEB-containing RNP particles identified in
Xenopus oocytes [288] represent translationally repressed mRNPs similar to
transport mRNPs that are found in neurons [24].
Bicoid Anterior-posterior pattern formation in the Drosophila embryo dur-
ing development is dependent on the localization and translation of bicoid
and oskar mRNAs. bicoid mRNA is localized at the anterior pole and trans-
lated after fertilization to produce a morphogen gradient that patterns the
anterior part of the embryo [354]. Bicoid is a homeodomain transcription
factor which, in addition to its function in transcription, binds the region in
the 3′ UTR of caudal mRNA termed the Bicoid-binding region (BBR, 120
nt long) and inhibits its translation [100, 355]. Bicoid contains an eIF4E-
binding motif which overlaps with the site for binding the Drosophila eIF4E-
homologous protein (d4EHP). 4EHP is evolutionarily conserved in metazoans
and plants. The amino acid residues of eIF4E which are implicated in its
binding to the cap structure are mostly conserved in d4EHP. While 4EHP
has 5′-cap-structure-binding activity, it does not interact with eIF4G, sug-
gesting that it could function as a negative regulator of translation since it
cannot function in ribosome recruitment. d4EHP interacts with both Bicoid
and the caudal mRNA 5′ cap structure, while Bicoid binds to BBR in its
3′ UTR. This set of interactions is required for efficient translational repres-
sion of caudal mRNA by preventing the association of eIF4F to the 5′ cap
structure (Fig. 7C, [66]).
It has been shown that d4EHP also inhibits hunchback mRNA translation
by interacting simultaneously with the mRNA 5′ cap structure and Brat
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(Fig. 7D, [65]). Brat is a component of the NRE complex which includes
Pumilio and Nanos proteins and binds the Nanos-responsive element (NRE)
in the 3′ UTR of hunchback mRNA [386].
hnRNP K and E1 Erythroid 15-lipoxygenase (LOX) is a key enzyme
which degrades mitochondrial membranes during the late stages of reticulo-
cyte maturation to erythrocytes. LOX protein appears to be produced only
in late-stage reticulocytes, although LOX mRNA is transcribed as the most
abundant message after globin mRNAs in bone marrow erythroid precursor
cells [401]. LOX mRNA translation must thus be temporally restricted. The
3′ UTR of LOX mRNA contains a CU-rich, repetitive sequence motif termed
the differentiation control element (DICE), which has been shown to mediate
this translational silencing [324]. The KH-domain proteins hnRNP K and E1
bind the DICE in the 3′ UTR which leads to translational repression at the
level of initiation [323].
This translational repression is independent of the poly(A) tail and can
control cap-dependent translation as well as translation mediated by the
EMCV or classical swine fever virus (CSFV) IRES elements, indicating that
repression is also independent of the cap structure [323, 322]. Translation ini-
tiation via the intergenic region IRES of the CrPV, which solely requires 40S
and 60S ribosomal subunits without any eIFs [428], is shown to bypass the
silencing mechanism [322]. Sucrose gradient and toeprint analyzes of trans-
lation initiation complexes revealed that during the hnRNP-K/E1-mediated
translational repression, the AUG codon is reached by the 43S preinitiation
complex but 80S complex formation is inhibited [322]. Thus, recruitment of
the 60S subunit is blocked during LOX mRNA translational silencing (Fig. 8)
which makes this mechanism different to the other known mechanisms de-
scribed above. hnRNP K also binds to the c-Src mRNA 3′ UTR element
Src3 and inhibits c-Src mRNA translation by blocking 80S ribosome forma-
tion [301].
1.7 Selective control: complex mechanisms
Recent studies on selective mechanisms of translational control mediated
by mRNA-binding proteins have demonstrated that many of them regulate
translation by using more than one mechanism. This ensures the tight trans-
lational control and correct localization of maternal mRNAs that encode
morphogens establishing the spatial axes of the embryo. Ectopic expression
of such proteins leads to severe developmental defects, so multiple trans-
lational control mechanisms and RNA localization must cooperate in their
deployment.
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Figure 8. Inhibition of 60S subunit joining by hnRNP K and E.
hnRNPs K and E1 bind to the differentiation control element (DICE) in the 3′ UTR of
LOX mRNA and block translation initiation at the step of 60S subunit joining to the 48S
preinitiation complex. The same mechanism regulates translation of c-Src mRNA.
Bruno and regulation of oskar translation During oogenesis in Droso-
phila, Oskar protein is selectively deployed at the posterior of the oocyte,
where it directs polar granule assembly and is responsible for posterior body
patterning and germ cell formation [200]. oskar mRNA is synthesized in
the nurse cells and, throughout early oogenesis, becomes concentrated in the
oocyte. During early oogenesis (stages 1-6), the mRNA first appears at the
posterior of the oocyte, where the minus ends of the microtubule array are
concentrated. At stages 7-8, the microtubules reorganize so that the ma-
jority of the minus ends become concentrated at the anterior of the oocyte.
Tracking the minus ends of the microtubules, oskar mRNA transiently lo-
calizes to the anterior of the oocyte during these stages. Finally, at stages
9-10, oskar mRNA is transported back to the posterior pole in a plus-end
directed manner, where it is translated [198]. Localization of oskar mRNA
is tightly coupled to translational control. Since factors that are involved in
localization may also affect translation indirectly, oskar mRNA appears to
be subject to multiple forms of repression [426].
Prior to its localization at the posterior pole, translation of oskar mRNA
is repressed by the RNA-binding protein Bruno, which was identified by its
ability to bind directly to the oskar 3′ UTR [218, 418, 304]. Repression
of Oskar synthesis by Bruno involves its binding to Bruno response elements
(BREs), which are repeat sequences clustering within two regions of the oskar
3′ UTR: one close to the coding sequence and one close to the poly(A) tail.
Mutation of the BREs in the oskar 3′ UTR results in precocious translation
of oskar mRNA, but does not interfere with its localization, suggesting that
Bruno regulates oskar mRNA translation directly [218]. Bruno contains three
copies of the RNA recognition motif (RRM). Either of two nonoverlapping
Selective control: complex mechanisms 30
parts of Bruno—RRMs 1 and 2 and RRM 3 plus 42 flanking amino acids—
can bind specifically to BRE-containing RNA, but both domains are required
for maximal binding [384].
Bruno accumulates in the oocyte and colocalizes with oskar mRNA. It
has been demonstrated that Bruno shuttles between the nucleus and cyto-
plasm, and may first bind oskar mRNA in the nucleus [384]. A role for
Bruno in Oskar regulation in vivo was demonstrated through the use of a
transgene, which encodes a form of oskar mRNA that retains BRE sequences
but is mislocalized to the anterior of the oocyte [418]. Ectopic translation of
oskar mRNA from this transgene leads to embryonic head defects, and this
phenotype is enhanced in the Bruno heterozygous flies [418]. Experiments in
Drosophila cell-free translation systems have demonstrated the direct role of
Bruno in oskar mRNA translational repression [254, 55].
Bruno has been proposed to inhibit initiation of translation via two routes
(Fig. 9): an interaction with the Cup protein (cap-dependent, [425, 304])
and sequestration of oskar mRNA in silencing particles (cap- and Cup-
independent, [61]).
Sucrose gradient analysis has demonstrated that the BRE/Bruno re-
pression mechanism inhibits 43S preinitiation complex recruitment to oskar
mRNA [61]. Consistent with this result, it has been shown that Bruno binds
the protein Cup which, in turn, binds the 5′-cap-binding eIF4E through a se-
quence conserved among eIF4E binding proteins. Cup competes with eIF4G
for eIF4E binding and therefore prevents cap-binding complex assembly and
43S recruitment to oskar mRNA [425, 446, 304].
The second BRE/Bruno-dependent silencing mechanism involves oskar
mRNA oligomerization and formation of large (50S-80S) silencing particles
that cannot be accessed by ribosomes [61]. Such a repression mechanism sug-
gests a mode of mRNA translational control that seems particularly suited
to coupling of translational repression with mRNA transport within the cell.
The particles could in principle contain other mRNAs regulated and assem-
bled into mRNPs by common components [61].
Interestingly, mutations in armitage, aubergine, spindle-E, andmaelstrom,
which encode proteins with a proposed function in the RNAi pathway, cause
precocious accumulation of Oskar protein in the early oocyte [76]. The Ar-
mitage protein is a putative RNA helicase with a direct role in the RNAi
pathway [404]. Aubergine is a member of the Argonaute family of proteins
which are the key components of the RNA-mediated silencing machinery
in many organisms [180]. Spindle-E encodes a putative DEAD/DEAH-box
RAN helicase. Both Aubergine and Spindle-E are required for RNAi in the
early embryo, as well as for silencing of Ste genes by Su(Ste) repeats through a
mechanism thought to involve repeat-associated siRNAs (rasiRNAs) [14, 13].
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Figure 9. Bruno-mediated translational repression of oskar mRNA.
Bruno binds the BREs in the oskar 3′ UTR and recruits Cup to inhibit eIF4G binding
to eIF4E, which prevents preinitiation complex formation. In addition, Bruno promotes
the oligomerization of oskar mRNAs through the BRE, which possibly renders the mRNA
inaccessible to the translation machinery.
Spindle-E is also implemented in rasiRNA-dependent chromatin silencing of
retrotransposons in the Drosophila germline [220]. Maelstrom is required for
normal localization of the RNAi factors Dicer and AGO2 [120]. Armitage,
Aubergine, Spindle-E, and Maelstrom all localize to nuage and are required
for rasiRNA production as well as silencing of long interspersed nuclear ele-
ments (LINEs) [255].
Intriguingly, all of these mutants in the RNAi pathway display prema-
ture translation of oskar mRNA before such defects are usually seen in cup
mutants. This suggests that RNAi-mediated repression may predominate
early in oogenesis, while Cup-mediated repression acts later [426]. However,
the defects in oskar mRNA localization and translation may result from the
cytoskeletal defects associated with these mutations [76] or more general de-
fects caused by derepression of genomic repeats and mobile elements. The
cytoskeletal and rasiRNA-mediated silencing defects in these mutants under-
score the complexity of their phenotypes and raises the possibility that the
defects in oskar mRNA translation are not direct. Proof that oskar mRNA
translation is directly regulated by an RNA-silencing mechanism would be
achieved by identification of the cis-acting elements within the oskar mRNA
that are required for RNA-mediated repression and the small RNA(s) that
recognize these elements [426].
Transport of oskar mRNA to the posterior of the oocyte requires many
proteins including the exon junction complex (EJC) components Mago, Y14,
and eIF4AIII, suggesting that during splicing the EJC is positioned so that
it can initiate the assembly of a transport mRNP prior to nuclear export
[309, 159, 292, 327]. In the cytoplasm, additional proteins are recruited to
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the oskar mRNP. Barentsz is recruited through an interaction with eIF4AIII
and Cup, and is the only protein apparently functioning solely for posterior
transport of oskar mRNA [407, 425, 327]. A number of factors, such as
Staufen [199, 360, 287], Vasa [45, 273], Apontic [254], Bicaudal C [268, 365],
Squid [312], Hrp48 [436, 183], YPS [272], and Me31B [303], have been shown
to be required for efficient translational control of oskar mRNA in vivo, but
their mode of action remains unclear.
The dsRNA-binding protein Staufen plays a distinct role, being required
not only for transport, but also for anchoring and translation of oskar at
the posterior end [199, 360, 287]. Similarly to Bruno, Hrp48 and Squid
interact with the oskar 3′ UTR. The mutations in hrp48 and squid cause
defects in oskar mRNA localization and ectopic production of Oskar protein
[436, 183, 312]. Me31B has been purified as part of a large mRNP complex
that contains EXU, YPS, Cup, eIF4E, Bruno, and oskar mRNA, indicating
that it acts in translational repression of oskar mRNA [303, 61].
A long poly(A) tail is required for efficient oskar translation, both in
vivo and in vitro, but is not sufficient to overcome BRE-mediated repression.
Moreover, accumulation of Oskar activity requires Orb, the Drosophila ho-
molog of CPEB [54]. Orb-mediated cytoplasmic polyadenylation stimulates
oskar translation to achieve the high levels of Oskar protein necessary for
posterior patterning and germline differentiation [54].
Smaug and nanos translation Drosophila Nanos is a posterior deter-
minant and translational repressor whose primary function is to regulate
translation of maternal hunchback mRNA (§ 1.6.6). Once Oskar protein
accumulates in the oocyte, it recruits maternal nanos mRNA to the poste-
rior by trapping and anchoring nanos mRNA that is diffusing throughout the
oocyte [414, 128, 413]. This mechanism is inefficient and only a small fraction
of the transcripts is localized to the posterior, where it is translated during
late oogenesis and embryogenesis. The remaining 96% of nanos mRNA is
found distributed throughout the bulk of the embryo [35, 129]. Unlocalized
transcripts are translationally repressed and degraded [82, 130, 383].
Repression of nanos mRNA translation is mediated by cis-acting stem-
loop translational control elements (TCEs) in the transcript’s 3′ UTR. TCE
is a bipartite RNA element: one stem-loop appears to represent the binding
site for an as yet unidentified translational repressor and is required for trans-
lational repression during late oogenesis [79, 122]. The other two stem-loops
which harbor a CUGGC motif are bound by the sequence-specific RNA-binding
protein Smaug, which functions as a translational repressor; such a stem-loop
is therefore termed the Smaug recognition element (SRE) [81, 82, 383, 382].
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Figure 10. Smaug-mediated translational repression of nanos mRNA.
Smaug binds the SRE in the nanos 3′ UTR and recruits the 4EBP Cup. Cup binds eIF4E
through the conserved sequence that is also found in eIF4G. As a consequence, eIF4G
is precluded from the 5′ end, and the preinitiation complex can not form. Smaug also
recruits the CCR4-CAF1-NOT deadenylase complex to the mRNA to promote shortening
of the poly(A) tail. These two mechanisms lead to an inhibition of translation. The grey
dashed arrow corresponds to an activating signal, the red blunted line correspond to an
inhibitory signal.
Smaug is conserved from yeast to humans and interacts with the SRE via
a sterile αmotif (SAM) domain, which is normally involved in protein-protein
interactions [19, 146, 147]. The eIF4E-binding protein Cup was identified
biochemically as a protein that interacts with the SAM domain of Smaug
[307]. Similarly to the role of Cup and Bruno in oskar mRNA translational
control (§ 1.7), it appears that the Smaug-Cup-eIF4E complex blocks the
interaction between eIF4E and eIF4G, as well as preventing eIF4F complex
formation at the 5′ cap and 43S PIC recruitment to nanos mRNA [307].
However, translationally repressed nanos mRNA is also associated with
polysomes [70]. One possible explanation for this apparent contradiction is
that Nanos synthesis is repressed by at least two trans-acting factors that
interact with the nanos 3′ UTR [79, 122]. In keeping with this model, nanos
mRNA is translated in the nurse cells and after it has been transported
to the oocyte, is first repressed by an unidentified factor in a Smaug-Cup-
eIF4E-independent way. This factor bound to the TCE may degrade or
destabilize the nascent/released polypeptide chain or block translation at
the step after initiation (elongation or termination) [70]. During the first
hours of embryogenesis, translational repression becomes Smaug-Cup-eIF4E-
dependent [81, 383], but the ribosomes may still remain bound to the mRNA
after an initiation block.
It has been shown that Smaug in embryos recruits the CCR4-CAF1-NOT
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deadenylation complex to the nanos mRNA, which results in shortening of
the poly(A) tail and translational repression [442]. Interestingly, it was found
that Oskar prevents Smaug binding the mRNA, and as a result promotes
translation of nanos mRNA in the posterior of the embryo. CCR4-CAF1-
NOT-dependent deadenylation was shown to be important for both degrada-
tion and translational repression of nanos mRNA in the bulk of the embryo
[442]. Thus it appears that Smaug represses nanos mRNA translation by an
additional Cup-independent mechanism which relies on recruitment of the
deadenylation complex to shorten the poly(A) tail.
SXL and msl-2 translation Dosage compensation is the process which
ensures that equal amounts of X-chromosome-linked gene products are ex-
pressed in males that carry one X chromosome and females that carry two
[274]. In Drosophila, dosage compensation is achieved by increasing the tran-
scriptional output of the X chromosome in males but not in females. Tran-
scriptional activation is mediated by the male-specific lethal (MSL) RNP
complex. The MSL complex does not assemble in female flies mainly because
they lack one component protein, male-specific lethal-2 (MSL-2). Transla-
tion of msl-2 mRNA in female flies is repressed by the female-specific RNA-
binding protein sex-lethal (SXL), containing two RNA recognition motifs
which also regulate sex determination (reviewed in [333]). SXL acts as both
an alternative splicing regulator to control sex determination and a transla-
tional repressor to control dosage compensation. It inhibits msl-2 expression
by first promoting the retention of a facultative intron in the 5′ UTR of msl-2
mRNA and then repressing its translation [27, 212, 134]. It has been demon-
strated that the only function of the retained intron is to provide the binding
sites for the SXL protein in the 5′ UTR. SXL binds to poly(U) stretches
present in the 5′ and 3′ UTRs of msl-2 mRNA. In contrast to most other
translational regulators, which act from either the 3′ or the 5′ UTR, efficient
inhibition of translation requires SXL binding to both UTRs [27, 212, 134].
Sucrose density gradient analysis and toeprint assays revealed that SXL
functions via a dual “failsafe” mechanism: SXL bound to the 3′ UTR of
msl-2 mRNA interferes with the initial recruitment of the 43S preinitiation
complex to the mRNA, while 5′ UTR-bound SXL stalls any residual scanning
43S complexes that have escaped the first inhibitory mechanism [29].
Scanning inhibition by SXL bound to the 5′ UTR does not seems to
operate by a simple steric hindrance mechanism, because mSXL, the Musca
domestica ortholog of Drosophila SLX, binds to the 5′ UTR of msl-2 mRNA
with the same affinity but does not inhibit translation [156, 29]. It is possible
that 5′ UTR-bound SXL interferes with the function of a factor required
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Figure 11. SXL-mediated translational control of msl-2 mRNA
SXL binds to uridine stretches in the 5′ and 3′ UTR of msl-2 mRNA. 3′ UTR-bound SXL
recruits UNR and probably other proteins to inhibit the initial recruitment of the 43S
preinitiation complex to the 5′ end of msl-2 mRNA. SXL bound to the 5′ UTR inhibits
the scanning of those 43S complexes that may have escaped the 3′-mediated inhibition.
Red blunted lines correspond to inhibitory signals.
for scanning, or forms a high-order complex of SXL molecules, perhaps in
conjunction with other proteins that block 43S PIC transit.
SXL-mediated inhibition of translation initiation is independent of the
cap structure, implying that the 43S complex recruitment block imposed
by SXL is different from that mediated by Maskin, Cup, or d4EHP, where
repression is achieved by blocking the formation of the cap-binding eIF4F
complex on the target mRNA [133]. SXL bound to the 3′ UTR requires the
RNA-binding protein upstream of N-ras (UNR) as a corepressor to efficiently
block msl-2 mRNA translation [156, 1, 101]. Interestingly, UNR protein is
expressed at similar levels in both male and female cells in culture and in
flies, but only interacts with msl-2 mRNA to modulate its translation when
SXL is present [101]. Presumably the SXL-UNR corepressor complex di-
rectly interacts with factors that affect small ribosomal subunit recruitment,
or may do so through additional bridging factors as part of a larger “core-
pressor assembly”. A candidate factor is Drosophila PABP, since mammalian
PABP interacts with UNR [59]. Although msl-2 mRNA translational inhi-
bition does not require a poly(A) tail [132], PABP appears to have a critical
function in initiation that is independent of the poly(A) tail [204], raising
the possibility that UNR might interfere with PABP-mediated recruitment
of the 43S complex to msl-2 mRNA [101].
Additional factors that specifically co-purify with the repressed mRNP
have been identified biochemically [101]. These include several known compo-
nents of translationally quiescent mRNPs: DEAD-box RNA helicases Me31B
and Rm62, YPS, dFMR1, and Rasputin (a Drosophila homolog of G3BP2,
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an RNA-binding protein). 3′ UTR-mediated translational inhibition by SXL-
UNR involves the accumulation of the repressed mRNA within unusually
heavy RNP particles, although no RNA oligomerization activity has been
detected, in contrast to Bruno-mediated oskar mRNA repression [29, 61].
Additional studies will be required to elucidate the mechanism by which SXL
and UNR bound at the 3′ end of msl-2 mRNA block translation initiation
at the 5′ end.
PUF domain proteins Drosophila Pumilio and C. elegans FBF (fem-3
binding factor) proteins are founder members of the evolutionary conserved
family of RNA-binding proteins known as the PUF family [388, 422]. PUF
proteins are typically characterized by a C-terminal RNA-binding domain,
known as the Pumilio homology domain (PUM-HD), composed of eight tan-
dem imperfect repeats, each of approximately 40 amino acids, flanked by
conserved N- and C-terminal regions [447, 445, 25]. The crystal structures of
the PUM-HD domains have revealed that the repeats are aligned in tandem
to form an extended curved crescent-like molecule [417, 103]. The crescent
provides two extended surfaces: one contacts RNA, and the other proteins.
The RNA binds to the concave surface of the domain in a sequence-specific
manner [388, 422]. Each of the eight repeats makes contact with a different
RNA base via stacking and backbone interactions provided by three aro-
matic and basic amino acid residues positioned in the middle of the repeat
[417, 103, 158].
PUF proteins bind specific sequence elements present in the 3′ UTR of
target mRNAs to control mRNAs’ translation and stability. Analysis of
many mRNAs associated with PUF proteins in different species has led to a
consensus eight-nucleotide sequence UGUANAUA which is recognized by PUF
proteins [135, 126, 294].
In Drosophila, Pumilio and Nanos are required for proper posterior seg-
mentation and abdomen formation of the embryo and are necessary for estab-
lishment of the posterior-anterior gradient of the transcription factor Hunch-
back [173, 187, 399]. Pumilio binds to the Nanos responsive element (NRE)
within the 3′ UTR of maternal hunchback mRNA and causes a translational
arrest [300, 429, 385]. Pumilio and Nanos are involved in the translational
control of maternal cyclin B mRNA in Drosophila [16, 202, 408]. In Xeno-
pus oocytes, Pumilio overexpression inhibits cyclin B1 mRNA translation
and anti-Pumilio antibody injection induces it. In addition to interacting
with CPEB, Pumilio also has binding sites of its own in the cyclin B1 3′
UTR, which contribute to the translational repression [302].
Recent studies on yeast and Drosophila have provided a general frame-
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Figure 12. PUF-protein-mediated translational control mechanisms.
(A) Direct interaction between the Pop2/CAF1 deadenylase and a PUF domain protein
(here, budding yeast Mpt5) recruits the CCR4-Pop2-NOT deadenylase complex to the
3′ UTR of HO mRNA. Pop2-promoted deadenylation prevents the binding of PABP,
thereby repressing translation of the mRNA. Mpt5 also recruits the complex containing
Dhh1/Me31B and Dcp1 which can cause decapping, translational repression or both. (B)
In Drosophila, the ternary NRE complex comprised of Nanos (Nos), Pumilio (Pum), and
Brain tumor (Brat) assembles on the Nos-responsive element (NRE) in the 3′ UTR of
hunchback mRNA and recruits d4EHP which blocks the eIF4F/5′-cap interaction. In
addition, the NRE complex can recruit the CCR4-CAF1-NOT deadenylase complex. Red
blunted lines correspond to inhibitory signals.
work for understanding how PUF proteins control mRNA translation and
stability [142, 143, 202, 421]. Pumilio nucleates formation of the complex
by recognizing the NRE in the 3′ UTR of hunchback mRNA and recruiting
Nanos [385]. The subsequent recruitment of Brain tumor to the Pumilio-
NRE-Nanos complex [386] results in translational inhibition via poly(A)-
dependent and poly(A)-independent mechanisms [58]. The yeast PUF pro-
tein Mpt5 interacts directly with Pop2p/CAF1 and recruits the deadenylase
complex. Moreover, PUF-Pop2 interaction is conserved in C. elegans and
humans [142, 143]. In Drosophila, Nanos has been shown to interact directly
with the NOT4 subunit of the CCR4-CAF1-NOT deadenylase complex [202].
These results suggest that a quaternary NRE complex consisting of Pumilio,
Nanos, Brain tumor, and hunchback mRNA may recruit the CCR4-CAF1-
NOT deadenylase complex and promote deadenylation of hunchback mRNA.
Brain tumor can also interacts with d4EHP and inhibit translation initiation
via a cap-dependent mechanism (§ 1.6.6, [65]).
Interestingly, it has been found that yeast PUF protein Mpt5 is physically
associated with the decapping enzyme subunit Dcp1 and the DEAD-box
RNA helicase Dhh1, which is the yeast ortholog of Me31B/RCK [142]. Dcp1
and Dhh1 are protein components of P bodies and other repressed mRNPs,
which are conserved from yeast to humans [109, 8]. In the C. elegans germ
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line, repressed maternal mRNAs and PUF proteins localize to P-body-like
mRNP granules together with DCAP-1/Dcp1, DCAP-2/Dcp2, CAR-1/Tral,
and CGH-1/Me31B [310]. Human Pum1 has been shown to be localized
in stress granules after arsenite treatment [294]. These findings suggest that
translational control mediated by PUF domain proteins may cause movement
of the repressed mRNPs to specific cytoplasmic RNA granules such as P
bodies, stress granules, or “germ line RNP granules related to P bodies (grP
bodies)” [310].
Fragile X mental retardation protein FMRP is an RNA binding pro-
tein highly expressed in the brain. Absence or mutation of FMRP leads
to Fragile X syndrome, an X-chromosome-linked dominant disorder and the
most frequent cause of inherited mental retardation [23]. FMRP belongs
to a family of heterogeneous nuclear ribonucleoproteins (hnRNPs) that are
involved in many aspects of mRNA metabolism and biology. The protein
contains several RNA binding domains including two KH motifs and one
RGG box. As expected from this domain structure, FMRP binds RNA ho-
mopolymers and mRNAs in vitro [18, 380]. In vivo, FMRP forms part of
a large mRNP complex that is involved in the transport and translation of
mRNA in neurons [23].
Most isoforms of FMRP contain both a functional nuclear localization
signal (NLS) and a nuclear export signal (NES), which indicates that it can
shuttle between the nucleus and the cytoplasm [102, 381]. In the nucleus,
one role of FMRP could be to associate with mRNAs and escort them out
of the nucleus.
The majority of cytoplasmic FMRP is associated with polysomes through-
out the length of the neurons, including dendritic spines [10, 117]. Micro-
tubule-associated FMRP is predominantly retained in translationally dor-
mant mRNP complexes. FMRP may shuttle between the mRNPs and poly-
somes depending on the translational state of the cell [415]. Consistent with
these results, FMRP relocates out of polysomes and into stress granules sub-
sequent to oxidative stress or heat shock [282, 216]. FMRP is also found
in transport mRNP granules, which travel in dendrites on microtubules and
are thought to be translationally arrested complexes of ribosomes, RNA-
binding proteins and RNAs [11, 206, 260, 24]. According to the current
model, FMRP regulates transport efficacy by regulating the association be-
tween mRNA cargo and microtubules. It acts as a molecular adaptor to
bind mRNA targets and suppress their translation during kinesin-mediated
transport to synaptic sites [89, 108].
The mechanisms which FMRP uses to regulate translation are not clear.
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The fact that FMRP has been found to co-sediment with actively translating
polysomes and with free mRNPs has complicated the issue. Several obser-
vations suggest that FMRP regulation might involve miRNAs. Drosophila
FMRP has been characterized as a component of the RISC (RNA-induced
silencing complex) [188, 56], and shown to interact with Rm62, the DEAD-
box helicase present both in the RISC and in the Microprocessor complex
involved in pre-miRNA processing [188, 149, 124]. Mammalian FMRP has
been shown to interact with mammalian AGO2 and miRNAs [197]. Both
FMRP and miRNAs are associated with polysomes [215, 308, 313, 340, 275].
Another small non-protein-coding RNA called BC1, unrelated to miRNAs
or other components of the RNAi pathway, was proposed to be involved
with FMRP-controlled translation. In this model, it has been proposed that
BC1 RNA that localizes to synaptodendritic domains operates as a requisite
adaptor by specifically binding to both FMRP and, via direct base-pairing, to
FMRP target mRNAs. The FMRP RNP is thereby brought into the vicinity
of the initiation codon and blocks the translation [444].
In contrast to these results, interactions of BC1 RNA with the FMRP
could not be documented by Wang et. al [416]. It has been shown that BC1
RNA inhibits a rate-limiting step in the assembly of the translation initiation
complex. A translational repression element is contained within the unique
3′ domain of BC1 RNA. Interactions of this domain with eIF4A and PABP
mediate repression, indicating that the 3′ BC1 domain targets a functional
interaction between these factors [416, 225]. Moreover, it was found that BC1
RNA specifically blocks the RNA duplex-unwinding activity of eIF4A but, at
the same time, stimulates its ATPase activity [257]. Thus, it is thought that
BC1 RNA acts as a general inhibitor of translation which directly interacts
with translation initiation factors, rather than an mRNA-specific inhibitor
as suggested by Zalfa et. al [444].
Recently, in a study conducted independently, five laboratories have re-
examined the issue of FMRP-BC1 -mRNA interactions in vivo and in vitro
[184]. They have reported that specific BC1 -FMRP interactions could be
documented neither in vitro nor in vivo. Significantly, the association of
FMRP with bona fide target mRNAs was independent of the presence of
BC1 RNA in vivo. The authors conclude that BC1 RNA is not required as
an adaptor to link previously reported target mRNAs to FMRP [184].
Although most investigators in the fragile X field agree that one func-
tion of FMRP is to repress translation, the exact mechanisms by which
it does so have not been elucidated. One possible mechanism of trans-
lation initiation inhibition has been proposed recently [305]. It has been
shown that FMRP-mediated repression of translation requires an interac-
tion with the cytoplasmic FMRP-interacting protein CYFIP1/Sra-1, which
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also binds the cap-binding factor eIF4E. The eIF4E-interacting domain of
CYFIP1 forms the characteristic “reverse L shaped” structure that is also
assumed by the canonical eIF4E-binding motif. CYFIP1 forms a complex
with specific FMRP-target mRNAs and blocks eIF4F assembly, interfering
with the eIF4E-eIF4G interaction [305].
1.8 Selective control: post-transcriptional regulation
by miRNAs
MicroRNAs (miRNAs) are short RNAs of approximately 22 nucleotides that
silence gene expression post-transcriptionally by binding to the 3′ UTRs of
target mRNAs. They have been implicated in a broad range of biological
processes including development, cellular differentiation, proliferation and
disease. In animal cells, miRNAs regulate their targets by translational inhi-
bition and mRNA destabilization. Although much is known about miRNA
biogenesis and biological function, the mechanistic details of the function of
miRNAs in repressing protein synthesis are still poorly understood (Fig. 13).
More than a hundred miRNA genes have been identified in Drosophila,
and 500-1000 in vertebrates and plants. According to several computational
predictions of miRNA targets, each miRNA regulates hundreds of mRNAs,
and one target mRNA could be combinatorially regulated by multiple miR-
NAs, suggesting that miRNA molecules may constitute a new layer of regu-
latory control over gene expression programs in many organisms [26, 50].
1.8.1 miRNA and miRISC biogenesis
Most miRNA genes are transcribed by RNAP II1 to generate a primary
miRNA (pri-miRNA) transcript, which are capped and polyadenylated, and
can range in size from hundreds of nucleotides to tens of kilobases [51, 249].
In mammals, the majority of miRNA loci are encoded within intronic regions
and transcribed as part of their hosting transcription units. Such intronic
miRNAs can be processed from unspliced introns before splicing catalysis
[217].
Pri-miRNAs fold into hairpin structures which are processed within the
nucleus by a multiprotein complex termed the Microprocessor. The core com-
ponents of this complex are the RNase III enzyme Drosha and the dsRNA-
binding domain (dsRBD) protein Pasha/DGCR8 [247, 85, 149, 160, 241,
124]. Drosha cleavage of the pri-miRNA stem produces an approximately
1An exception are miRNAs lying within repetitive Alu elements, which are transcribed
by RNAP III [41].
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70-nt hairpin precursor miRNA (pre-miRNA) that contains 2-nt 3′ overhang,
characteristic of RNase III-mediated cleavage [160].
An alternative biogenesis pathway exists for miRNAs derived from short
intronic hairpins termed “mirtrons”. Their nuclear processing appears to
bypass Drosha cleavage. Instead, mirtron hairpins are defined by the action
of the splicing machinery and lariat-debranching enzyme, which yield pre-
miRNA-like hairpins [34, 362, 317].
The mirtron pathway merges with the canonical miRNA pathway dur-
ing hairpin export by Exportin-5 which transports the pre-miRNA into the
cytoplasm via a Ran-GTP-dependent mechanism [39, 266, 438].
In the cytoplasm, pre-miRNAs are cleaved by another RNase III enzyme,
Dicer [181, 213], which forms a complex with the dsRBD proteins Loqua-
cious/TRBP and PACT [64, 123, 366, 196, 248]. The final processing yields
the mature ∼ 22-nt miRNA:miRNA? duplexes with protruding 2-nt 3′ over-
hangs. The Dicer-Loquacious complex recruits the Argonaute protein (AGO1
in Drosophila) and they form a trimeric complex that initiates the assembly
of the miRNA-induced silencing complex (miRISC) [148, 271]. The miRNA
strand with relatively lower thermodynamic stability of base-pairing at its
5′ end is incorporated into the miRISC, whereas the miRNA? strand is typ-
ically degraded [371, 98, 214]. Strand separation and miRISC loading has
been proposed to occur by unwinding of the miRNA:miRNA? duplex via
an unidentified RNA helicase followed by transfer of the miRNA strand to
AGO1 [403, 339].
The most important and best-characterized components of miRNPs are
proteins of the Argonaute family (reviewed in [180, 339]). There are five
Argonaute proteins in D. melanogaster (AGO1-3, PIWI, and Aubergine).
AGO1 is dedicated to the miRNA pathway, and AGO2 mainly functions in
RNAi. Apart from the Argonaute proteins, miRISCs often include other
proteins, which probably function as miRNP assembly or regulatory fac-
tors, or as effectors mediating the repressive miRNP functions [339]. In
Drosophila, AGO1 directly interacts with GW182, an RNA-binding protein,
and this interaction is required for miRNA-mediated translational repression
and mRNA decay [347, 30, 112]. This requirement can be bypassed by tether-
ing GW182 directly to mRNA in cells depleted of AGO1 [30]. Thus, GW182
(possibly in conjunction with other proteins) appears to be capable of in-
ducing translational repression and mRNA degradation acting downstream
of AGO1 (reviewed ind [90]). Consistent with this conclusion is the finding
that depleting mammalian cells of the GW182 paralog TNRC6B impairs the
ability of miRNAs to downregulate gene expression [190, 261, 284].
Once incorporated into the miRISC, the miRNA guides the complex to
its mRNA targets by base-pairing interactions. In cases of perfect or near-
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Figure 13. miRNA-mediated silencing pathway in Drosophila.
miRNAs are processed from primary transcripts (pri-miRNAs), which are either tran-
scribed by RNAP II from independent miRNA genes or are portions of intronic sequences
of mRNAs. A single pri-miRNA transcript often contains several different miRNA hair-
pins. These hairpin structures with imperfectly base-paired stems are processed by the
RNase III type endonuclease Drosha which is a component of the Microprocessor com-
plex that also includes the dsRNA-binding protein Pasha/DGCR8. The Microprocessor
complex processes pri-miRNAs to ∼ 70-nt hairpins known as miRNA precursors (pre-
miRNAs). Some spliced-out introns correspond precisely to pre-miRNAs (mirtrons), thus
circumventing the requirement for Drosha-mediated processing. Pre-miRNAs are then
transported to the cytoplasm by Exportin-5, where they are cleaved by another RNase
III-like enzyme, Dicer1 (complexed with the dsRNA-binding protein Loquacious/TRBP)
to yield ∼ 21-bp miRNA duplexes. After unwinding of the duplexes, one strand is selected
to function as a mature miRNA, while the other miRNA? strand is degraded. Occasion-
ally, both strands give rise to mature miRNAs. Dicer1-mediated processing is coupled with
the assembly of mature miRNAs into RNP complexes called miRNPs or miRNA-induced
silencing complexes (miRISCs). The key protein components of the miRISC are AGO1
and GW182. It can also contain further proteins that function as regulatory factors or
effectors mediating the inhibitory function of miRNPs. The miRISC binds to the 3′ UTR
of target mRNAs and prevents the production of proteins in different possible ways. These
include: induction of target mRNA deadenylation and decapping, inhibition of translation
initiation or elongation, and stimulation of nascent polypeptide degradation. Grey dashed
arrows correspond to activating signals; red blunted lines correspond to inhibitory signals.
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perfect complementarity to the miRNA, target mRNA can be cleaved and the
fragments degraded; otherwise, the mRNA expression is inhibited by a com-
plex mechanism ([182, 92, 278] and see below). Repression normally requires
perfect contiguous base-pairing of the mRNA target with the “seed region”
of the miRNA (residues 2-8) [93, 47]. In contrast, base-pairing between the
mRNA target site and the 3′-proximal part of the miRNA is much less criti-
cal, although good base-pairing here can compensate for a suboptimal “seed
match”.
Recent studies suggest that the exact configuration of the mismatches
defines whether miRNAs elicit decay or translational repression [5]. In ad-
dition, the mRNA sequences flanking the target sites, the number of target
sites, the distance separating them and their position in the 3′ UTR may all
influence the efficiency of repression [153].
1.8.2 miRNA-mediated control of mRNA translation and decay
mRNA decay Initial studies in C. elegans showed that the miRNA lin-4
binds to the 3′ UTR of the lin-14 mRNA and this causes a strong decrease
of lin-14 protein levels without affecting the mRNA levels, indicating that
lin-4 inhibits gene expression at the level of translation [246, 321, 423]. Sub-
sequent studies, however, have clearly demonstrated that animal miRNAs do
induce significant degradation of target mRNAs in addition to translational
repression [432, 141, 30, 22].
The mechanism of miRNA-mediated mRNA destabilization is best un-
derstood in Drosophila. MicroRNAs cause target mRNA decay by directing
them to the general mRNA degradation machinery (reviewed in [127]). This
process requires miRISC components AGO1 and GW182, the CCR4-CAF1-
NOT deadenylase complex, the decapping enzyme DCP2, and several decap-
ping activators including DCP1, Ge-1, EDC3, and Me31B/RCK (Fig. 13;
[30, 113]). According to the current model, GW182 is recruited to miRNA
targets through direct interaction with AGO1, where it contributes to trans-
lational repression and marks the transcript for degradation via deadenyla-
tion and decapping [30, 113].
In eukaryotic cells, the general mRNA degradation pathway is initiated
by poly(A) tail shortening. This step is reversible—deadenylated transcripts
that bear the correct cis-regulatory signals, in principle, can be re-adenylated
and return to polysomes [127]. The deadenylated mRNAs that must be de-
stroyed undergo irreversible decapping by the DCP2-DCP1 decapping com-
plex, which exposes them to 5′ → 3′ exonucleolytic degradation, presumably
by Xrn1. Alternatively, the unprotected 3′ end lacking the poly(A) tail can
be attacked by a large complex of 3′ → 5′ exonucleases called the exosome
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(reviewed in [127, 90, 111]).
The relative contribution of accelerated mRNA decay to the overall influ-
ence of miRNAs varies widely from message to message. In some instances, it
appears to be the principal mechanism of downregulation, whereas in others
its effect can be quite modest compared to that of translational repression
[30].
Accelerated deadenylation with subsequent mRNA decay appears to be
an independent mechanism by which miRNA-mediated silencing is accom-
plished, and can be uncoupled from translation and translational control.
Blocking translation by introducing a large stem loop into the 5′ UTR does
not itself trigger poly(A) removal or impair the ability of miRNAs to do so
[434]. Likewise, an ApppN-capped miRNA target which was not translated
due to the defective cap structure was rapidly deadenylated, indicating that
deadenylation promoted by miRNAs is not caused by the lack of translation
initiation and does not require active translation [290, 411]. It has also been
shown that in Drosophila cells and human cell extracts, miRNA-mediated
mRNA decay can occur even when translation is inhibited by cycloheximide
[411, 113].
Although deadenylation of the target mRNA abrogates the cap/poly(A)
synergy and reduces the efficiency of its translation, it is not the only mech-
anism which miRNAs employ to control translation. The observation that
mRNAs lacking a poly(A) tail, or containing a 3′ histone stem-loop in place
of a poly(A) tail, also undergo miRNA-mediated translational repression sug-
gests that a poly(A) tail per se is not absolutely required for the repression
[341, 178, 434].
Controversy over modes of translational control Although miRNAs
have been known for some time to downregulate translation [423], the ex-
act mechanism used to achieve this is still under debate. Indeed, published
studies indicate that miRNAs may repress protein expression in several dis-
tinct ways, raising the possibility that more than one mechanism is involved
(Fig. 14):
• inhibition of translation initiation, including inhibition of cap recogni-
tion and 43S PIC recruitment [178, 341, 412, 281, 219, 400, 411], and
inhibition of the 60S subunit joining [63];
• inhibition of elongation or premature termination of translation [373,
275, 340];
• cotranslational protein degradation [321, 313].
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Figure 14. Hypothetical mechanisms of translational repression by miRNAs
(A) Inhibition of translation initiation by blocking cap recognition and subsequent 43S
reinitiation complex recruitment. Competition between RISC and eIF4E for cap binding
is one possible mechanism. (B) Inhibition of translation initiation by impeding the asso-
ciation of the small and large ribosomal subunits. (C) Inhibition of translation elongation
or premature ribosome termination (drop-off). (D) Recruitment of a protease which cause
cotranslational degradation of nascent polypeptides. The grey dashed arrow corresponds
to an activating signals; red blunted lines correspond to inhibitory signals.
A number of observations suggests that miRNAs inhibit the initiation of
translation (Fig. 14A, B). First, it has been shown that miRNAs and their
targets are not associated with the polysomal fraction in sucrose gradients
but rather with the free mRNP pool in mammalian cells, which is a character-
istic sign of impaired initiation [341]. Second, experiments utilizing in vitro-
transcribed mRNAs transfected into cells, or translated in cell-free systems
recapitulating miRNA silencing, have demonstrated that cap-independent
IRES-mediated translation initiation may be insensitive to repression by
miRNAs, suggesting that miRNAs inhibit translation initiated by a cap-
dependent mechanism [178, 341, 281, 400, 411]. Finally, it has been reported
that adding purified cap-binding translation initiation complex eIF4F coun-
teracted miRNA-mediated repression [281].
The discovery that the central domain of human AGO2 exhibits sequence
similarities to eIF4E and binds to m7GTP on Sepharose beads has suggested
a concrete mechanism by which miRNAs may inhibit translation initiation:
competition between the RISC and eIF4E for cap binding [219]. Two con-
served phenylalanine residues were identified, which when mutated abolished
both the cap binding and the silencing activity of the human protein [219].
However, substitutions of the corresponding phenylalanines in Drosophila
AGO1 do not affect m7GTP Sepharose binding but do disrupt interactions
with GW182 and miRNAs [112]. These results suggest that the function of
the conserved phenylalanines is unrelated to cap binding and underscore the
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essential role of GW182 in miRNA-mediated translational repression [112].
An alternative mechanism of miRNA action was recently proposed in [63].
AGO2 has been found in a multiprotein complex containing eIF6 (which
binds the 60S subunit to prevent its precocious interaction with the 40S
subunit) and the 60S ribosomal proteins. The authors showed that partial
depletion of eIF6 in either human cells or C. elegans rescues mRNA targets
from miRNA inhibition. According to their model, AGO2 recruits eIF6,
then the large and small ribosomal subunits might not be able to associate,
causing translation to be repressed (Fig. 14B, [63]). This model has been
challenged recently by a study that demonstrated that eIF6 is not generally
required for silencing in Drosophila [112]. In addition, the role of eIF6 in 60S
ribosomal subunit biogenesis suggests that the depletion of this protein may
have secondary effects.
In contrast to all the above results, which are consistent with inhibition of
an initiation step, early investigations into silencing mediated by C. elegans
lin-4 and let-7 miRNAs and recent studies in mammalian cells have suggested
that repression operates at a post-initiation step [321, 373, 275, 313, 340].
Unlike the results that support the initiation block hypothesis, these studies
have reported that miRNAs and their targets are associated with polysomes.
These polysomes were shown to be actively translating mRNA targets be-
cause they were sensitive to a variety of antibiotics that inhibit translation
[275, 313, 340]. In addition, despite reports to the contrary, it was ob-
served that reporter target mRNAs driven by the HCV or CrPV IRESs were
susceptible to miRNA-mediated silencing. This implies that the repression
mechanism operates at some stage after the initiation step [340, 267].
These observations have led to proposals that miRNAs might cause re-
tarded elongation by the translating ribosomes, possibly coupled to prema-
ture termination (ribosome drop-off, Fig. 14C, [340]), or induce cotransla-
tional degradation of nascent polypeptides (Fig. 14D, [373, 313]).
Although these conflicting findings are difficult to reconcile, and neither
an initiation block mechanism nor a post-initiation block mechanism is easily
dismissed, the two modes of regulation are not mutually exclusive, and some
experiments designed to detect one may have obscured the other (reviewed
in [111, 433, 391, 119]. For example, it is possible that initiation is always
inhibited, but when the elongation step is also repressed, ribosomes would
queue on the mRNA, thereby masking the effect of an initiation block. It
seems reasonable that miRNA-mediated repression is manifested in multi-
ple ways, including one that inhibits the earliest events of cap-dependent
initiation and another that affects later, post-initiation steps in translation.
P bodies and stress granules are known to be temporary sites of storage
for repressed mRNAs (reviewed in [109, 8]. The detection of AGO proteins,
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miRNAs and mRNAs repressed by miRNAs in P bodies and stress granules
implicated these cytoplasmic compartments in miRNA repression and in the
fate of repressed mRNAs [341, 38, 30, 190, 284, 262, 251]. However, it was
demonstrated that the miRNA pathway remains unaffected in cells lacking
microscopically visible P bodies [439, 110]. Thus, P bodies are not required
for miRNA-mediated repression which is initiated in the soluble cytoplasmic
fraction, and that the localization of the silencing machinery in P bodies is
a consequence rather than a cause of silencing [439, 110, 178, 341].
It is worth noting that under certain conditions, or in specific cells,
miRNA-mediated repression can be effectively reversed or prevented, which
makes this regulation much more wide-ranging and dynamic [38, 290, 370,
175]. The context of the 3′ UTR is important since it can contain multiple cis-
regulatory elements, such as binding sites for RNA-binding proteins which
might counteract, modulate, or influence the extent and mode of miRNA
regulation in a target-specific manner (reviewed in [252]).
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2 Genome-wide analysis of mRNAs regulated
by Drosha and Argonaute proteins
in Drosophila
RNA silencing pathways are conserved mechanisms that regulate gene ex-
pression at both the transcriptional and post-transcriptional levels in a se-
quence specific manner (reviewed in [50, 150, 285]). These pathways are
triggered by the presence of dsRNA of diverse origin, which may originate
from viral replication, transcription of endogenous miRNA genes, pseudo-
genes and repetitive sequence elements or during transposition of mobile
genetic elements [50, 150, 285, 319]. dsRNAs can also be introduced into
the cell artificially. To enter silencing pathways, dsRNA molecules and pri-
miRNAs are first processed by the RNase III-like enzymes Drosha and/or
Dicer [50, 150, 285]. In Drosophila, Dicer-2 converts long dsRNAs into 21-
22-nucleotide siRNAs [250, 50]. Processing of pri-miRNA hairpins encoded
in the genome into ca. 22-nt-long miRNAs requires the consecutive action of
Drosha and Dicer-1 [85, 149, 247, 250].
The siRNAs and miRNAs are incorporated into multimeric RNA-protein
complexes referred to as siRNA- or miRNA-induced silencing complexes
(siRISCs or miRISCs), which elicit decay or translational repression of com-
plementary mRNA targets [50, 285]. siRNAs are fully complementary to
their targets and elicit mRNA degradation via a pathway known as RNA
interference. Similarly, plant miRNAs are often fully complementary to their
targets and elicit mRNA decay. In contrast, animal miRNAs are only par-
tially complementary to their targets and either elicit mRNA decay or repress
translation without affecting transcript levels [50, 111].
Argonaute proteins are essential components of RISC [180]. The Droso-
phila genome encodes five AGO paralogs (AGO1-3, PIWI and Aubergine).
This family of highly basic proteins is characterized by a central PAZ domain
and a C-terminal PIWI domain [180]. The PAZ domain is involved in the
specific recognition of the 2-nt 3’ overhangs of siRNAs and miRNAs. The
PIWI domain adopts an RNase H-like fold. The PIWI domains of human
and Drosophila AGO2, and of Drosophila AGO1 are catalytically active and
can cleave mRNAs fully complementary to siRNAs or miRNAs [180].
Current evidence suggests that despite their similar domain organiza-
tions, Argonaute paralogs are not redundant in Drosophila [78, 87, 291, 318,
326, 344, 427]. Indeed, Drosophila PIWI, and Aubergine have been ini-
tially implicated in heterochromatin formation and are required for the es-
tablishment and maintenance of the germline [78, 326]. Recent studies have
demonstrated that these two Argonaute paralogs together with AGO3 are
2.1 Identification of transcripts regulated by RNA silencing 50
the key components of the Piwi-associated RNA (piRNA) pathway (reviewed
in [12, 314, 162]). In addition to miRNAs and siRNAs, a third small RNA
silencing system has been uncovered that prevents the spreading of mobile ge-
netic elements in the germ line. The nature of the primary piRNA-generating
transcript is still not clear, but RNAi-like cleavage events are likely to define
the 5′ ends of mature piRNAs [12, 314, 162].
Drosophila AGO2 mediates siRNA-guided endonucleolytic cleavage of
mRNAs, whereas Drosophila AGO1 plays a role in translational repression or
mRNA decay triggered by miRNAs. This lack of redundancy is further sup-
ported by the observation that mutations or knockouts of Argonaute paralogs
in Drosophila have different phenotypes [87, 318, 427].
The results presented in this section have been published [348].
2.1 Identification of transcripts regulated by RNA
silencing pathways
To identify transcripts regulated by the Argonaute proteins, expression pro-
files of Drosophila Schneider cells (S2 cells) individually depleted of AGO1,
AGO2, PIWI or AUB were analyzed using whole genome oligonucleotide mi-
croarrays. To distinguish clearly transcripts whose levels are regulated by
the miRNA pathway, RNA expression levels in cells depleted of Drosha were
also profiled. The efficacy of the depletions were assessed by Western blot
analysis. Four days after addition of dsRNA, the steady-state expression
levels of Drosha, AGO1, AGO2 and AUB had declined to about 10% of the
levels detected in untreated cells (Fig. 15A, lane 4 versus lane 1).
On day 9, the residual levels of the proteins were less than 10% of those
observed in control cells (Fig. 15A, lanes 5). Depletion of Drosha, AGO1
or AGO2 also inhibited cell proliferation, confirming the effectiveness of the
dsRNAs (Fig. 15C). In the absence of specific antibodies against PIWI, I
determined the extent of its depletion by RT-PCR (Fig. 15B). Importantly,
depletion of AGO1 did not affect the expression of AGO2 or Drosha. Con-
versely, AGO2-depletion had no effect on AGO1 or Drosha expression levels
(data not shown).
The following section of work was done in conjunction with Jan Re-
hwinkel. For each depleted protein, we obtained two (Drosha, AUB and
PIWI), three (AGO2) or six (AGO1) independent expression profiles from
RNA samples isolated on day 9 (see Materials and Methods for a description
of the RNA samples). For AGO1, whose depletion leads to more widespread
changes in RNA levels, a time course was also performed and expression
profiles from RNA samples collected on days 3, 5 and 9 of the same knock-
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down were analyzed (Fig. 15D, asterisks). Total RNA was isolated from
mock-treated cells as a reference (control) sample. To identify mRNAs regu-
lated non-specifically in response to the dsRNA treatment, mRNA profiles in
cells treated with enhanced green fluorescent protein (EGFP) dsRNA were
examined (data not shown).
Detectable transcripts were assigned to three classes according to their
relative expression levels. These were: (1) transcripts at least 1.5-fold under-
represented compared to the reference sample (blue); (2) not significantly
changed (less than 1.5-fold different from the reference, yellow); and (3) at
least 1.5-fold over-represented (red). A transcript was considered only if its
class assignment was the same for all the independent day 9 profiles (or the
same in 5 of 6 profiles for AGO1). I validated changes in RNA levels for
selected mRNAs by Northern blot (see below and data not shown).
Fewer than 2% of transcripts showed altered expression in cells depleted
of PIWI or AUB (Fig. 15D and Supplementary Table I in [348]). Most of
these transcripts have low levels of expression in wild type cells and we did
not investigate them further. In cells depleted of Drosha, AGO1 or AGO2,
between 6% and 18% of transcripts were differentially expressed (Fig. 15D).
The expression profiles in cells depleted of Drosha or AGO1 (day 9) were
significantly correlated (rank correlation r = 0.7; Fig. 15 D), indicating that
depletion of these proteins affects the expression of a common set of RNAs.
Some of the RNAs in this set changed levels concordantly in AGO2 depleted
cells (Fig. 15 D). In agreement with this, the rank correlation coefficient be-
tween AGO2 and AGO1 (day 9) profiles was r = 0.7 and between Drosha and
AGO2 profiles r = 0.4, indicating that Drosha, AGO1 and AGO2 regulate
the expression levels of common targets.
2.2 Depletion of Drosha and AGO1 leads to similar
expression profiles
To investigate further the similarity of the cellular response to the depletion of
Drosha, AGO1 or AGO2, mRNAs belonging to specific classes in the Drosha
knockdown (at least 1.5-fold over- or under-represented, respectively) were
selected and their levels analyzed in the AGO1 or AGO2 knockdowns. It
was observed that of the 233 transcripts at least 1.5-fold over-represented
in Drosha-depleted cells, 58% and 16% were at least 1.5-fold up-regulated
in the AGO1 (day 9) and AGO2 knockdowns, respectively (Fig. 16A and
Supplementary Table II in [348]). Similarly, of the 233 down-regulated RNAs
in Drosha-depleted cells, 61% and 16% exhibited the same effect on regulation
in AGO1 (day 9) and AGO2 depleted cells, respectively (Fig. 16 A and
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Figure 16. RNAs regulated by Drosha, AGO1 or AGO2.
(A) Expression profiles of RNAs at least 1.5-fold over- or under-represented in the two
independent profiles obtained for Drosha ([348], Supplementary Table II). (B) Expression
profiles of RNAs at least 1.5-fold over- or under-represented in at least five of six profiles
obtained for AGO1 on day 9 ([348], Supplementary Table III). (C) Expression profiles
of RNAs at least 1.5-fold over- or under-represented in the three independent profiles
obtained for AGO2 ([348], Supplementary Table IV). In all panels, transcripts detectable
in Drosha, AGO1 and AGO2 depleted cells (5868 RNAs) are considered.
Supplementary Table II in [348]).
Likewise, RNAs showing differential expression in AGO1-depleted cells
(days 3, 5 and 9) had expression profiles similar to those in the Drosha
knockdown, although the relative changes in expression levels were more
pronounced in AGO1-depleted cells on day 9 (Fig. 16 B and Supplementary
Table III in [348]). These results indicate that Drosha and AGO1 regulate
common targets, in agreement with the role of these proteins in the miRNA
pathway [85, 149, 247, 318]. As mentioned above, a subset of transcripts reg-
ulated by AGO2 showed similar expression levels in cells depleted of Drosha
or AGO1 (Fig. 16 C and Supplementary Table IV in [348]), suggesting func-
tional overlap between the three proteins.
2.3 Predicted miRNA targets are significantly enriched
among up-regulated transcripts
Given the role of Drosha and AGO1 in the miRNA pathway [85, 149, 247,
318], changes in mRNA levels observed after their depletion are most likely
to be caused by the inactivation of this pathway. We therefore decided
to investigate whether the transcripts up-regulated in Drosha- or AGO1-
depleted cells were among predicted miRNA targets. The overlap between
both sets can be used to distinguish between transcripts whose levels are
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directly or indirectly affected by miRNAs. The Drosophila genome encodes
152 miRNAs [152]. At the time of this analysis ca. 100 miRNAs were
known [14, 151, 238, 239] of which 53 had been cloned [14, 238, 239], and 39
had unique (non-redundant) seed sequences (i.e. eight most 5′ nucleotides).
We tested the enrichment for targets of non-redundant cloned miRNAs pre-
dicted in [394] using an algorithm based on experimentally derived rules for
miRNA-target recognition [47], and found a significant enrichment for pre-
dicted miRNA targets among transcripts up-regulated in the Drosha knock-
down (p = 5.8 · 10−24) and AGO1 knockdown (p = 3.0 · 10−34). Interestingly,
transcripts up-regulated in the AGO2 knockdown were also significantly en-
riched in miRNA predicted targets (p = 1.8 · 10−9), suggesting that some
miRNAs may not discriminate between AGO1- or AGO2-containing RISCs
(Supplementary Table V in [348]). Targets predicted in other studies were
also represented in the list of up-regulated genes [106, 356, 395]. No signif-
icant enrichment for predicted targets was found amongst down-regulated
transcripts (p-values of order unity), suggesting that these transcripts repre-
sent secondary targets of the miRNA pathway.
2.4 Identification of a core set of transcripts regulated
by the miRNA pathway
To identify potential miRNA targets, we generated a list of transcripts up-
regulated at least 1.5-fold in the two profiles obtained for Drosha and in at
least 5 of 6 profiles obtained for AGO1 (day 9). 136 mRNAs fell into this
class, representing 2.3% of detectable RNAs (Fig. 17A and Supplementary
Table VI in [348]). Although the cut-off ratio of 1.5 is low relative to the
standard deviation of all detectable spots in the array2, the stringent filtering
criterion (i.e. regulation in at least 7 of 8 independent profiles) reduces the
likelihood of selecting false positives. Consistent with this, only 4 of these
transcripts changed levels more than 1.5-fold in cells treated with AUB, PIWI
or GFP dsRNA ([348], Supplementary Table VI). These RNAs were defined
as core transcripts, whose levels are regulated by the miRNA pathway.
The list of core transcripts includes hid and reaper mRNAs, which are
validated miRNA targets [47, 395]. Indeed, it was found that both hid and
reaper mRNAs were at least 2-fold up-regulated in cells depleted of Drosha
or AGO1 (day 9; Supplementary Table VI in [348]). Unexpectedly, both hid
and reaper were at least 1.7-fold up-regulated in AGO2-depleted cells ([348],
Supplementary Table VI). Furthermore, among the 136 core transcripts, 31
2When two independent total RNA samples were compared all spots had an average
ratio of 1.07± 0.50 after intensity-dependent normalization.
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Figure 17. Core transcripts regulated by the miRNA-pathway.
(A) Expression profiles of RNAs at least 1.5-fold over-represented in Drosha and AGO1
(day 9) depleted cells (core transcripts; Supplementary Table VI in [348]). (B) Northern
blot analysis of total RNA samples isolated from S2 cells. Probes specific to the miRNAs
indicated above the lanes were used. tRNAAla served as a loading control. (C) Gene
ontology (GO) terms significantly enriched within the lists of core transcripts (grey bars).
Black bars indicate the percentage of detectable transcripts associated with a specific GO
term. Numbers in italics indicate p-values. (D) The histogram shows the distribution of
signal intensities for all transcripts detected in samples isolated from control cells (yellow
bars), and for the list of core transcripts in control cells (red bars) or in AGO1-depleted
cells (day 9; blue bars). The vertical and horizontal axes represent the fraction of probe
sets and the normalized signal intensities, respectively. Numbers in italics indicate average
signal intensities.
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were at least 1.5-fold up-regulated in the three independent profiles obtained
for AGO2 (Fig. 17A and [348], Supplementary Table VI). This lends addi-
tional support to the hypothesis that some miRNAs may not discriminate
between AGO1- or AGO2-containing RISCs.
The miRNAs with the most significant target gene enrichment among
the core transcripts were the K-Box miRNAs (i.e. miRs-2/13, miR-6 and
miR-11, p ∼ 10−12–10−6, Table 1). Targets of miR-308, miR-8 and miR-
314 were also significantly enriched (p ∼ 10−9–10−6). The enrichment for
miR-14 targets (p = 6 · 10−4) and miR-9a/b (p = 1 · 10−2, Table 1) was also
significant, although these miRNAs have not been shown to be expressed in
S2 cells. These results suggest that miR-9 and miR-14 might be expressed
in S2 cells under these experimental conditions. Indeed, these miRNAs are
detectable in S2 cells (Fig. 17B).
Table 1. Enrichment of predicted miRNA targets amongst core transcripts.
p-value miRNA No. of targets
(core/detectable)
1.2 · 10−22 Cloned miRNAs redundant 90/1674
2.6 · 10−22 Cloned miRNAs non-redundant 89/1645
1.8 · 10−12 miR-6 23/148
8.2 · 10−12 miR-13b 22/144
8.2 · 10−12 miR-2a 22/144
8.2 · 10−12 miR-2b 22/144
1.1 · 10−11 miR-13a 22/146
2.3 · 10−9 miR-314 15/82
1.5 · 10−8 miR-308 18/142
2.7 · 10−6 miR-8 16/162
4.3 · 10−6 miR-11 11/78
2.4 · 10−4 miR-184 5/22
4.9 · 10−4 miR-92b 12/155
6.0 · 10−4 miR-14 8/75
6.5 · 10−4 miR-317 7/58
3.3 · 10−3 miR-92a 9/121
3.7 · 10−3 miR-34 6/59
4.0 · 10−3 miR-279 6/60
4.0 · 10−3 miR-286 6/60
7.3 · 10−3 miR-263b 6/68
8.6 · 10−3 miR-9b 8/116
Analysis of the biological function of the proteins encoded by core tran-
scripts using gene ontology terms [17] reveals that some functional groups are
over-represented in the list of core transcripts in comparison to the detectable
transcripts (Fig. 17C and [348], Supplementary Table VI). In particular, a
significant enrichment was observed of genes involved in developmental pro-
cesses (p = 5 ·10−3), axonogenesis (p = 4 ·10−3), organogenesis (p = 7 ·10−3),
cell adhesion (p = 1 · 10−2), and signal transduction (p = 1 · 10−2).
Compared to the distribution of abundance of detectable transcripts (Fig.
17D, yellow bars), core transcripts show a bias towards low abundance in wild
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type cells (Fig. 17D, red bars), but an almost normal distribution in AGO1-
depleted cells (blue bars). This suggests that the low abundance of these
transcripts seen in wild type cells is due to down-regulation by the miRNA
pathway.
2.5 Core transcripts represent authentic miRNA tar-
gets
To investigate whether predicted miRNA targets in the list of core transcripts
represent authentic targets, 3′ UTRs derived from eight core transcripts were
cloned into a firefly luciferase sensor reporter [347]. Transcripts were selected
that were also regulated by AGO2. Four of them were predicted miR-9a/b
targets. A previously validated miR-9b target, Nerfin [394], served as a pos-
itive control. When co-transfected with at least one of the predicted cognate
miRNAs, six out of eight of the 3′ UTRs led to a reduction of luciferase ac-
tivity (relative to the activity observed in the absence of the miRNA; Fig. 18
A, asterisks).
It was found that predicted miR-9 targets were often regulated exclu-
sively by either miR-9a or miR-9b (Fig. 18 A; e.g. CG10011 and Nerfin),
indicating that these miRNAs are not redundant, despite their sequence sim-
ilarity. Also, for some reporters (e.g. CG4851, Sema-1b, and CG12505), co-
expression of an miRNA led to an increase in luciferase protein expression
(Fig. 18 A). One possible explanation for these results is that these miRNAs
silence the expression of a negative regulator.
The results described above raised the question of whether predicted
miRNA targets not included in the list of core transcripts also represent
authentic targets. We therefore tested two 3′ UTRs derived from transcripts
(CG30337 and CG33087) that were regulated in Drosha and AGO1 depleted
cells, but were not in the list of core transcripts because they were not de-
tectable in two experiments. These reporters were also down-regulated by at
least one of the miRNAs predicted to recognize these 3′ UTRs (Fig. 18 A).
This observation confirms the assumption that the filtering criterion to select
core transcripts (regulation in 7 of 8 independent profiles, and detectable in
all profiles) is stringent and some genuine targets are excluded.
In addition, nine 3′ UTRs were selected from predicted targets of miR-
9a/b, miR-13a/b and miR-14, whose expression levels remained unchanged
in depleted cells and were comparable to those of the core transcripts in wild-
type cells. Four out of nine 3′ UTRs tested repressed luciferase expression in
the presence of the cognate miRNA (Fig. 18 B, asterisks). Note that for these
3′ UTRs, not all miRNAs predicted to have binding sites have been tested,
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Figure 18. Core transcripts represent authentic miRNA targets.
(A, B) Reporter plasmids constitutively expressing firefly luciferase flanked by the 3′
UTRs of predicted miRNA targets and plasmids expressing miRNA primary transcripts
were co-transfected in S2 cells as indicated. Renilla luciferase was included as a trans-
fection control. Firefly luciferase activity was normalized to that of the Renilla luciferase
activity in 3 independent experiments (n = 3). Normalized firefly luciferase activities in
the absence of miRNAs were set to 100%. Mean values are shown. Error bars represent
standard deviations. Asterisks indicate a significant reduction of firefly luciferase activity.
In panel (A) all miRNAs predicted to have binding sites in a given 3′ UTR are tested,
while in panel (B) only a subset of miRNAs having potential binding sites are tested per
reporter.
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so the fraction of these transcripts representing authentic miRNA targets is
likely to have been underestimated.
Taken together, this shows that although the majority of predicted mi-
RNA targets in the list of core transcripts are genuine targets of the miRNA
pathway, this list is not comprehensive and additional targets may be iden-
tified when less stringent criteria are applied. Furthermore, not all miRNA
targets are subject to down-regulation of mRNA levels, or might not be reg-
ulated at all in S2 cells.
2.6 AGO2 associates with miRNAs
Previous studies from our laboratory have showed that expression of fire-
fly luciferase from the reporters harboring Vha68-1 or CG10011 3′ UTRs
in the presence of miR-9b or miR-12 could be restored in cells depleted of
AGO1, but not of AGO2 [347], despite Vha68-1 and CG10011 mRNA lev-
els being changed in AGO2-depleted cells. Similar results were obtained for
the reporter containing the Nerfin 3′ UTR (Fig. 19A). Depletion of Drosha
also led to a partial restoration of firefly luciferase expression from these re-
porters, providing further evidence for a regulation of these reporters via the
miRNA pathway (Fig. 19A). The lack of restoration in AGO2-depleted cells
is not caused by an inefficient depletion, because silencing of firefly luciferase
expression by co-transfecting a fully complementary siRNA (Luc-siRNA) is
impaired in these cells ([348], Supplementary Fig. 1B and [347]). Thus,
depletion of AGO2 inhibits siRNA-guided, but not miRNA-guided gene si-
lencing as reported in [318].
These results contrast with the observation that AGO1 and AGO2 regu-
late the expression levels of a common set of miRNA targets. We therefore
reasoned that regulation by AGO2 may not be observed with the reporter
assays described above as in this case both the reporter and the miRNAs are
over-expressed. To investigate whether AGO2 associates with endogenous
miRNAs, Jan Rehwinkel performed immunoprecipitations from total lysates
of S2 cells expressing an HA-tagged version of AGO1, AGO2 or, as a control,
maltose binding protein (MBP). The presence of miRNAs associated with the
precipitated proteins was analyzed by Northern blot. Although the expres-
sion levels of these proteins was comparable, HA-AGO1 immunoprecipitated
very inefficiently (Fig. 20A). Nonetheless, miR-13b and bantam coimmuno-
precipitated with HA-AGO1 (Fig. 20B). HA-AGO2 also immunoprecipitated
these miRNAs above background levels, indicating that a small fraction of
endogenous miRNAs can be found in association with AGO2 (Fig. 20B).
These results provide an explanation for the observation that a subset of
miRNA targets is regulated by AGO2.
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Figure 19. Depletion of AGO2 inhibits siRNA-guided, but not miRNA-guided
gene silencing.
(A) S2 cells were treated with the indicated dsRNAs on days 0 and 4. On day 6, cells
were transfected with a mixture of plasmids comprising: plasmids expressing firefly lu-
ciferase (F-luc) flanked by the indicated 3′ UTRs, plasmids expressing miRNA primary
transcripts (grey bars) or the corresponding empty vector (black bars) and a plasmid ex-
pressing Renilla luciferase (R-luc). F-luc and R-luc activity were measured four days after
transfection. F-luc activity was normalized to that of the R-luc and set to 100 in cells trans-
fected with the empty vector and treated with EGFP dsRNA (black bars). Mean values
are shown. Error bars represent standard deviations from 3 independent experiments. (B)
S2 cells were treated with the indicated dsRNAs (on day 0 and day 4). On day six, cells
were transfected with plasmids expressing firefly and Renilla luciferase. siRNAs targeting
F-luc (Luc) or a control siRNA (control) were co-transfected as indicated. F-luc and R-luc
activity were measured four days after transfection. F-luc activity was normalized to that
of the R-luc and set to 100 in cells treated with the control siRNA and EGFP dsRNA. The
following siRNA sequences were used: luciferase siRNA (5′-CGUACGCGGAAUACUUCGAdTdT),
control siRNA (5′-GGACAGAUUCAAAUAACAAdTdT). The siRNAs were transfected at a final
concentration of 26 nM.
2.7 A few transcripts are regulated exclusively in the
individual knockdowns
To determine whether Drosha, AGO1 and AGO2 have evolved specialized
functions, we searched for transcripts exclusively regulated in one of the
knockdowns but clearly unaffected (less than 1.3-fold) or showing inverse
correlation in the other knockdowns. Only four transcripts were found to be
exclusively regulated in Drosha-depleted cells (Fig. 21 A, E).
Initial cleavage of pri-miRNAs is catalyzed by Drosha, which exists in a
multiprotein complex. Along with Drosha the complex also contains Pasha
(partner of Drosha), a double-stranded RNA binding protein [85]. I tested
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Figure 20. AGO2 associates with miRNAs.
(A) Immunoprecipitation of HA-tagged AGO1, AGO2 or MBP from total cell lysates.
The right panel shows a longer exposure of the immunoprecipitated samples to visualize
the presence of AGO1. (B) The presence of miR-13b or bantam in the immunoprecipitates
shown in (A) was analyzed by Northern blot.
the expression levels of the two up-regulated genes (CG15861 and CG31642)
in the Pasha knockdown (Fig. 22A). I found that the genes were also up-
regulated in the cells depleted of Pasha.
In baker’s yeast, dsRNA stem-loop structures found in intronic regions
of some transcripts trigger degradation of unspliced pre-mRNAs and lar-
iat introns. The dsRNA regions are cleaved by Rnt1p, the yeast ortholog
of RNase III, which creates an entry site for complete degradation by the
Xrn1p and Rat1p exonucleases and by the nuclear exosome [83]. Rnt1p also
selectively inhibits Mig2 gene expression by directly cleaving a stem-loop
structure within the mRNA coding sequence [131].
A similar mechanism might be involved in the regulation of CG15861 and
CG31642 by Drosha and Pasha. Interestingly, CG31642 resides in the intron
4 of the gene Stathmin-14 (CG31641), see Fig. 22C. If this hypothesis is true
and the mechanism of regulation does not rely on miRNAs, then unspliced
pre-mRNA levels of these genes would be increased in cells depleted of Drosha
and Pasha. To test this I performed RT-PCR using primers specifically
detecting unspliced pre-mRNAs.
I found that the pre-mRNA levels of the genes regulated by Drosha were
increased in Drosha- and Pasha-depleted cells (Fig. 22B, C). The levels of
Stathmin-14 (CG31641) pre-mRNA containing intron which flanks the se-
quence of CG31642, were also elevated in cells depleted of Drosha and Pasha
(Fig. 22B, C, primers E and F).
Transcripts were also identified which are exclusively regulated by AGO1,
but not by Drosha or AGO2, and transcripts regulated by AGO2, but not by
Drosha or AGO1 (Fig. 21B, C, F). The latter would be explicable if AGO2
regulates the expression of these transcripts by a mechanism involving, for
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Figure 22. RNAs exclusively regulated in the Drosha knockdown.
(A) The levels of the RNAs exclusively up-regulated by Drosha were analysed by Northern
blot in cells depleted of Drosha, Pasha, and both Drosha and Pasha. (B) RT-PCR was
used to specifically detect unspliced pre-mRNA. Primer pairs for each pre-mRNA amplicon
are indicated on the right. The positive or negative signs on the right of the panels indicate
that the reverse transcriptase was included (RT+) or omitted (RT-). The rp49 mRNA
served as an internal control. Numbers below the panels show the quantification with the
control signal set to 1. (C) Schematic representation of the gene structures. Binding sites
of the primers used for RT-PCR are shown as coloured bars.
example, siRNAs that are not processed by Drosha.
Furthermore, transcripts were identified which were regulated exclusively
by Drosha and AGO1 but unaffected in AGO2-depleted cells (Fig. 21D),
or transcripts regulated by AGO1 (showing correlated expression in AGO2-
depleted cells) but unaffected by Drosha-depletion (not shown). Finally, it
was observed that Dicer-1 and Dicer-2 mRNAs were at least 1.5-fold up-
regulated in AGO1-depleted cells (in four of six profiles). Drosophila Dicer-1
mRNA has one target site for miR-314 and Dicer-2 mRNA has sites for miR-
280 and miR-315 (note that these sites are not conserved in D. pseudoob-
scura). This suggests that a feedback mechanism regulates the expression
of genes involved in RNA silencing. This feedback mechanism appears to
be conserved, as expression of Dicer-like 1 (DCL1) is regulated by miR-162
in Arabidopsis thaliana [435], and the expression of AGO1 is regulated by
miR-168 [410].
Among the transcripts exclusively regulated by AGO2-depletion, I found
the transposable element (TE) blood (Fig. 21C). This prompted an investi-
gation into whether additional transposon-derived transcripts are regulated
in depleted cells. There are 96 families of transposable element in Drosophila,
which represent 22% of the genome [205, 207]. TEs are represented by 85
probe sets on the microarray, most of which correspond to LTR (long ter-
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Figure 23. Argonaute proteins regulate expression of transposons in S2 cells.
(A) Expression profiles of detectable transposons. (D) The expression levels of selected
transposons were analyzed by RT-PCR. The numbers 1 and 2 above the lanes indicate
that RNA samples were isolated from cells treated with two non-overlapping dsRNAs (1
and 2) for each protein. The positive or negative signs on the left of the panels indicate
that the reverse transcriptase was included (RT+) or omitted (RT-). The rp49 mRNA
served as an internal control.
minal repeat) and non-LTR retrotransposon families. I found that 21% and
41% of detectable TEs were at least 1.5-fold up-regulated in cells depleted of
AGO1 or AGO2, respectively (Fig. 23A, B and [348], Supplementary Tables
III and IV). With two exceptions, transposons up-regulated in cells depleted
of AGO1 were also up-regulated in the AGO2 knockdown, providing further
evidence for functional crosstalk between these proteins.
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3 A role for Drosophila RNA-helicase Belle
in translational control
3.1 Belle is a cytoplasmic protein that does not localize
to P bodies
To study the subcellular localization of Belle protein, Drosophila S2 cells were
transfected with a plasmid encoding HA-tagged Belle. In immunofluores-
cence experiments using primary anti-HA antibody and secondary TRITC-
coupled antibody, I observed that HA-tagged Belle localizes to the cytoplasm
(Fig. 24A). The localization of the protein was heterogenous, suggesting that
Belle might partially localize to some RNA granules. To determine whether
Belle localizes to P bodies, co-localization experiments were performed using
S2 cells co-transfected with HA-Belle and EGFP-tagged Me31B, which is a
known component of P bodies in Drosophila. The two proteins showed no
co-localization in the foci (Fig. 24B). In addition to this, I observed that the
foci formed by EGFP-DCP1, another known P body component, did not
contain HA-Belle (Fig. 24C).
I obtained similar results with an EGFP-fusion of Belle co-transfected
with HA-Ge-1, which is yet another P body component in Drosophila S2
cells. Subcellular localization of EGFP-tagged Belle was different from the
HA-tagged protein. EGFP-Belle formed discrete cytoplasmic foci of varying
number and size, and showed considerably less diffused cytoplasmic staining.
Consistent with the result obtained with HA-Belle, these foci showed no
co-localization with Ge-1 (Fig. 24D).
3.2 Belle is required for cell viability
To understand the functions of Belle in Drosophila, I performed an RNAi-
mediated knock-down experiment in S2 cells using dsRNA spanning ca. 700
nt of Belle mRNA. To ensure the maximum reduction of the endogenous
protein level, dsRNA treatment of S2 cells was done twice (on day 0 and later
on day 4 of the experiment). I confirmed the efficiency of the depletion by
Western blot analysis using rabbit polyclonal anti-Belle antibody produced
in our laboratory (Fig. 25B).
S2 cells depleted of the essential translation initiation factors eIF4E and
the DEAD-box RNA helicase eIF4A, which are required for efficient cell pro-
liferation, served as a positive control. Me31B, another DEAD-box helicase,
decapping co-activator and translation regulator was also depleted from S2
cells.
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Figure 24. Subcellular localization of Belle in S2 cells.
(A) Confocal fluorescent microphotograph of S2 cell expressing HA-tagged Belle. Cells
were fixed and stained with anti-HA primary antibody and then with TRITC-coupled
secondary antibody (red signal). DNA was stained with Hoechst 33342 (blue). (B)
Confocal image of fixed S2 cell co-expressing HA-Belle and EGFP-fusion of Me31B. The
HA-tag signal is shown in red and the EGFP signal is green. Overlap of the two colours
appears yellow. DNA was stained with Hoechst 33342 (blue). (C) Confocal image of fixed
S2 cell co-expressing HA-Belle (red signal) and EGFP-DCP1 (green signal). (D) Confocal
fluorescent microphotograph of fixed S2 cell co-expressing EGFP-Belle (green signal) and
HA-Ge-1 (red signal). Scale bar is 5 µm.
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Figure 25. Belle is required for S2 cells proliferation.
(A) S2 cells growing in suspension were treated with dsRNAs specific for Drosophila Belle,
Me31B, eIF4E, eIF4A, and EGFP. Depletion of Belle inhibits cell growth, similar to the
depletions of Me31B, eIF4E, eIF4A. (Experiment was done three times, a representative
growth curve is shown.) (B) Cells from the same experiment were analyzed by Western
blotting with polyclonal antibody against Belle. Dilutions of the sample from EGFP
dsRNA treated cells isolated on day 8 were loaded to assess the efficiency of the depletion.
Tubulin served as a loading control.
I found that the depletion of Belle inhibit proliferation of S2 cells, similarly
to the depletions of Me31B, eIF4A and eIF4E, as shown in Fig. 25A. This
result is in line with a previous study that demonstrated that Belle is required
for larval growth, as well as male and female fertility [201].
3.3 Protein synthesis is inhibited in cells depleted of
Belle
Previous studies on Ded1p, the yeast homolog of Belle, had demonstrated
that this protein is required for translation initiation [68, 84, 186]. Recent
results from Roy Parker’s laboratory suggested that the yeast homolog of
the DEAD-box helicase Me31B, Dhh1p, is required for global translational
repression in response to stress (glucose deprivation or amino acid starvation),
during which the vast majority of mRNAs undergo translational repression
[73].
To test whether Belle is required for translation control in Drosophila, I
studied the efficiency of general protein synthesis by metabolic labeling in S2
cells individually depleted of Belle, Me31B, eIF4A and eIF4E by RNAi. The
experiment was performed at normal growth conditions (25◦C) and during
heat-shock-induced stress (at 37◦C) (Fig. 26). I observed that in cells de-
pleted of Belle, the incorporation of [35S]-methionine into newly synthesized
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Figure 26. Belle is required for efficient translation in S2 cells.
(A) S2 cells from the same experiment shown Fig. 25 were pulse labeled with [35S]-
methionine for 1 h. Total lysates from equivalent numbers of cells were analyzed by
SDS-PAGE followed by Coomassie blue staining (left panel) and autoradiography (right
panel). Wild type cells, treated with protein synthesis inhibitor cycloheximide, served as a
control for translation shut down. The position of heat shock proteins is indicated on the
right. (B) Northern blot analysis of Hsp70 mRNA levels in the control (EGFP dsRNA
treated) and Belle-depleted S2 cells before (25◦C) and after (37◦C) induction by the heat
shock.
proteins decreased significantly relative to the control cells (Fig. 26A, lane 3
versus lane 1 and 2). Moreover, the expression of HSP70 protein following
heat stress was also reduced (Fig. 26A, lane 10 versus lane 8 and 9) despite
the fact that the corresponding mRNA was strongly induced (Fig. 26B). Al-
though all knock-down cells showed similar growth inhibition (see Fig. 25A),
depletion of Belle had the strongest effect on protein synthesis, comparable
to the effect of depletion of the translation initiation factor eIF4A. This re-
sult suggests that the effect of the depletions on general protein synthesis
is not only due to cell growth arrest, and that Belle is required for efficient
translation in S2 cells.
To confirm this result, I analyzed polyribosome profiles of S2 cells in-
dividually depleted of Belle, eIF4A and eIF4E (Fig. 27). The profiles were
obtained from cytoplasmic lysates, prepared from equivalent amounts of cells.
The lysates were loaded on 15%-45% sucrose density gradients, and lysate
components were separated in the gradient according to their sedimentation
coefficients by ultracentrifugation. The polysome profiles from depleted cells
were compared to a control profile from S2 cells treated with EGFP dsRNA.
The profile from cells treated with Belle dsRNA was similar to the pro-
files obtained from eIF4E- and eIF4A-depleted cells. All three profiles were
characterized by an increase of the 80S (monosome) peak and a decrease of
the polysome peaks, suggesting that translation was impaired in these cells
(Fig. 27).
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Figure 27. Polyribosome profiles of S2 cells treated with dsRNAs specific for
Drosophila Belle, eIF4E, eIF4A, and EGFP.
The positions of peaks, corresponding to ribosome-free mRNPs, ribosomal subunits (40S
and 60S), monosomes (80S) and polysomes, are indicated on the control profile, obtained
from EGFP dsRNA treated S2 cells. “Top” and “bottom” mark the top (15% sucrose)
and the bottom (45% sucrose) of the sucrose density gradient, respectively.
3.4 Belle represses translation of bound mRNA
The next question to be answered was whether Belle is able to elicit trans-
lation control when it is bound to a reporter transcript. To address this,
I decided to make use of the tethering assay described in [30]. This assay
involves the expression of λN-HA-fusion proteins that bind with high affinity
to five BoxB sites (5BoxB) in the 3′ untranslated region (UTR) of a firefly
luciferase reporter mRNA (F-luc-5BoxB reporter) (Fig. 28A). S2 cells were
transiently transfected with the F-luc-5BoxB reporter, a plasmid expressing
Belle fused to the λN-HA peptide (λN-HA-Belle), and a plasmid encoding
Renilla luciferase (R-Luc) as a transfection control. 48 hours after transfec-
tion, cells were harvested and the steady-state levels of reporter luciferase
activities were quantified by the dual luciferase assay. The firefly luciferase
activity levels were normalized to that of Renilla to compensate for possible
differences in transfection efficiencies.
The tethering of Belle caused a reduction in the level of firefly luciferase
activity to ca. 40% of the level detected in cells expressing the λN-HA pep-
tide alone (Fig. 28B). To determine whether Belle silences firefly luciferase
expression by inhibiting translation directly or indirectly by reducing mRNA
levels, I analyzed the steady-state levels of the F-luc-5BoxB mRNA by North-
ern blot and normalized to the levels of the control R-Luc mRNA. Surpris-
ingly, expression of the λN-HA-Belle fusion caused an increase in the levels
of the reporter mRNA (ca. 1.6-fold relative to the levels detected in cells
expressing the λN-HA peptide alone) (Fig. 28B).
To test whether the ability of Belle to repress translation of bound mRNA
was dependant on its helicase activity, I introduced single amino acid sub-
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Figure 28. Tethering of λN-HA-Belle represses translation of firefly reporter.
(A) Schematic representation of the firefly luciferase (F-luc) 5BoxB reporter. (B) S2
cells were transfected with a mixture of plasmids comprising the F-luc-5BoxB reporter, a
plasmid expressing Renilla luciferase (R-Luc) and plasmids encoding the λN-HA peptide
and λN-HA-Belle. Protein levels were measured by luciferase assay (black bars). The
reporter mRNA levels (white bars) were analyzed by Northern blot with the probes against
F-luc and R-luc. The levels of the F-luc-5BoxB reporter were normalized to the levels of
R-luc reporter. Normalized values were set to 1 in cells expressing the λN-HA peptide
alone. Mean values ± standard deviation of three independent experiments are shown.
stitutions in its putative helicase domain. The selection of amino acids was
based on the mutational analysis of mammalian DEAD-box RNA helicase
eIF4A, reported in [331], given the highly conserved nature of the helicase
core domain. Analogous mutations in mammalian eIF4A completely abol-
ished the unwinding activity of the protein, but had different effects on ATP-
binding and hydrolysis activities (Table 2). The domain architecture of Belle
is shown in Fig. 29A with mutated residues indicated in red. I expressed
these mutants of Belle in S2 cells (Fig. 29B) and tested in the tethering
assay (Fig. 30).
Table 2. Biochemical activities of eIF4A mutants.
Motif eIF4A ATP-binding (%) ATPase (%) Unwinding (%)
Walker A (AXXXXGKT) WT 100 100 100
Walker A (AXXXXGKT) AXXXXGNT 2 0 0
Walker B (DEAD) DQAD 60 0 0
C-terminal VI (HRIGR) QRIGR 60 30 0
Modified from Pause and Sonenberg, 1992.
I found that two mutants (K345N and E460Q) were unable to repress
translation of the firefly reporter mRNA (Fig. 30A). The third H645Q mutant
showed the same effect on reporter translation as the wild type Belle. The
inhibitory effect of λN-HA-Belle affected only tethered mRNA, while an F-
luc reporter lacking the 5BoxB sites was translated even more efficiently in
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Figure 29. Expression of Belle mutants in S2 cells.
(A) Schematic representation of the domain organization of Belle. Mutated amino acid
residues are indicated in red. (B) The expression of Belle mutants was confirmed by
Western blot. HA-tagged proteins were detected using anti-HA antibody.
the presence of over-expressed protein (Fig. 30A).
I measured the steady-state levels of the F-Luc-5BoxB mRNA by North-
ern blot analysis and normalized to the levels of the control R-Luc mRNA.
Expression of the wild type λN-HA-Belle and the two mutants (E460Q and
H645Q) caused a marked increase in the levels of the reporter mRNA (around
1.8-2-fold relative to the levels detected in cells expressing the λN-HA pep-
tide alone) (Fig. 30C, black bars). Tethering of the K345N mutant increased
the F-luc-5BoxB reporter level only ca. 1.2-fold. No stabilizing effect was
seen on transcripts lacking the tethering sites (Fig. 30C, white bars).
After normalizing firefly luciferase activity to the corresponding mRNA
levels, the bound wild type λN-HA-Belle led to a net 4-fold reduction in
protein expression (Fig. 30D), and the same net effect was observed for the
H645Q mutant. The other two mutants (K345N and E460Q) had no net
effect on reporter protein expression. The differences between the activities
of Belle mutants in the tethering assay correlated with the properties of
eIF4A mutants, summarized in Table 2.
This result suggests that the putative ATPase activity of Belle is required
for translation repression of bound F-luc-5BoxB mRNA.
3.5 Tethering of Belle induces the formation of heavy
mRNPs which are different from polysomes
Actively translated mRNAs form polysomes which sediment faster during
ultracentrifugation, and appear in the “heavy” gradient fractions, close to
the bottom of the gradient. The result of inefficient translation initiation
or elongation is that less ribosomes are associated with the mRNAs, so the
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Figure 30. Tethering of λN-HA-Belle represses translation of bound mRNA in
ATP-dependant manner.
(A) S2 cells were transfected with the F-luc-5BoxB reporter (black bars) or the F-luc
control (reporter lacking the tethering sites, white bars), a plasmid expressing Renilla
luciferase, and vectors expressing the λN-HA peptide or λN-HA-Belle, either wild type
or mutated. Firefly luciferase activity was normalized to that of Renilla and set to 1 in
cells expressing the λN-HA peptide alone. Mean values ± standard deviations from three
independent experiments are shown. (B) Firefly luciferase reporter mRNAs and R-luc
mRNA levels were analyzed by Northern blot. (C) The levels of F-luc-5BoxB (black bars)
and F-luc (white bars) reporter mRNAs were normalized to the mRNA levels of R-luc
reporter. Normalized values were set to 1 in cells expressing the λN-HA peptide alone.
Mean values ± standard deviation of three independent experiments are shown. (D) The
normalized values of firefly luciferase activity shown in A were divided by the normalized
mRNA levels shown in C to estimate the net effect of tethering Belle on protein synthesis.
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mRNAs sediment slowly and appear in the “light” fractions, close to the
top of the gradient. Therefore, the position of an mRNA on a gradient is
dependent on its translation efficiency.
To understand the mechanism of Belle-mediated translation repression
of the bound F-luc-5BoxB mRNA, I analyzed polysome profiles from S2
cells transfected with the F-luc-5BoxB reporter, a Renilla luciferase (R-Luc)
transfection control and plasmids encoding the λN-HA peptide, λN-HA-Belle
wild type or K345N mutant. The distribution of the F-luc-5BoxB and R-luc
reporters between different gradient fractions was monitored.
The cells were harvested 48 hours after transfection and lysed in hyper-
tonic, detergent-containing lysis buffer. One half of each lysate was treated
with 30 mM ETDA to disassemble the polysomes. The lysates were loaded
on 15%-45% sucrose density gradients, and lysate components were separated
by ultracentrifugation according to their sedimentation coefficients. The gra-
dients were fractionated and the corresponding UV profiles were recorded
(Fig. 31A). The RNA samples extracted from the gradient fractions were
analyzed by Northern blot (Fig. 31B).
As was expected, in S2 cells expressing the F-luc-5BoxB reporter, R-luc
transfection control and λN-HA peptide alone, the reporter mRNAs were
actively translated and appeared in the “heavy” polysome fractions of the
gradient (Fig. 31B). EDTA-mediated polysome disruption caused a shift of
the reporter mRNAs from the “heavy” to the “light” fractions, close to the
top of the gradient.
Tethering of λN-HA-Belle to the F-luc-5BoxB reporter caused a slight
shift of the mRNA towards the bottom of the gradient. The distribution of
the control R-luc reporter mRNA in the gradient remained unchanged. In-
terestingly, disruption of polysomes with EDTA in this case did not make the
same shift of the F-luc-5BoxB reporter to the top of the gradient, as was the
case with tethering of the λN-HA peptide alone. The control R-luc reporter
mRNA was shifted to the “light” gradient fractions, as before. Tethering
of a λN-HA-Belle K345N mutant, lacking putative ATPase activity, to the
F-luc-5BoxB reporter had the same effect on the position of the mRNA in
the gradient, with or without EDTA treatment.
I analyzed the protein samples extracted from the gradient fractions by
Western blot using anti-Belle polyclonal antibody (Fig. 31C). I found that
only a minor fraction of endogenous Belle co-migrates with polysomes in the
sucrose gradients. EDTA-mediated polysome disassembly did not dramati-
cally affect the distribution of the protein in the gradient, but a slight shift
from the “heavy” fractions was detectable (Fig. 31C). At the same time, λN-
HA-Belle co-migrated with the F-luc-5BoxB mRNA in the sucrose gradient.
As was expected, this distribution of the protein in the gradient was resistant
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to EDTA treatment.
These results indicate that tethering of λN-HA-Belle to the F-luc-5BoxB
reporter mRNA induces the formation of a heavy mRNP complex, which is
resistant to EDTA treatment at concentrations sufficient for polysome dis-
assembly. Tethering of the λN-HA-Belle K345N mutant also induces the
formation of heavy mRNP particles. This process does not depend on the
putative ATPase activity of Belle, and is not sufficient for translation repres-
sion of the bound mRNA.
3.6 Tandem affinity purification of proteins associated
with Belle in Drosophila S2 cells
The next step in characterizing the molecular function of Belle was to identify
proteins that associate with the protein. I decided to take the approach
which involved establishing polyclonal Drosophila S2 cell lines expressing C-
terminal TAP-tagged wild type Belle and Belle mutants on induction with
copper sulfate. Wild type Belle and the K345N mutant, lacking putative
ATPase activity, were purified along with interacting proteins by tandem
affinity chromatography (Fig. 32).
After colloid Coomassie or silver staining, the gel pieces which contained
proteins of interest were excised, proteins were digested in-gel with trypsin,
and peptides were extracted from the gel blocks. Peptide mixtures were ana-
lyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Raw spectra were processed, and the peak lists searched in-house using Mas-
cot Daemon MS analysis. This identified 213 proteins associated with wild
type Belle and 225 proteins associated with the Belle K345N mutant. Pro-
teins identified with a Mascot score ≥50 were considered significant, whereas
all lower-scoring proteins were either included or discarded after inspection
of individual spectra. This resulted in the inclusion of 5 additional proteins
with scores of between 43 and 48. By combining the two purification results,
and after removal of redundant hits, I identified 336 different proteins which
are shown in Table 6. The proteins in the table are listed according to a sum
of their Mascot scores, obtained in two different affinity purifications using
wild type Belle or Belle K345N mutant.
3.7 Characterization of proteins associated with Belle
in Drosophila S2 cells using Gene Ontology
Although the chosen approach did not detect proteins stoichiometrically in-
teracting with Belle, it identified many more proteins with the ability to
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Figure 32. Purification of proteins associated with Belle by tandem affinity chro-
matography.
(A) Schematic representation of tandem affinity purification principle. (B) S2 cells bear-
ing a plasmid encoding C-terminal TAP-tagged Belle under inducible metallothionein pro-
moter were treated with copper sulfate overnight. Twelve hours after addition of copper
sulphate, proteins bound to TAP-tagged Belle were purified in presence of RNase A and
separated by SDS-PAGE. Lane 1, proteins purified from lysates of wild type S2 cells; lane
2, proteins bound to TAP-tagged Belle wild type, lane 3, proteins bound to TAP-tagged
Belle K395N mutant.
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RNA metabolism
RNA metabolism 16.6%
Translation 16.3%
Signal transduction 12.8%
Uncharacterised 12.8%
Vesicle-mediated transport 8.6%
Protein degradation 7.4%
Protein folding 4.5%
Metabolic enzymes 4.2%
Other 2.4%
DNA replication/repair 3%
Cytoskeleton associated 6.8%
Nuclear-cytoplasmic transport 3%
Cell cycle/mitosis 1.8%Translation
Signal transduction
Uncharacterised
Vesicle-mediated transport
Protein degradation
Cytoskeleton associated
Protein folding
Metabolic enzymes
Other function
Figure 33. Functional characterization of proteins associated with Belle in
Drosophila S2 cells.
A pie diagram showing the classification of 336 identified proteins according to Gene On-
tology, assisted by manual data mining of references in Flybase and Ensembl. A total
of ca. 13% of proteins were completely uncharacterised according to the sources. The
remaining proteins were grouped by GO function and were encompassed into twelve main
categories: DNA replication and repair, RNA metabolism, translation, cytoskeleton asso-
ciated, vesicle-mediated transport, nuclear-cytoplasmic transport, cell cycle and mitosis,
signal transduction, protein degradation, protein folding, metabolic enzymes, and other.
bind Belle than anticipated. To classify the 336 proteins on a functional ba-
sis, I characterized them according to the Gene Ontology (GO) database [17]
supported by additional manual data mining of previously published work
(Fig. 33, Table 6).
A total of 111 proteins (33%) fell within GOs that would be expected to
have a function in mRNA translation and turnover, such as those involved
in RNA binding, mRNA processing, splicing, localization, translation, de-
capping, and deadenylation (Fig. 33, Table 6). This percentage remained
unchanged when two purifications (with the wild type protein and with the
mutant) were inspected separately (Fig. 34A, B) and was even higher (ca.
42%) when proteins that came out in both purifications were considered
(Fig. 34C, D).
A more formal and detailed functional categorization of proteins inter-
acting with Belle was carried out on the basis of a relatively small number of
high-level GO terms. This involves the mapping of a set of annotations for
the proteins of interest to a specified subset of high-level GO terms called GO
slim ontology. Generic GO slim ontology is updated regularly and is avail-
able from the GO website. The GO website provides an algorithm, map2slim
written by Chris Mungall at Berkeley Drosophila Genome Project, to map
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RNA metabolism
Translation
Signal transduction
Uncharacterised
Vesicle-mediated transport
Protein degradation
Protein folding
Metabolic enzymes
Other
DNA replication/repair
Cytoskeleton associated
Nuclear-cytoplasmic transport
Cell cycle/mitosis
Wild type Belle
17.4%
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12.2%10.8%
6.6%
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5.2%
1.9%
3.8%
1.9%
0.5%
Belle K345N
16.4%
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11.1%
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5.8%
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Wild type Belle & Belle K345N
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7.9%8.9%
5%
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6.9%
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2%
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Wild type Belle
Belle K345N
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Figure 34. A comparison of the two sets of proteins interacting with wild type
Belle and Belle K345N mutant in Drosophila S2 cells.
(A) A pie diagram showing the Gene Ontology classification of 213 proteins identified
after affinity purification of wild type Belle. (B) A GO classification of 225 proteins,
identified after affinity purification of Belle K345N mutant. (C) Venn diagram showing
an overlap between the two experimental data sets. Numbers in circles correspond to the
numbers of proteins found in each subset. (D) A GO classification of 101 proteins, found
in both experimental data sets.
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annotations to a slim ontology. I used a web tool developed in Princeton
University called GO Term Mapper which employs the algorithm map2slim
and some of the modules included in the GO-TermFinder distribution writ-
ten by Gavin Sherlock and Shuai Weng at Stanford University [43]. GO
Term Mapper groups proteins from a submitted list into broad categories
according to molecular function, biological process, or cellular component.
307 annotated proteins out of 336 proteins associated with wild type Belle or
with the K345N mutant were categorized (Fig. 35). Because gene ontology is
a directed acyclic graph3, a GO term used for a specific annotation might be
a child of multiple terms in the slim set. Also, individual proteins often have
several annotations to different terms to reflect their multiple functions, roles
or locations. Because one protein’s annotations frequently map to many slim
terms, pie diagrams that are traditionally used to illustrate the functional
distribution of genes are not a good representation of the data. The sum of
the annotations is larger than 100%, that is, proteins are found in more than
one slice of the pie [351]. I used a bar diagram as more appropriate here
(Fig. 35).
Consistent with the “manual” characterization (Fig. 34), I observed that
the main fraction of proteins associated with Belle fell into molecular func-
tion and biological process categories related to RNA-binding and transla-
tion. Another highly populated molecular function category was nucleotide
binding (Fig. 35A). Regarding biological process categories, organelle and
cytoskeleton organization and biogenesis together contained more than 60%
of proteins associated with Belle. This observation is in line with a study on
microtubule interactome, which identified Belle and 59 other proteins that
co-purified with Belle in our experiments as microtubule-associated in early
Drosophila embryos [177].
Interestingly, I found that roughly 15% of proteins associated with Belle
were in a cellular component category “lipid particle”. According to a mass
spectrometry analysis of lipid-droplet proteome reported in [57], Belle was
found among proteins significantly represented in the lipid-droplet fraction,
together with 32 other proteins (ca. 40% of the lipid-droplet proteome) that
associated with Belle in our experiments.
To compare coarsely two experimental sets of proteins associated with
wild type Belle and the K345N mutant, each set was categorized indepen-
dently usingGO TermMapper (Fig. 36). The goal of such functional profiling
is to determine which processes might be different in two particular sets of
3Directed acyclic graph (DAG) is a graph in which the GO terms are nodes and the
relationships among them are edges. Parent-child relationships are defined, with parent
term representing more general entities than their child terms; and unlike a simple tree, a
term in a DAG can have multiple parents.
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Figure 35. Functional categorization of proteins associated with Belle using
generic GO slim terms.
A classification of 307 annotated proteins out of 336 associated with the wild type or
K345N mutant Belle according to molecular function (A), biological process (B) and
cellular component (C) GO slim terms. The category “other” consists of all categories
that contain less than 2% (molecular function and cellular component) or 5% (biological
process) of annotated proteins associated with Belle.
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proteins. This can be done by determining which GO slim terms are repre-
sented differently within the protein set. By simple comparison of the two
GO slim terms profiles we detected a few minor differences between two pro-
tein sets obtained from two parallel purifications using either the TAP-tagged
wild type Belle or K345N mutant (Fig. 36).
3.8 Functional enrichment analysis
The simple approach of calculating “enrichment/depletion” for each GO slim
term (that is, a higher proportion of genes with certain annotations among
the protein set than among all of the proteins) is far from perfect because any
enrichment value can occur just by chance. Therefore, enrichment (or de-
pletion) alone should not be interpreted as unequivocal evidence implicating
the GO term in the phenomenon studied without an appropriate statistical
test.
To extract GO terms that are significantly over- and under-represented in
the sets of proteins obtained experimentally, I used two different web-based
applications, allowing for easy and interactive querying. The reason for us-
ing two different functional profiling programs is that the output p-values
provided by different applications may vary dramatically (several orders of
magnitude for some GO terms). Factors that can cause such wildly differ-
ent results for the same input data include: the method used to map gene
identifiers; sources and versions of annotation files; the method of annota-
tion propagation (for example, direct annotations only versus propagated to
parents); the statistical testing method (for example, one-sided versus two
sided); and the multiple hypothesis correction method [351].
The first program that was used was GO Term Finder. It calculates
p-values using hypergeometric distribution [43]. To adjust the p-values for
multiple hypothesis testing GO Term Finder runs 1000 simulations. The
corrected p-value is calculated as the fraction of simulations having any p-
value as good or better than the observed p-value. Comparison of simulation
corrected p-values with Bonferroni corrected p-values actually suggests that
the Bonferroni correction is not conservative enough4.
An alternative methodology for multiple hypothesis testing is to calcu-
late the false discovery rate (FDR), which is the expected proportion of true
4The Bonferroni correction is the most commonly used multiple hypothesis correction
method, whereby the α-value is simply divided by the number of tests, and the overall
chance of finding any false positive remains the same as in a single hypothesis experiment.
The Bonferroni correction assumes that the tests are independent and is considered a
conservative adjustment. In our case, the hypotheses (GO terms which are nodes) are not
independent, because the nodes themselves structured in a DAG [43].
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Figure 36. Two sets of proteins associated with wild type Belle or K345N mutant
categorized separately from each other.
A classification of annotated proteins (201 out of 213 associated with the wild type Belle
and another 201 out of 225 associated with K345N mutant) according to molecular function
(A), biological process (B) and cellular component (C) GO slim terms. The category
“other” consists of all categories that contain less than 2% (molecular function and cellular
component) or 5% (biological process) of annotated proteins associated with Belle.
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null hypotheses rejected out of the total number of null hypotheses rejected.
Based on 50 simulations, GO Term Finder calculates the FDR for each hy-
pothesis from the real data as the average number of nodes per simulation
that have p-values as good or better than the real node’s p-value, divided by
the number of nodes in the real data that have a p-value as good or better
than that p-value. Comparison of p-values corrected by simulation versus
the FDR shows that using the corrected p-values is likely to result in more
false negatives [43].
The second web application was FatiGO [2]. This program first defines
the GO level at which the statistical contrast is going to be performed.
Deeper terms in the GO hierarchy are more precise, but the number of genes
with annotations decreases at deeper GO levels. GO level 3 constitutes a
good compromise between information quality and number of genes anno-
tated at this level. For genes annotated at deeper levels than the selected
level, FatiGO climbs up the GO hierarchy until the terms for the said level
are reached. The use of the parent terms increases the size of the classes
(genes annotated with a given GO term), making it easier to find relevant
differences in distributions of GO terms among clusters of genes. Once the
collections of GO terms corresponding to the two data sets of genes are pre-
pared, a Fisher’s Exact test for 2× 2 contingency tables is applied.
P -value adjustment is based on three different ways of accounting for
multiple hypothesis testing. These are the step-down minP method of West-
fall and Young [420], the false discovery rate (FDR) method of Benjamini
and Hochberg [31], which offers control of the FDR only under independence
and some specific types of positive dependence of the test statistics, and the
FDR method of Benjamini and Yekutieli [32], which offers strong control
under arbitrary dependency of test statistics.
Each program was sequentially provided with two lists of Flybasecgid gene
IDs, corresponding to proteins associated with wild type Belle (213 proteins)
and the K345N mutant (225 proteins) in the affinity purifications. The back-
ground set was the list of Flybasecg IDs of all Drosophila protein coding
genes, retrieved from BioMart, a query-oriented data management system
developed jointly by the Ontario Institute for Cancer Research (OiCR) and
the European Bioinformatics Institute (EBI).
The results of this functional profiling performed by two different pro-
grams is summarized in Table 5. The p-value cut-off applied to the list of
GO terms was 0.01. The output of GO Term Finder contained a bigger
number of entries with much lower corresponding adjusted p-values (several
orders of magnitude) than the output of FatiGO, which proved to be more
conservative. Only those GO terms that were present in both output files
(which in practice included all the results from FatiGO) are listed in Table 5.
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Enrichment was calculated as a ratio of the percentage of a particular
GO term in the experimental data set to the percentage of the same GO
term in the list of all Drosophila proteins. The discrepancy in the values of
enrichment calculated for the same GO terms by two programs are due to the
fact that these applications use different methods of annotation propagation.
GO Term Finder uses direct annotations only, while FatiGO uses annotations
that are propagated to parents. This leads to a different number of genes
being associated with a particular GO term and alters the percentage of the
term. The differences in the p-values are due to the statistical testing and
multiple hypotheses correction methods.
Regardless of which program was used the results were similar, so that all
GO terms that were identified as significantly enriched by FatiGO (p < 0.01)
were also present in the list provided by GO Term Finder. This included a set
of 54 GO terms significantly enriched in annotations of proteins associated
with wild type Belle, and a set of 43 GO terms for the K345N mutant.
The overlap between these two sets consisted of 39 GO terms. From the
remaining GO terms, 15 were specific to wild type Belle and 4 to K345N
mutant (highlighted in Table 5).
This specificity reflects the difference between the two sets of proteins
associated with wild type Belle and the mutant lacking ATPase activity. In-
directly, this could help to understand what this ATPase activity is most vital
for. There were significantly more proteins associated with wild type Belle
which were involved in processes such as RNP complex formation, cell cycle
and intracellular transport, including cytoskeleton and vesicle organization
and biogenesis (Table 5).
Functional enrichment analysis using FatiGO was also applied to iden-
tify which InterPro terms are over-represented in proteins associated with
Belle. Each InterPro term corresponds to a unique entry of the InterPro
database, which is a database of protein families, domains, repeats and sites
[299]. In addition to Gene Ontology terms, FatiGO simultaneously checked
for significant over-representation of InterPro terms. This information is im-
portant to find out which protein domains or sequence motifs are required
for interaction with Belle.
Multiple test correction to account for the multiple hypothesis tested (one
for each InterPro term) was performed as described above. The results of
this analysis are presented in Table 3.
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Table 3. InterPro terms significantly enriched in annotations of proteins associated
with Belle.
Enrichment Adjusted p-value
InterPro term Description Bellewt BelleK345N Bellewt BelleK345N
IPR000357 HEAT 11.7 15.1 2.16 · 10−5 4.34 · 10−9
IPR002194 Chaperonin TCP-1, con-
served site
38.9 41.9 2.16 · 10−5 8.24 · 10−7
IPR001844 Chaperonin Cpn60 29.2 31.4 4.35 · 10−5 3.22 · 10−6
IPR002423 Chaperonin Cpn60/TCP-1 29.2 31.4 4.35 · 10−5 3.22 · 10−6
IPR000629 RNA helicase, ATP-
dependent, DEAD-box,
conserved site
16.7 13.8 9.23 · 10−5 1.83 · 10−3
IPR000225 Armadillo 14.6 7.9 1.04 · 10−3 5.80 · 10−1
The HEAT repeat is a tandemly repeated module consisting of 37-47
amino acids, occurring in a number of cytoplasmic proteins including hunt-
ingtin, the 65 kD alpha regulatory subunit of protein phosphatase 2A (PP2A)
and the PI3-kinase TOR [9]. Arrays of HEAT repeats appear to function as
protein-protein interaction surfaces. It has been noted that many HEAT
repeat-containing proteins are involved in intracellular transport processes.
The armadillo (Arm) repeat is an approximately 40 amino acid long tandemly
repeated sequence motif. Animal Arm-repeat proteins function in various
processes, including intracellular signalling and cytoskeletal regulation, and
include such proteins as β-catenin and the nuclear transport factor importin-
α, amongst others [163]. The Armadillo repeat was not significantly enriched
in proteins associated with the mutant of Belle (Table 3, p > 0.01).
Both HEAT and Arm repeats are found in the Armadillo-like helical do-
main which consists of a multi-helical fold comprised of two curved layers
of alpha helices arranged in a regular right-handed superhelix. These super-
helical structures present an extensive solvent-accessible surface that is well
suited to binding large substrates such as proteins and nucleic acids.
The TCP-1 family of proteins act as molecular chaperones for tubulin,
actin and probably some other proteins. They are weakly, but significantly,
related to the cpn60/groEL chaperonin family. Drosophila proteins that
belong to this family have been shown to be associated with microtubules
[177].
Interestingly, the DEAD-box ATP-dependent RNA helicase conserved
site was found as significantly enriched. This indicates that Belle can interact
with other DEAD-box proteins. The DEAD-box helicases are involved in var-
ious steps of RNA metabolism, including nuclear transcription, pre-mRNA
splicing, ribosome biogenesis, nucleocytoplasmic transport, translation, RNA
decay and organellar gene expression.
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3.9 Bioinformatic analysis of interactions of proteins
associated with Belle
The affinity purification approach identified many proteins involved in trans-
lation and mRNA metabolism, but it did not provide information regarding
how these proteins work in concert with Belle and each other to elicit their
biological functions. To identify functional and structural modules or com-
plexes within the set of proteins associated with Belle I decided to build a
network of already known interactions of these proteins.
Protein-protein interactions mapped either by focused studies or by high-
throughput techniques are freely available in public repositories. A number
of software tools are available for network visualization and analysis. Here I
used Cytoscape to obtain and process network data. Cytoscape is an open
source bioinformatic software platform for visualizing molecular interaction
networks and biological pathways and integrating these networks with anno-
tations, gene expression profiles and other data [375, 72].
In Cytoscape, nodes representing biological entities, such as proteins or
genes, are connected with edges representing pairwise interactions, such as
determined protein-protein interactions. Nodes and edges can have associ-
ated data attributes describing properties of the protein or interaction. Based
on attribute values, Cytoscape can set visual aspects of nodes and edges. The
program also allows users to employ additional software modules, or “plu-
gins” that provide additional functionality in areas such as data query and
download services, data integration and filtering, GO enrichment analysis,
and protein complex or domain interaction detection [72].
The DroID-Plugin for Cytoscape was used, which provides access to
the Drosophila Interactions Database (DroID) from within the Cytoscape
environment. The Drosophila Interactions Database (DroID) is a “meta”
database which assembles gene or protein interaction data from a variety of
sources into one location. This database currently includes gene-gene and
protein-protein interactions. Because methods used to detect protein inter-
actions rarely record which protein variant from a gene was used, protein
interactions in the database are represented by pairs of genes. The precise
way to interpret a protein interaction represented as “gene A - gene B” is that
one or more proteins encoded by gene A interact with one or more proteins
encoded by gene B.
The core of DroID consists of three protein-protein interaction data sets
generated mostly in high-throughput yeast two-hybrid (YTH) screens. Finley
YTH includes data generated in the Finley laboratory using the LexA yeast
two-hybrid system (Zhong, Patel, Zhang, Mangiola, Stanyon, Finley, un-
published; [393], and Schwartz, Yu, Gardenour, Finley, Ideker, submitted).
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CuraGen YTH contains interactions detected in a high throughput yeast
two-hybrid screen conducted at the CuraGen Corporation [140]. Hybrigen-
ics YTH includes interactions detected in high throughput yeast two-hybrid
screens conducted at Hybrigenics [121].
DroID also contains experimentally derived physical interactions other
than those from the three major YTH data sets described above. These in-
teractions are collected from the large databases (BioGRID, IntAct, MINT).
The ordinal database source and information is available for each interaction.
Gene-gene interactions downloaded from Flybase which represent inter-
actions between two gene alleles are also included in the DroID database.
For example, an allele of one gene may enhance or suppress the phenotype
of an allele in another gene, or the combination of two alleles may result in
a “synthetic” phenotype not observed for either of the individual alleles.
Detected Drosophila protein interactions do not cover the whole fly pro-
teome. The DroID database collected and integrated protein-protein in-
teractions for yeast, worm, and human from online interaction databases
(BioGRID, IntAct, MINT). Proteins in the obtained interaction sets were
then mapped to fly orthologs using InParanoid [350], which is an orthology
mapping algorithm. Thus, in addition to detected Drosophila protein inter-
actions the DroID database covers predicted interactions between Drosophila
proteins based on experimental evidence for interactions between orthologous
proteins in other species.
From the 336 proteins associated with Belle, 221 formed 1402 interactions
with each other, including interactions of a protein with itself. The resulting
network is shown in Fig. 37. Proteins are indicated by circular nodes and
interactions by lines or edges. The colour of an edge corresponds to the
nature of the interaction it represents, as shown in the figure legend. The
legend is explained below:
• D.m. main YTH—interactions of Drosophila proteins that were found
in the three high-throughput yeast two hybrid screens conducted by
the Finley laboratory, CuraGen and Hybrigenics.
• D.m. other physical—experimentally derived physical interactions of
Drosophila proteins collected from the large online databases such as
BioGRID, IntAct, and MINT, which were not present in the main YTH
data sets.
• D.m. genetic—genetic interactions of Drosophila genes downloaded
from Flybase.
• S.c. predicted—high confidence physical interactions of Saccharomy-
ces cerevisiae orthologs of Drosophila proteins collected from BioGRID,
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IntAct and MINT databases.
• H.s. predicted—high confidence physical interactions of human or-
thologs of Drosophila proteins collected from BioGRID, IntAct and
MINT databases.
• Other—physical interactions collected from the literature and from un-
published results from our laboratory.
To identify clusters (highly interconnected regions) I employed the MCODE-
Plugin for Cytoscape which finds clusters in a network [21]. Clusters in a
protein-protein interaction network often represent protein complexes and
parts of pathways. I used MCODE with the default parameter settings and
identified 11 clusters with number of nodes ≥ 3 and score ≥ 1 (Table 4).
Table 4. Clusters identified using MCODE-Plugin in the network of proteins
associated with Belle.
Cluster Score Nodes No. Edges
Ribosome and eIFs 20.93 43 943
Splicing complex 5 11 66
Chaperonin-containing T-complex 2.857 7 20
COPI vesicle coat 2.167 6 19
CCR4-NOT complex 2 5 14
Proteasome 1.429 7 16
Tubulin complex 1.4 5 11
DNA replication factor complex 1.25 4 9
mRNA cleavage and polyadenylation complex 1 3 6
Cell cycle checkpoint complex 1 3 6
Signal recognition particle 1 3 4
Analysis of the Gene Ontology annotations of the proteins that cluster
together shows that the clusters represent real protein complexes found in
the cell. Proteins that belong to the same cluster are coloured the same on
Fig. 37. In addition to these MCODE identified protein complexes, I included
complexes that were known from the literature but were only partially present
(RISC, decapping enhancer complex, poly(A)-binding complex, microtubule-
associated complex and AP-2 clathrin adaptor complex). Taking all these
protein complexes into account, the interaction network of proteins associated
with Belle could be simplified, as shown in Fig. 38.
3.10 Belle interacts with translation factors and RNA-
binding proteins
To confirm the results of the affinity purification, I performed immunopre-
cipitations from total lysates of wild type S2 cells and cells expressing tagged
3.10 Belle interacts with translation factors and RBPs 90
Proteasome
40S
eIF
complex
Poly(A)-binding
complex
RISC
R4/NOTCC
complex
AP-2
complex
Tubulin
complex
COPI vesicle
coat
Cell cycle checkpoint
complex
DNA replication
complex
Microtubule-associated
complex
60S
CCT
complex
Decapping enhancer
complex
SRP
Splicing
complex
3´-end processing
complex
Figure 38. Putative protein complexes identified by the network cluster analysis.
A simplified representation of the interaction network of proteins associated with Belle
in Drosophila S2 cells. Putative protein complexes (nodes) are coloured as corresponding
proteins in Fig. 37. Only direct interactions between complexes are shown (edges).
3.10 Belle interacts with translation factors and RBPs 91
α-HA
α-Belle
10% Input α-HA-IP
116
97
 55
 66
212
 42.7
KDa
97
H
A
-M
B
P
H
A
-A
G
O
2
H
A
-M
e3
1B
H
A
-T
ra
l
H
A
-e
IF
4E
H
A
-e
IF
4G
158
H
A
-M
B
P
H
A
-A
G
O
2
H
A
-M
e3
1B
H
A
-T
ra
l
H
A
-e
IF
4E
H
A
-e
IF
4G
10% Input α-Belle IP
α-Belle
α-EDC3
α-Tral
Pre-I α-Belle
RNase A– + – +
α-PABP-C
α-Ge-1
α-GW182
– + – +
Pre-I α-Belle
A B
Figure 39. Endogenous Belle interacts with translation initiation factors and RNA
binding proteins.
(A) Lysates from S2 cells were immunoprecipitated using anti-Belle rabbit serum (α-
Belle) or rabbit pre-immune serum (Pre-I). Inputs (10%) and immunoprecipitates (IPs)
were analyzed by Western blotting using polyclonal antibodies against endogenous pro-
teins as indicated on the right. Immunoprecipitates were performed in the presence (+)
and absence (-) of RNase A. (B) Epitope HA-tagged versions of MBP (maltose binding
protein), AGO2, Me31B, Tral, eIF4E and eIF4G were transiently expressed in S2 cells
as indicated above the panels. Cell lysates were immunoprecipitated using a monoclonal
anti-HA antibody. Inputs (10%) and immunoprecipitates (IPs) were analyzed by Western
blotting using a polyclonal anti-HA antibody. The presence of endogenous Belle in the
immunoprecipitates was tested by Western blotting with anti-Belle antibody.
versions of proteins identified by mass spectrometry. Using the antibod-
ies available in our laboratory I immunoprecipitated endogenous GW182,
a miRNP complex component [347, 30]; PABP-C, the cytoplasmic poly(A)-
binding protein; and Tral (Trailer Hitch/Lsm14), EDC3 and GE-1, which are
components of the decapping enhancer complex [424, 118, 405]. GW182 was
not on the list of Belle-associated proteins and therefore it served as a neg-
ative control. EDC3 was not detected either but was nevertheless included
because other components of decapping enhancer complex (Me31B and Ge-1)
were present amongst proteins associated with Belle. I found that endoge-
nous Belle co-immunoprecipitated with endogenous PABP-C and Tral; the
signal of EDC3 was barely above the background level. The interactions
were RNA-dependent and were not observed in the presence of RNase A
(Fig. 39A).
In cases when antibodies were not available I used an epitope-tagging ap-
proach and expressed HA- or EGFP-tagged versions of the proteins of inter-
est. Endogenous Belle was found to co-immunoprecipitate with HA-tagged
versions of AGO2, Me31B, Tral, eIF4E and eIF4G although the relative
binding efficiency was low (Fig. 39B).
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Figure 40. Interaction of Belle with eIF4E and eIF4E-T.
(A, B) HA-tagged wild type Belle or the indicated Belle mutants were cotransfected in
S2 cells with EGFP fusions of eIF4E. (C) HA-tagged wild type Belle was cotransfected
with EGFP fusions of eIF4E-T. Cell lysates were immunoprecipitated using a monoclonal
anti-HA antibody. Inputs (10%) and immunoprecipitates were analyzed by Western blot-
ting using polyclonal anti-HA and anti-GFP antibodies. In all panels HA-tagged maltose
binding protein (MBP) served as a negative control.
eIF4E binds to the mRNA 5′ cap structure m7GpppN (where N is any
nucleotide), and promotes ribosome binding to the mRNA in the cytoplasm.
It has been demonstrated that DDX3, the human ortholog of Belle, is an
eIF4E-binding protein [378]. Several eIF4E-binding proteins recognize eIF4E
via a consensus YxxxxLΦ motif (the symbol “Φ” represents a hydrophobic
residue) [353]. The sequence of DDX3 contains a functional eIF4E-binding
motif (YIPPHLR) that interacts with a conserved Y73 residue within the
dorsal surface of eIF4E, as occurs with other eIF4E-binding proteins [378].
This motif with a single substitution of I to V is present inD. melanogaster
Belle at amino-acid residues 46-52 (Fig 29A). To determine whether the inter-
action of Belle with eIF4E is dependent on this putative eIF4E-binding mo-
tif, I introduced amino-acid substitutions in the YVPPHLR motif (Fig. 29A)
and examined the effect of the mutations on eIF4E-binding. The mutants
of Belle in which the conserved Y64 or L51 residue was replaced with A
showed the same level of binding to eIF4E as the wild type Belle (Fig. 40A).
Combining these two mutations together also did not change the the ability
of Belle to bind eIF4E (Fig. 40B), suggesting that the YVPPHLR motif is
not required for the Belle-eIF4E interaction. Interestingly, the K345N muta-
tion which abolishes the putative ATPase activity of Belle also impaired the
Belle-eIF4E interaction (Fig. 40A). This finding is consistent with the results
of the affinity purification (see Table 6).
eIF4E-T (Transporter) is a nucleocytoplasmic shuttling protein that con-
tains a functional eIF4E-binding motif, which mediates the nuclear import
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of eIF4E via the importin-α/β pathway by a piggy-back mechanism [95]. In
human cells, eIF4E and eIF4E-T also interact with RCK/p54 (the human or-
tholog of Me31B) and localize to cytoplasmic P bodies. The D. melanogaster
ortholog of eIF4E-T is a gene product of CG32016, the protein that was found
associated with Belle in my affinity purification. I found that a small frac-
tion of EGFP-tagged CG32012-PC (the longest isoform of D. melanogaster
eIF4E-T) co-immunoprecipitated with HA-Belle (Fig. 40C). The short iso-
form CG32012-PE, which lacks the protein’s N-terminal fragment with the
eIF4E-binding motif, did not co-immunoprecipitate above the background
levels observed with the negative control, an HA-tagged version of MBP
(data not shown). It is likely that the interaction of Belle and eIF4E-T is
not direct and is probably mediated by eIF4E.
The results of the affinity purification of Belle complexes corroborated
by immunoprecipitation assays suggest that Belle interacts with Me31B. In
the D. melanogaster oocyte, Me31B is found within maternal mRNA gran-
ules and is required for the proper translational control and localization of
the oskar mRNA. These mRNP complexes contain the RNA localization
protein EXU and Y-box domain protein YPS [303]. EXU contains RNase
D-type exonuclease domain that is similar to those found in deadenylases
[295]. In the early Drosophila embryo Me31B is localized to polar granules
where it forms complexes with the Tudor-domain protein TUD or with the
DEAD-box helicase VAS. Both complexes also contain the PIWI-like protein
AUB, eIF4A and TER94, the transitional ER membrane associated AAA
ATPase [402]. In S2 cells, Me31B associates with decapping enzyme DCP2,
and with decapping activator DCP1 and enhancer of decapping EDC3 [405].
Another complex that contains Me31B and DCP1 also includes Tral, YPS
and translation repressor CUP ([424] and Tritschler et al., in press).
Dhh1p, the S.cerevisiae ortholog of Me31B, physically interacts with sev-
eral proteins involved in mRNA decapping including the decapping enzyme
Dcp1p and Pat1p. Dhh1p also associates with Pop2p, a subunit of the CCR4-
NOTmRNA deadenylase complex [74]. Moreover, Dhh1p and Pat1p function
as translational repressors [73].
Since Me31B is able to interact with many different proteins, I selected
several Me31B partners which were identified in the affinity purification of
Belle complexes and also included some Me31B partners that were not on the
list of Belle-associated proteins. I tested whether EGFP fusions of selected
proteins co-immunoprecipitate with HA-tagged Belle when co-expressed in
S2 cells.
I found that EGFP-PAT1 (CG5205), the fly ortholog of yeast Pat1p, co-
immunoprecipitated with HA-tagged Belle (Fig. 41A). I obtained a similar
result for EGFP fusions of EDC3 (Fig. 41C), YPS (Fig. 41E) and CAF1
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Figure 41. Interaction of Belle with different partners of Me31B.
HA-tagged wild type Belle was cotransfected in S2 cells with EGFP fusions of PAT1 (A),
DCP1 (B), EDC3 (C), EXU (D), YPS (E) and CAF1 (F). Cell lysates were immuno-
precipitated using a monoclonal anti-HA antibody. Inputs (10%) and immunoprecipitates
were analyzed by Western blotting using polyclonal anti-HA and anti-GFP antibodies. In
all panels HA-MBP served as a negative control.
(CG5684), the Drosophila ortholog of yeast Pop2p (Fig. 41F). Only a small
fraction of EGPF-DCP1 and EGFP-EXU co-immunoprecipitated with HA-
Belle (Fig. 41B and D). Consistent with that, only PAT1 and CAF1 were
identified in our affinity purification (Table 6).
Drosophila AGO2 is a key component of the siRNA-mediated gene silenc-
ing pathway [180]. In S2 cells AGO2 is associated with dFMR1, the fly or-
tholog of FMRP, and the DEAD-box helicase Rm62, the fly ortholog of mam-
malian p68/DDX5 [188]. AGO2 colocalizes with dFMR1, Tral, Me31B and
Rm62 in RNP granules in embryos [293]. Mammalian p68 is also found in the
Microprocessor complex [149, 125] together with DDX3 and DDX17/p72 (the
mammalian orthologs of Belle and CG10077, respectively). AGO2, Rm62
and CG10077 were identified as Belle-associated proteins in the affinity pu-
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Figure 42. Interaction of Belle with AGO2, DEAD-box helicases and RNA-binding
proteins.
HA-tagged wild type Belle was cotransfected in S2 cells with EGFP fusions of AGO2 (A),
Rm62 (B), CG10077-PA (C), dFMR1 (D), Imp (E), Pasilla (F) and Penguin (G). Cell
lysates were immunoprecipitated using a monoclonal anti-HA antibody. Inputs (10%)
and immunoprecipitates were analyzed by Western blotting using polyclonal anti-HA and
anti-GFP antibodies. In all panels HA-MBP served as a negative control.
rification (Table 6). This result was confirmed by the co-immunoprecipitation
assay (Fig. 42A, B, C).
The fragile X mental retardation protein (FMRP) is involved in regu-
lation of mRNA translation, stability and localization [443]. In dendrites,
mammalian FMRP is a component of RNA-transporting granules composed
of many kinds of proteins, including DDX3, p68/DDX5, translation factors
EF-1α, eIF2α, eIF2β and SYNCRIP (proteins which were also identified in
the affinity purification, Table 6). These granules are transported by kinesin
coordinately with opposite motors, such as dynein [206]. dFMR1 shares the
fundamental and characteristic molecular architecture with the mammalian
homologues (KH RNA-binding domains), implying functional conservation.
In S2 cells, dFMR1-containing RNP granules are transported along micro-
tubules by both kinesin-1 and cytoplasmic dynein [260]. In neuronal cells
dFMR1 interacts with Me31B and Tral, where it forms neuronal granules
together with AGO2, eIF4E, PABP, DCP1, UPF1, and the translational
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regulators YPS, Imp and Pumilio [24]. Although dFMR1 was identified
in the affinity purification of Belle protein partners, it was not efficiently
co-precipitated with Belle from lysates of cells expressing HA-Belle and an
EGFP fusion of dFMR1 (Fig. 42D).
Drosophila IGF-II mRNA binding protein (Imp) is a homolog of the
chicken zipcode binding protein ZBP1, and of the human IFG-II mRNA-
binding protein, all of which contain four KH RNA-binding domains. Imp
RNP particles are actively transported in oogenesis, as well as in neurons
by the microtubule motors, dynein and kinesin. In addition, Imp associates
with dFMR1 in Drosophila ovaries [42].
Pasilla is a Drosophila NOVA-like protein that contains two KH RNA-
binding domains. Its mammalian homologs are implicated in splicing regu-
lation in neurons [334].
Although both Pasilla and Imp have a rather low Mascot score on the list
of proteins associated with Belle (Table 6), both co-precipitated with Belle
(Fig. 42E, F).
Pumilio is a member of a widespread PUF protein family of RNA-binding
proteins that is implicated in mRNA translation and stability control [422].
Another recently annotated D. melanogaster protein that belongs to this
family is Penguin. Peptides with a low Mascot score matching Pumilio and
Penguin were identified in our mass spectrometry analysis of affinity purified
Belle-associated proteins (Table 6). Consistent with this, only the association
of Penguin with Belle was confirmed by the co-immunoprecipitation assay
(Fig. 42G).
3.11 Belle associates with mRNAs that are regulated
at the level of translation
The results of the affinity purification and co-immunoprecipitation assays
suggest that endogenous Belle is associated with various types of mRNPs in
the cell. If the function of Belle is to regulate translation then it is likely that
these mRNPs contain mRNAs that are regulated on a translational level. To
test this hypothesis I decided to analyze the RNAs that co-immunoprecipitate
with the endogenous protein in lysates from Drosophila S2 cells. For this,
lysates were immunoprecipitated in presence of RNase inhibitor using anti-
Belle or pre-immune rabbit serum. Total RNA was extracted from the im-
munoprecipitates and an RT-PCR was performed using primer pairs specific
for different RNA species. I decided to look for ribosomal 18S RNA; protein-
coding mRNAs of CG2852 and CG17068 which are expressed at a low level;
a highly-abundant Rp49 mRNA; and mRNAs which expression is regulated
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Figure 43. Belle is associated with various mRNAs in S2 cells.
Lysates from S2 cells were immunoprecipitated using anti-Belle rabbit serum (α-Belle)
or rabbit pre-immune serum (Pre-I). Total RNA extracted from the immunoprecipitates
was analyzed by RT-PCR using primers specific to the genes indicated on the left. The
positive or negative signs on the right of the panels indicate that the reverse transcriptase
was included (RT+) or omitted (RT-).
at the post-transcriptional level. These included Act5C and cyclin B mRNAs
(translational control), and mRNAs of an LTR (17.6 ) and non-LTR retro-
transposon (Juan), which are regulated by RNAi (Fig. 43).
Several mRNAs were found to be efficiently and specifically co-immuno-
precipitated with endogenous Belle. The efficiency of precipitation was inde-
pendent of the abundance of a particular mRNA in the cell. This is demon-
strated in Fig. 43, based on a comparison of the signals of Act5C and Rp49
mRNAs (highly abundant); 17.6 and Juan mRNAs (less abundant); and
CG2852, CG17068 and cyclin B mRNAs (rare). Ribosomal 18S RNA was
present in immunoprecipitates obtained both with anti-Belle and pre-immune
serum.
Interestingly, among the seven mRNAs tested, Act5C and cyclin B mR-
NAs were the most efficiently precipitated (Fig. 43). β-Actin mRNA is lo-
calized near the leading edge in several cell types (reviewed in [75]). The 3′
UTR contains the “zipcode” sequence which is absolutely essential for correct
targeting and localized translation of β-actin mRNA. Several regions in the
zipcode are conserved among β-actin mRNAs of several species, in particular
the sequence ACACCC, two copies of which are present in the Act5C mRNA
3′ UTR. This sequence is recognized by ZBP1, a KH-domain RNA-binding
protein. The D. melanogaster ortholog of ZBP1 is Imp, which was found to
be associated with Belle (Table 6 and Fig. 42E).
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Translation of cyclin B mRNA in Drosophila is regulated in the embryo by
Pumilio, Nanos, and the deadenylase complex and PNG kinase complex [16,
33, 202, 408]. Two Drosophila PUF-domain proteins, Pumilio and Penguin,
as well as the deadenylase complex components CAF1, CCR4 and NOT
proteins were found to be associated with Belle.
Taken together these results suggest that Belle associates with mRNAs
that are regulated at the level of translation.
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4 Genome-wide analysis of mRNAs regulated
by Drosha and Argonaute proteins
in Drosophila
The first part of my thesis work was dedicated to identification of mRNAs
regulated by Drosha and Argonaute proteins at the genomic level. In this
chapter I will discuss in more detail the results published in [348] and de-
scribed in § 2, taking into account the progress that was achieved in the
miRNA field after these results have been published.
4.1 Transcripts regulated by Drosha and Argonaute
proteins
Using microarray analysis of Drosophila cells depleted of Drosha and Arg-
onaute proteins, we show that transcripts whose levels are likely to be di-
rectly regulated by silencing pathways (up-regulated transcripts) represent
less than 20% of the Drosophila S2 cells transcriptome (Fig. 15 D, Fig. 16
and [348], Supplementary Tables). However, computational predictions of
miRNA targets indicate that more than 30% of the transcriptome is targeted
by miRNAs [106, 256, 356, 395, 394]. There are several possible explanations
for these seemingly contradictory results. Firstly, I observed that not all au-
thentic targets change levels in a detectable manner (Fig. 18). This indicates
that although microarrays are a valuable tool to identify miRNA targets (see
also [256]), many targets may escape detection using this approach. Second,
some miRNAs and targets are expressed in a tissue specific manner, so it
is likely that only a subset of miRNA/target pairs is expressed in S2 cells
[106, 115, 238, 244, 394]. Finally, current models of miRNA function sug-
gest that miRNAs expressed in a given cell type target transcripts that are
already expressed at low levels, but avoid house keeping genes or genes that
are expressed in these cells at high levels [115, 256, 394]. Targets which are
expressed at low levels may escape detection by microarray analysis. Nev-
ertheless, among transcripts regulated by the Argonaute proteins we found
several that are expressed at relatively high levels, suggesting that miRNAs
not only silence the expression of undesirable low abundance transcripts, but
may also play a role in fine-tuning the expression of abundant mRNAs.
4.2 Crosstalk between AGO1 and AGO2
AGO1 and AGO2 are thought to have non-overlapping functions in Droso-
phila [318, 344]. In this study we show that these proteins regulate the
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expression levels of a common set of miRNA targets (Fig. 16). The observa-
tion that Drosha also regulates these transcripts strongly supports the idea
that regulation is mediated by miRNAs. In agreement with this, it was ob-
served that AGO2 can associate with endogenous miRNAs, although less
efficiently than AGO1 (Fig. 20). In this way, AGO2 may also regulate the
expression levels of a subset of miRNA targets. Nonetheless, when miRNA
function was assayed by over-expressing miRNAs together with luciferase-
based mRNA reporters, it was observed that miRNA-mediated translational
repression requires AGO1, but not AGO2. It is therefore possible that in this
assay the fraction of miRNAs incorporated into AGO2-containing RISCs is
too small to observe changes in the expression levels of the reporter. Dicer-1 is
involved in miRNA biogenesis and is also required for the assembly of RISCs
[250], so our observations suggest that Dicer-1 may load AGO2-containing
RISCs with miRNAs, at least to some extent.
A partial functional overlap between AGO1 and AGO2 is also suggested
by the observation that these proteins regulate the expression of a common
set of transposable elements (Fig. 23).
Apart from the commonly regulated transcripts, we have also identified
transcripts individually regulated by AGO2, but not by Drosha or AGO1,
suggesting that AGO2 may regulate the expression of these transcripts by
an miRNA-independent mechanism that might involve endogenous siRNAs.
Recent studies on an endogenous small interfering RNA pathway have
led to the discovery of diverse intramolecular and intermolecular substrates
that generate endo-siRNAs in Drosophila [137, 315, 316, 208, 80, 69]. These
findings suggest broad and possibly conserved roles for endogenous RNAi in
regulating host-gene expression and transposable element (TE) transcripts
(reviewed in [319]). Most of these endo-siRNA classes are derived from TE,
from complementary annealed transcripts, and from long “fold-back” tran-
scripts called hairpin RNAs (Fig. 44).
Consistent with my observation that AGO2 regulates the expression of
TEs, deep sequencing of the small RNAs that directly associate with AGO2
revealed that TEs are a substantial source of endo-siRNAs of precisely 21
nt [208, 80]. A similar result has been obtained by sequencing small RNAs
enriched for AGO2-loaded RNAs [137] or by analyzing total head or cultured-
cell RNAs [69].
It has also been demonstrated that siRNAs can be produced from cis-
natural antisense transcript (cis-NAT) arrangements, genomic regions that
encode exons on both DNA strands and can involve 5′, 3′ or internal ex-
ons. Only a subset of co-expressed cis-NAT pairs are selected for endo-
siRNA production (ca. 140), presumably reflecting endogenous functional
use. Virtually all cis-NAT-siRNAs in flies are derived from 3′ UTR overlaps
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Figure 44. Substrates for endo-siRNA production in D. melanogaster. Modified
from [319].
[137, 315, 208, 80].
Bioinformatic studies in Drosophila revealed a number of loci that pro-
duce endo-siRNAs from extended inverted repeats transcribed into hairpin
RNAs (hpRNAs), the stems of which were up to 400 base pairs in length [316].
At least seven distinct loci generate endo-siRNAs [316, 208, 80]. As with siR-
NAs from artificial long-inverted repeats, the siRNA duplexes derived from
hpRNAs are phased and direct AGO2 to carry out target transcript cleavage.
Generation of endo-siRNAs is dependent on Dicer-2 and, surprisingly,
on the Dicer-1 partner Loquacious [315, 316, 208, 80, 69]. The endogenous
siRNA biogenesis pathway is shown in Fig. 45.
In agreement with the results obtained in our study, known miRNAs
comprised more than 97% of AGO1-associated RNAs and up to 8% of the
AGO2-bound species in S2 cells. The contribution of transposons and satel-
lite repeats to AGO2-associated endo-siRNAs is 27% and just 0.5% in the
case of AGO1-associated RNAs.
The remaining endo-siRNAs are derived from hpRNAs or from cis-NATs
[80]. Relative levels of endo-siRNAs generated from each convergent cis-
NAT were low, and no or little change (up to a ∼ 1.3-fold increase) in the
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Figure 45. Endo-siRNA pathway in D. melanogaster. Modified from [319].
Drosophila cells produce several sources of endogenous dsRNA—transposable elements
(TEs), cis-natural antisense transcripts, trans-natural antisense transcripts and hairpin
RNA transcripts—that are processed into endo-siRNAs that load mostly AGO2. These
repress transposon transcripts or endogenous mRNAs.
expression of such genes was detected in AGO2 mutant ovaries. This result
explains why genes regulated by endo-siRNAs were not considered regulated
in our AGO2 knock-down experiments.
4.3 miRNAs affect mRNA expression levels
The levels of hid and reaper mRNAs (two experimentally validated miRNA
targets [46, 395]), increase in cells in which the miRNA pathway is impaired.
Moreover, by analyzing changes in mRNA levels, additional miRNA targets
in Drosophila have been identified and validated (Table 1, Fig. 17, 18). The
observation that miRNA targets change levels following inhibition of the
miRNA pathway lends further support to the idea that miRNAs can reduce
the levels of the targeted transcripts, and not just the expression of the
translated protein [22, 256, 368]. Along these lines, it has recently been shown
that miRNAs can trigger a strong reduction in target levels in mammals,
zebrafish, Drosophila and C. elegans [432, 141, 30, 22]. It was observed that
among the 136 core transcripts, 21% are between 1.5 and 2-fold up-regulated,
73% exhibited changes in the 2-5-fold range and 6% were at least 5-fold up-
regulated in AGO1-depleted cells ([348], Supplementary Table VI). Thus,
although changes in transcript levels can be used to validate miRNA targets
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[256], the effects can be modest and, as mentioned above, not all targets can
be identified using this approach.
In human cells the Argonaute proteins localize to P bodies [262, 341, 361,
374]. These are specialized cytoplasmic foci in which the enzymes involved in
mRNA degradation in the 5′ to 3′ direction co-localize (e.g. the DCP1:DCP2
decapping complex, and the 5′ to 3′ exonuclease XRN1 [361, 374]). In ad-
dition, mRNA decay intermediates, miRNA-targets and miRNAs have been
observed in P-bodies suggesting a functional link between P-bodies and RNA
silencing pathways [361, 374]. Consistent with this, several groups have re-
cently shown that P body components play a crucial role in silencing path-
ways [91, 191, 261, 347]. In particular, the RNA-binding protein GW182
(a P body component in metazoa) and the DCP1:DCP2 decapping complex
are required for miRNA-mediated gene silencing in Drosophila cells [347].
Likewise, human GW182 plays a role in silencing mediated by miRNAs and
siRNAs [190, 261]. Finally, the C. elegans protein AIN-1, which is related
to GW182, is also required for regulation of a subset of miRNA targets
[91]. Together with the observation that miRNAs inhibit cap-dependent,
but not cap-independent, translation initiation [341], these observations sug-
gest a model in which miRNA targets are stored in P-bodies after transla-
tion inhibition, where they are maintained in a silenced state by associating
with proteins that prevent translation or possibly by removal of the cap
structure [91, 261, 341, 347, 361, 374]. Decapping or simply the storage of
miRNA targets in P-bodies may make these mRNAs susceptible to degra-
dation, providing a possible explanation for the reduction in mRNA levels
[262, 347, 361, 374]. In agreement with this, depletion of a 5′ to 3′ exonuclease
in C. elegans partially restores the levels of miRNA targets [22].
More recent studies have demonstrated that in animal cells, miRNAs
cause decay of mRNA targets by directing mRNAs to the general mRNA
degradation machinery. This hypothesis is supported by studies in zebrafish
embryos, C. elegans, Drosophila and human cells showing that miRNAs ac-
celerate deadenylation and decapping of their targets [30, 141, 434, 113].
Nevertheless, not all authentic miRNA-targets change expression levels.
Thus it is possible that the extent of the degradation depends on the number
of miRNA binding sites and/or the stability of the miRNA:mRNA duplexes.
It is also possible that the rate of mRNA decay triggered by miRNAs for some
targets does not exceed the rate of transcription, and thus the steady-state
levels of these targets remain unchanged. It would therefore be of interest
to determine whether miRNAs generally cause a reduction in the half-life of
targeted transcripts.
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4.4 Drosha regulate mRNAs independently
of Argonaute proteins
DsRNA stem-loop structures found within intronic regions or the coding se-
quence of some transcripts are cleaved by the RNase III enzyme Rnt1p in S.
cerevisiae [83, 131]. This cleavage triggers degradation of pre-mRNAs and
lariat introns or mature mRNAs, therefore inhibiting gene expression. Hu-
man and Drosophila Drosha forms a large complex (500 kDa in Drosophila)
known as “Microprocessor”, in which it interacts with its cofactor, DGCR8
(or Pasha in Drosophila) [85, 149]. Both proteins are essential for pri-miRNA
processing [149, 160] (Fig. 13). Several studies suggest that the Drosha com-
plex may also cleave preribosomal RNA [124, 149, 247, 431], but whether
Microprocessor is able to cleave pre-mRNAs remains unknown.
Two transcripts (CG15861 and CG31642 ) were clearly found to be ex-
clusively up-regulated in Drosha-depleted cells (Fig. 21A, E). I found that
these genes were also up-regulated in Pasha depleted cells (Fig. 22A), consis-
tent with a role for Pasha in promoting Drosha-mediated cleavage of dsRNA
hairpins of pri-miRNA [85]. The fact that the expression levels of these
genes were not up-regulated in AGO1- and AGO2-depleted cells argues for
their independence from miRNA/siRNA-mediated repression. In addition,
pre-mRNA levels of CG15861, and CG31642, as well as Stathmin-14 which
contains the complete sequence of CG31642 within its fourth intron, were in-
creased in Drosha- and Pasha-depleted cells, suggesting that Drosha cleaves
unspliced pre-mRNAs. However, an indirect effect on transcription of these
genes can not be completely ruled out. It remains to be established whether
Drosha indeed cleaves the CG15861 and CG31642 pre-mRNAs.
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5 A role for Drosophila RNA-helicase Belle
in translational control
As a result of numerous studies, RNA helicases of the DEAD-box family have
been linked to different stages of RNA metabolism (reviewed in [77, 259]).
They have been implemented in transcription, processing, splicing, export,
localization, translational control and decay of mRNAs [357]. In all these
processes, inappropriate or transitory RNA-RNA or RNA-protein interac-
tions can be deleterious for subsequent steps, and therefore they require
energy-driven helicases to allow the correct assembly of the complexes.
Although most DEAD-box helicases have similar enzymatic activities, it
is often difficult to assign a defined molecular function to a given DEAD-
box helicase in a particular cellular process [357]. In addition, the same
DEAD-box protein can be involved in several diverse processes [357, 77] and
even have a dual function in promoting two opposite activities. For example
Ded1p, the S. cerevisiae ortholog of Belle, has been suggested to promote
translation initiation [68, 84], while other observations raise the possibility
that Ded1p has both a positive and negative role in translation [28].
Similar data are accumulating regarding the role of DDX3, the human
ortholog of Belle, in translation. A potential function for DDX3 in trans-
lation initiation was suggested by the observation that human DDX3 (as
well as Drosophila Belle and the mouse ortholog PL10) can rescue the lethal
phenotype of a ded1 null mutant [269, 68, 201]. A homolog of DDX3 was de-
tected both in free mRNP and polysome fractions in Chironomus tetans [306].
Moreover, human DDX3 associates with the translation initiation complex
components eIF4A, eIF2α and PABP1, and promotes translation of mRNAs
containing a long or structured 5′ UTR [240]. A complementary study has
shown that DDX3 interacts with the cytoplasmic multi-subunit translation
initiation factor eIF3 in an RNase insensitive manner and promotes transla-
tion [245].
However, experiments involving RNAi knock-down and over-expression
of DDX3 in mammalian cells have led to the view that this protein does
not function in translation initiation, but instead represses cap-dependent
translation by acting as an eIF4E-inhibitory protein [378]. It has been also
demonstrated that in HeLa cells under stress conditions DDX3 is recruited to
stress granules and that over-expression of DDX3 induces relocalization of its
interacting partners (eIF4A, eIF4E, PABP) to stress granules [240]. Stress
granules are cytoplasmic mRNP granules that are formed by aggregation of
non-translating mRNAs as a response to stress [8].
In addition, mammalian DDX3 has been identified as a component of
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RNA-transporting granules in neurons together with ribosomal proteins,
RNA-binding proteins, transported mRNAs and transporting motor pro-
teins [206, 105]. Although not proven, it is thought that the mRNAs are
transported in a translationally quiescent state [44].
Taken together, these observations indicate that mammalian DDX3 and
its yeast ortholog Ded1p have conserved roles both in translation initiation
and repression. In this work I have tried to delineate a possible role for
Drosophila Belle in translational control using several different approaches.
5.1 The subcellular localization of Belle
The subcellular localization of mammalian DDX3 has been difficult to estab-
lish. Several previous studies reported that DDX3 was found mainly in the
nucleus with only low levels in the cytoplasm [325, 441]. In another study,
however, DDX3 was detected in endoplasmic reticulum in discrete foci [269].
A further, more recent study has shown that DDX3 shuttles between the
nucleus and the cytoplasm, binds the export receptor CRM1, and locates to
nuclear pores [437]. DDX3 and other DEAD-box helicases were also found
among proteins associated with the spliceosome [448, 286].
DEAD-box RNA helicases often localize to various RNA granules (see
[109, 7] and references wherein). P bodies in many species, including S.
cerevisiae, D. melanogaster and mammals contain the helicase Dhh1 (Me31B
or RCK/DDX6) [376, 439], which is also concentrated in sponge bodies,
maternal mRNPs and neuronal transport RNA granules [303, 24]. Germ-
line-specific RNA granules in Drosophila such as nuage and polar granules
contain the DDX4-like helicase Vasa [253].
As mentioned above, DDX3 along with the DDX5/p68, DDX6/RCK and
DDX17/p72 DEAD-box helicases was detected in neuronal transport mRNP
granules [206, 105] and in stress granules under stress conditions [240]. A
recent study from R. Parker’s laboratory has shown that S. cerevisiae Ded1p
is a component of yeast P bodies. Moreover, it was observed that Drosophila
Belle colocalizes with dFMR1 in foci in the neurites [28]. These results argue
that DDX3 and its orthologs are conserved components of P bodies and
related RNA granules.
In the original immunofluorescence study in Drosophila ovaries, Belle was
found to be concentrated in the perinuclear region of nurse cells (nuage) and
in the posterior pole of oocytes [201].
I used HA- and EGFP-tagged versions of Belle to localize the protein in
Drosophila S2 cells. I observed that Belle forms large aggregates in the cyto-
plasm (Fig. 24). The distribution of the HA-tagged protein in the cytoplasm
was remarkably similar to the localization of endogenous Belle in cell bodies
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of Drosophila neurons [28]. Moreover, the EGFP-fusion of Belle showed less
diffused cytoplasmic staining and formed discrete foci of varying number and
size. Interestingly, these foci were different from P bodies, since no colocal-
ization with P body markers Me31B, DCP1 and Ge1 was observed (Fig. 24B,
C, D). The deviance of localization patterns of HA- and EGFP-Belle might
be due to the difference in the expression levels of the fusion proteins, or
alternatively, due to the properties of the tag.
The nature of Belle heterogenous distribution in the cytoplasm is not
clear. Stress granules are dynamic cytoplasmic sites containing aggregates
of mRNAs bound to the 48S preinitiation complex and proteins involved in
translation repression, RNA metabolism and signaling pathways (reviewed
in [8, 7, 6]). I found that known stress granule components such as trans-
lation factors (eIF4A, eIF4E, eIF4G, eIF2, eIF3), 40S ribosomal subunit
components, PABP, and translational regulators (Me31B, Ataxin-2, Pumilio,
dFMR1, G3BP2, AGO2, UPF1) were associated with Belle (Table 6; § 3.10).
This observation raises the possibility that Belle is a component of Drosophila
RNA granules that are similar to mammalian stress granules.
Another possible explanation could be that a considerable fraction of over-
expressed Belle is localized to lipid droplets. Lipid droplets are ubiquitous
organelles found in yeast, plants and animals, which serve as storage sites
for energy-rich lipids [277]. Recently, a general role for lipid droplets as
transient storage depots for proteins in temporary excess has been proposed
[57]. This study has characterized the lipid-droplet proteome and identified
Belle as a protein significantly represented in the lipid-droplet fraction [57].
Interestingly, I found that ca. 26% (33 of 126) of the proteins described in
the study by Cermelli et al. as “represented abundantly and significantly in
the lipid-droplet fraction” were associated with Belle in the tandem affinity
purification.
5.2 Belle is required for cell viability and general
translation efficiency
It has been demonstrated that bel is an essential gene that is required for
larval growth as well as male and female fertility [201]. Belle can rescue the
lethal phenotype of a ded1 null mutant [201]. Depletion of Ded1p inhibits
translation in yeast cells where this protein has a role in promoting transla-
tion initiation [68, 84, 28]. In contrast to these observations, two independent
studies have provided evidence that depletion of human DDX3 either does
not significantly affect [240] or enhances protein synthesis up to 150% in
HeLa cells [378]. It has been also shown that over-expression of DDX3 ex-
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erts an inhibitory effect on cell growth [60] and inhibits general translation
efficiency in a dosage-dependent manner (27-50%) in HuH7 cells [378].
Therefore, it was important to determine whether Drosophila Belle is
required for cell proliferation and general translation efficiency or functions
as translational repressor. In the latter case, Belle could function in a similar
way to Dhh1p, the yeast ortholog of Me31B, and Pat1p which are required
for global translational repression of the vast majority of mRNAs in response
to stress (glucose deprivation or amino acid starvation) [73].
I have observed that proliferation was significantly inhibited in Drosophila
S2 cells depleted of Belle, Me31B, eIF4E and eIF4A, indicating that these
proteins are required for cell proliferation (Fig. 25A). Using in vivo labeling
experiments, I have demonstrated that the efficiency of protein synthesis is
decreased in such cells both at normal growth conditions (25◦C) and dur-
ing heat-shock-induced stress (at 37◦C), when the expression of heat shock
proteins is induced (Fig. 26A).
Inhibition of cell proliferation leads to a certain decrease in protein syn-
thesis. Interestingly, although all knock-down cells showed similar growth
inhibition, depletion of Belle had the strongest effect on protein synthesis,
comparable to depletion of the essential translation initiation factor eIF4A
(Fig. 26A, Fig. 27). This indicates that Belle is required for efficient trans-
lation in S2 cells.
Depletion of eIF4E (CG4035) does not have such a strong effect on pro-
tein synthesis as eIF4A depletion (Fig. 26A, Fig. 27). The D. melanogaster
genome contains seven genes encoding eight eIF4E isoforms [168]. In Droso-
phila embryos, cap-dependent translation relies mainly on the eIF4E-1 iso-
form encoded by CG4035 which also encodes the eIF4E-2 isoform [168].
However, it is likely that eIF4E isoforms are partially redundant and can
substitute for the missing isoform eIF4E-1 and eIF4E-2 in S2 cells depleted
of CG4035.
During the stress induced by heat-shock, protein synthesis was efficiently
inhibited in control cells and cells depleted of Belle, Me31B and translation
factors (Fig. 26A). This result suggests that Belle and Me31B, unlike yeast
Dhh1p, are not required for global translational repression in response to
stress. Moreover, the expression of HSP70 protein in Belle-depleted cells
was also reduced in comparison to control cells (Fig. 26A, lane 10 versus
lane 8 and 9), although Hsp70 mRNA was strongly induced (Fig. 26B). This
observation lends support to the idea that Belle is required for translation and
its depletion does not affect transcription and nuclear processing of mRNA.
Analysis of polysome profiles of S2 cells depleted of Belle, eIF4A and
eIF4E demonstrates a similarity between them. All three profiles are char-
acterized by an increase of the peaks corresponding to the 40S and the 60S
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ribosomal subunits and the monosome peak, and a decrease of the polysome
peaks. These features are the hallmarks of a translation initiation defect.
Moreover, I observed that Belle is associated with translation initiation
factors eIF4G, eIF4E, eIF4A, multi-subunit factors eIF2 and eIF3 as well as
translation elongation factor EF1α (Table 6, Fig. 39, 40). At least some of
these interactions are conserved in mammals [245, 240, 105, 206]. Consistent
with these observations, endogenous Belle was found mainly in free mRNP
fractions and only a small fraction of the protein co-migrates with polysomes
after sedimentation in sucrose gradients (Fig. 31C).
Taken together, these results suggest that Belle has an essential function
in the cell to promote general translation initiation.
5.3 Belle functions as a translational repressor
Apart from its role in translation activation, Belle is able to repress transla-
tion of a bound mRNA in the tethering assay described in [30]. I observed
that tethering of Belle to the 3′ UTR of an F-luc 5BoxB reporter mRNA
caused translational repression and stabilization of the mRNA (Fig. 28).
The translational repression activity of Belle was dependent on its putative
ATPase activity (Fig. 30).
Although the observation that Belle is required for translation, but acts
as a translational repressor in the tethering assay may seem contradictory,
they might reflect the dual function of Belle in translational control. One
possible explanation would be that Belle is required for general translation
initiation but can also repress translation of a subset of mRNAs contain-
ing cis-regulatory sequences in the 3′ UTR. In the latter case, additional
trans-acting proteins which are able to interact with Belle and bind these
cis-regulatory sequences would be required for the repression. The observa-
tion that Belle interacts with several mRNA-binding proteins implemented
in translational control (Table 6, Fig. 41, 42) supports this possibility. Teth-
ering of Belle directly to the reporter 3′ UTR circumvents the need for such
trans-acting proteins and puts Belle in the context required for translational
repression.
The mechanism of this translational repression is not clear. Polysome
profile analysis demonstrated that tethering of λN-HA-Belle to the reporter
mRNA induces the formation of heavy mRNP complexes which are different
to polysomes and contain λN-HA-Belle (Fig. 31B, C). The putative ATPase
activity of Belle was required for translational repression but was dispensable
for the formation of the heavy mRNPs. This suggests that heavy mRNPs
may represent precursors of the repressed mRNPs but their formation may
not be necessary for inhibition of translation.
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The assembly of heavy mRNPs as an initial step in the translational
repression mechanism in Drosophila is not without precedent. It has been
reported for miRNA-mediated silencing (“pseudo-polysomes”, [400]) and for
the repression of oskar mRNA translation by Bruno (“silencing particles”,
[61]). Whether Belle mediates translational repression via assembly of heavy
mRNPs in vivo is an open question.
There are two observations that argue that the answer to this question
is positive. First, Belle localizes to nuage in nurse cells and the posterior
pole of Drosophila oocytes which contain maternal mRNPs [201]. Second,
Belle colocalizes with dFMR1 in foci in the neurites which are likely to be
large transport RNA granules [28, 24, 206, 105]. It is widely accepted that
mRNAs are transported as part of large mRNPs. Although not proven, it is
thought that the maternal and other localized mRNAs are transported in a
translationally quiescent state [44]. Therefore, in order for specific mRNAs
to be transported and localized, they must first be sequestered from the
translational machinery in the cytoplasm and organized into mRNPs. The
sequestration from translation is likely to start in the nucleus or right after the
export of the mRNAs to the cytoplasm. Consistent with this, Belle was found
concentrated in the perinuclear region of nurse cells (nuage) in Drosophila
ovaries [201]. DDX3, the human ortholog of Belle, also concentrates at the
cytoplasmic side of the nuclear pore complex [437]. Finally, I found several
RNA-binding proteins involved in translational control to be associated with
Belle in S2 cells (Table 6, Fig. 41, 42). Thus, it is possible that Belle,
in concert with various RNA-binding proteins, mediates the formation of
large translationally dormant mRNPs from mRNAs targeted for translational
repression or localization.
5.4 The association of Belle with various protein com-
plexes reflects its functional diversity
Functional proteomics relies on the hypothesis that the association of proteins
suggests their common involvement in a biological function. Thus, charac-
terization of the molecular partners of a protein has become a critical part
of analyzing its biological function, alongside knocking down its expression
by RNAi and studying its subcellular localization. In order to characterize
proteins associated with Belle, I made use of a tandem affinity purification
approach followed by mass spectrometry analysis. This approach permitted
the identification of potential partners of Belle in Drosophila S2 cells and
helped to delineate its role in translational control.
In total, 336 proteins were found to be associated either with wild type
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Belle or the K345N mutant (Table 6), with 101 proteins present in both pu-
rifications (Fig. 34). Because mass spectrometry is such a sensitive technique,
an undesired side effect is that contaminating proteins such as keratins and
highly abundant or “sticky” proteins are also identified in purification exper-
iments. The large number of Belle-associated proteins raised the question of
the specificity of their interactions with Belle.
To address this question, I performed a detailed bioinformatic analysis of
the obtained protein set. This included protein annotation using Gene Ontol-
ogy (§ 3.7), functional enrichment analysis (§ 3.8) and protein interaction net-
work cluster analysis (§ 3.9). Interactions of a small subset of Belle-associated
proteins were evaluated by a complementary co-immunoprecipitation assay
(Fig. 39–42).
As shown in Fig. 33 and 34, the majority of annotated proteins associated
with Belle are either directly implemented in translation (translation factors
and ribosome structural components), or involved in translational control and
other aspects of mRNA metabolism, including splicing, processing, 3′-end
formation, localization and degradation (RNA-binding proteins, DEAD-box
helicases, nucleases).
Categorization of Belle-associated proteins using GO slim terms was con-
sistent with this observation (Fig. 35, 36). Functional enrichment analysis
has demonstrated that the sets of proteins associated either with wild type
Belle or the K345N mutant are significantly (p < 0.01) enriched in translation
factors, structural constituents of ribosomes, RNA-binding proteins and AT-
Pases (Table 5). At this point, a distinction was observed between proteins
associated with wild type Belle or the K345N mutant. Significantly more
proteins associated with wild type Belle were involved in RNP complex bio-
genesis and assembly, the cell cycle, intracellular transport, organization and
biogenesis of the cytoskeleton and vesicles (Table 5). This indicates that the
putative ATPase activity of Belle is required for some specific interactions.
Finally, I analyzed all the protein interactions with Belle which were pre-
viously known and/or predicted with high level of confidence. An interaction
network was built which consisted of 221 proteins showing 1402 interactions
with each other (Fig. 37). This result indicates that the set of proteins
associated with Belle is not a random set, but most of these proteins are
functionally and physically connected.
A machine-algorithm-assisted search for highly interconnected regions
(clusters) in the network has revealed the presence of several previously
known biological complexes (Table 4, Fig. 37, 38). Consistent with the role
of Belle in promoting translation, translation initiation factors, PABP, and
components of large and small ribosomal subunits formed the largest cluster.
The poly(A)-binding protein (PABP) is thought to stimulate translation
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by mechanisms which are complex and may involve redundant or alterna-
tive pathways [86]. These include promoting mRNA circularization through
simultaneous interactions with eIF4G and the 3′ poly(A) tail and stimula-
tion independent of PABP poly(A)-binding activity. mRNA circularization
promotes the recycling of terminating ribosomes by bridging two ends of an
mRNA. Alternatively, PABP can promote 48S initiation complex formation,
60S ribosomal subunit joining and interaction of eIF4E with the cap struc-
ture [204]. The PABP C-terminal region (PABC) is also found in members of
the hyperplastic discs protein (HYD) family of E3 ubiquitin-protein ligases
[270].
PAIP1 binds to PABP and acts as a translational enhancer. It also in-
teracts with eIF4A and eIF3 facilitating the bridging of the 5′ and 3′ ends
of mRNA. PAM2, the domain of PAIP1 which interacts with the PABP C-
terminal region, is also found in Ataxin-2. Human Ataxin-2 interacts with
DDX6/RCK/p54 and localizes to stress granules.
PABP, PAIP1, HYD and Ataxin-2 were found associated with Belle (Ta-
ble 6, Fig. 39). The interaction of Belle with PABP was RNase sensitive,
suggesting that it is mediated by mRNA (Fig. 39A). Thus, it is likely that
Belle is a component of mRNPs that contain circularized mRNA.
HYD mediates ubiquitin-dependent proteolysis of specific protein targets
(reviewed in [86]). Thus, another PABP-binding protein PAIP2A is ubiquiti-
nated upon binding to HYD through its PAM2 motif. The affinity of PAIP2A
to the HYD PABC domain is significantly weaker than to that of PABP;
therefore, under physiological conditions, the higher affinity of PAIP2 for
PABP protects PAIP2A from HYD-dependent proteolysis. However, upon
reduction in PABP levels, PAIP2A becomes free to associate with HYD and
is subsequently ubiquitinated and degraded by the proteasome. Although
PAIP1 also binds to the PABC domain of HYD, it is not degraded upon
reduction in PABP levels, suggesting that an additional unknown factor is
required for specific ubiquitination of PAIP1 [86]. Consistent with the role
of HYD in ubiquitination and proteasome-mediated proteolysis, several pro-
teasome subunits were found to be associated with Belle (Table 4, Fig. 37,
38).
Interestingly, the next largest cluster was comprised of RNA-binding pro-
teins implicated in splicing (Table 4, Fig. 37, 38). In addition to this, a cluster
of proteins involved in mRNA cleavage and polyadenylation was identified.
It raises a possibility that Belle might possess some functions in the nucleus.
For example, Belle could participate in export of a subset of mRNAs. The ob-
servation that human DDX3 is a nucleo-cytoplasmic shuttling protein which
binds to CRM1, localizes to nuclear pores and participates in Rev-dependent
export of intron-containing HIV-1 RNA supports this possibility [437].
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Translation and mRNA turnover are strongly linked together. Inhibi-
tion of translation initiation diverts mRNAs to P bodies for decay, whereas
inhibition of translation elongation stabilizes mRNAs on polysomes. These
observations indicate that translation competes with mRNA decay [127, 109].
The poly(A) tail is both a determinant of mRNA stability and of translation
efficiency. The first step in mRNA decay, deadenylation, is therefore also a
means to inhibit the translation of mRNAs.
Consistent with this, a cluster formed by components of the CCR4-CAF1-
NOT deadenylase complex was identified (Table 4, Fig. 37, 38). Interaction
of Belle and CAF1 was confirmed by co-immunoprecipitation (Fig. 41F).
In Drosophila, translational repression mediated by miRNAs and the PUF-
domain translational regulator Pumilio is coupled with the recruitment of the
CCR4-CAF1-NOT complex and subsequent deadenylation [30, 202]. Two an-
notated Drosophila PUF-domain proteins Pumilio and Penguin were found to
be associated with Belle (Table 6, Fig. 42G). These observations support the
hypothesis that Belle is involved in translation repression and deadenylation
mediated by RNA-binding proteins.
In the normal mRNA degradation pathway, decapping follows deadeny-
lation. The core decapping complex is a dimer that consists of DCP1 and
DCP2. DCP2 contains the MutT domain and supplies the catalytic ac-
tivity [397]. In higher eukaryotes, there are additional components (Ge-1,
EDC3, Tral, PAT1, Me31B) which modulate decapping activity and link
decapping to translation control and mRNA localization ([40, 74, 118, 258]
and Tritschler et al., in press). However, decapping activity is separable
from localization function at least in the case of oskar mRNA since DCP2
is absent from the localized mRNPs [258]. Components of the decapping
enhancer complex were found to be associated with Belle (Table 6, Fig. 39,
41), providing additional support to the view that Belle is a component of
translationally repressed mRNPs.
Finally, the observation that translationally regulated cyclin B mRNA
co-immunoprecipitates with Belle fits with this hypothesis (Fig. 43). In
Drosophila embryos, translational repression of cyclin B mRNA occurs via
a poly(A)-dependent mechanism [409]. In the pole cells, Pumilio binds to
the cis-regulatory element NRE in the cyclin B mRNA 3′ UTR and recruits
Nanos [16]. Nanos has been shown to recruit the CCR4-CAF1-NOT dead-
enylation complex to the mRNA, which results in shortening of the poly(A)
tail and in translational repression [202].
A considerable number of proteins (60) found to be associated with Belle
(including Belle itself) were also found among 270 previously identified micro-
tubule-associated proteins (MAPs) [177]. Tubulin, actin and many actin-
binding proteins were also identified in the affinity purification (Table 6).
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This is not surprising, since about 50% of the translational machinery is
associated with the cytoskeleton in eukaryotic cells [169]. Different experi-
ments demonstrated that the association of polysomes with the cytoskeleton
depends on the integrity of actin filaments. The translation elongation factor
EF1α is involved in β-actin binding, bundling and anchoring mRNA to actin
filaments (reviewed in [75]). Given that EF1α and Belle were found to be as-
sociated together (Table 6), it is likely that Belle is present in actin-anchored
mRNPs involved in localized translation. EF1α associates with actin fila-
ments in regions where actin mRNA is anchored. Consistently, I found that
Act5C mRNA was co-immunoprecipitating with Belle (Fig. 43). Finally, the
CCT complex which interacts with the β-actin nascent chain [161] and serves
as a chaperonin for actin and tubulin, was found to be associated with Belle
in the affinity purification (Table 6, Fig. 37, 38).
Interestingly, the CCT chaperon complex and nascent peptide associ-
ated complex subunit-α (NACα) were identified as protein components of
DDX3-containing RNA granules purified from developing brain [105]. It was
proposed that these complexes stabilize nascent proteins which are attached
to ribosomes arrested at the stage of elongation [105]. Although I did not
find any NAC components to be associated with Belle, three subunits of the
signal-recognition particle (SRP) were identified in the affinity purification
(Table 6, Fig. 37, 38). SRP mediates translational arrest only of ribosomes
synthesizing proteins possessing an N-terminal signal peptide that targets
them to the endoplasmic reticulum. However, it is unlikely that SRP and
the CCT chaperon complex mediate a general translation arrest in trans-
ported mRNP granules.
Act5C mRNA 3′ UTR contains two copies of the conserved “zipcode”
sequence, ACACCC, which is essential for correct targeting and localized trans-
lation of β-actin mRNA in many species (reviewed in [75]). This sequence is
recognized by the zipcode-binding protein ZBP1, a KH-domain RNA-binding
protein. The D. melanogaster ortholog of ZBP1 is Imp, which was found to
be associated with Belle (Table 6 and Fig. 42E).
Therefore, another possible explanation of the association of Belle with
cytoskeleton and cytoskeleton-binding proteins could be that Belle is present
in transport mRNP granules. Transport of different populations of mRNP
granules requires different motor proteins to specify the site of localization.
mRNP granules are moved by microtubule-dependent motors such as kinesin-
1 and 2 [221, 15, 206], acting coordinately with actin-based myosin II and
V [263, 242, 440], since both microtubules and actin filaments are involved
in rapid linear transport of mRNA in the same cell [144]. In Drosophila
S2 cells, dFMR1 is able to form transport RNA granules that are moved
by kinesin-1 and cytoplasmic dynein [260]. Consistent with this, dFMR1, a
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kinesin motor protein Pavarotti (MKLP1), a myosin V motor protein Didum,
and a dynactin complex component Glued were found associated with Belle
(Table 6).
Plus- and minus-end-directed motors are also required for bidirectional
vesicle transport. In Drosophila, mutations in kinesin, dynein or Glued block
bidirectional vesicle transport in axons [179, 276]. Similarly, plus-end move-
ment of lipid droplets in Drosophila embryos was severely impaired when
either dynein or Glued was mutated [155]. Belle and many Belle-associated
proteins are protein components of lipid droplets in Drosophila [57]. There-
fore, it is likely that a fraction of Belle is localized to lipid droplets that are
transported along microtubules in a dynein- and dynactin-dependent man-
ner.
In yeast, the endoplasmic reticulum (ER) couples mRNA trafficking and
local translation (reviewed in [328]). Several localized mRNAs code for
membrane-bound proteins which undergo translocation to the ER upon trans-
lation, to be properly sorted through the secretory pathway. ER vesicles with
such localized mRNAs attached to them are transported by myosin V via the
actin filaments linking mRNA localization to ER transport.
I found that 6 of 7 coatomer subunits of the COPI vesicle coat were
associated with Belle (Table 6, Fig. 37, 38). In animal cells, COPI-coated
vesicles mediate traffic between the ER and the Golgi complex and within
the Golgi complex (for the review see [264]).
Some proteins synthesized in the ER are retained there by a diarginine
(RR) motif that is “recognized” by the COPI retention machinery [264, 296].
14-3-3ε and ζ were identified as interacting proteins for the diarginine motif
of the C-terminus of the potassium channel α subunit, Kir6.2. 14-3-3 proteins
competed for binding to the dibasic region with the COPI machinery, which
suggests that bound 14-3-3 masks the COPI interaction site and thus causes
the release of Kir6.2 from the ER [49]. Interestingly, the two isoforms of
the 14-3-3 protein, ε and ζ, were found to be associated with Belle, as well
as other known partners of 14-3-3, including clathrin coat components, coat
recruitment GTPases, Rab GTPases, GTPase-activating proteins (GAPs),
guanine-nucleotide exchange factors (GEFs) as well as actin and heat shock
proteins (Table 6; Fig. 37, 38). Enabled, the voltage-dependent potassium
channel subunit with a C-terminal RR motif which can serve as a putative
ligand of 14-3-3 proteins and COPI machinery, was also identified in the
affinity purification of Belle (Table 6).
The biological meaning of the interaction of Belle with the components of
the ER protein sorting system is not clear. The proteins identified in various
14-3-3 interactome studies differ greatly [49]. Consistent with my results,
DDX3, PABP, translation factors, ribosomal proteins, the CCT complex and
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other chaperons have been identified as 14-3-3-binding proteins in human cells
[283].
The observation that Belle is associated with protein kinases involved in
signal transduction is not surprising. According to recent data, higher levels
of control exist to monitor RNA binding proteins and translational regulators
[408]. It is likely that many RNA binding proteins are sensitive to signalling
cascades that monitor the local and external environment of the cell, which
enable them to modulate mRNA translation at an appropriate rate to suit
changing cellular circumstances.
An intriguing connection between Belle and the RNAi pathway comes
from the observation that Belle is associated with AGO2, the key component
of the siRNA-mediated silencing machinery (Table 6; Fig. 42A). Previously,
it was demonstrated that AGO2, RpL5, RpL11 and Rm62 (the Drosophila
ortholog of human DDX5/p68) interact directly and form a complex with
dFMR1 in Drosophila S2 cells [188]. Consistent with this result, I identified
all the components of the dFMR1 complex in the affinity purification of Belle
and confirmed some interactions by a co-immunoprecipitation assay (Table 6;
Fig. 42A, C, and D). The function of dFMR1 in the RNAi pathway is yet to
be determined, whereas RNA-helicases such as Belle and Rm62 may facilitate
ATP-dependent unwinding of the siRNA duplex to generate active RISC of
AGO2 and the small RNA. It is also conceivable that Belle and Rm62 may
be involved in downstream events such as target RNA recognition, as an
RNA chaperon or an RNPase. In agreement with these possibilities, it was
shown that Belle and Rm62, but not dFMR1 alone, are required for efficient
RNAi in S2 cells [406, 188]. It is likely that Belle (and Rm62) functions
redundantly and can be substituted by other RNA-helicases. Consistent
with this, proteomic analysis of AGO1- and AGO2-containing mRNPs in
human cells revealed the presence of a large number of different DEAD-box
RNA-helicases, including DDX5/p86 [164].
5.5 Concluding remarks
Diverse regulatory mechanisms are used redundantly to regulate mRNA
translation and stability with the required precision. Many trans-acting
proteins and cis-regulatory sequences play multiple specific roles in these
mechanisms. This study on the function of Belle in translational control has
revealed a perfect example of such versatility. In an attempt to integrate
my results into the general picture of post-transcriptional gene regulation, I
propose the following model of Belle function (Fig. 46).
Belle is an essential Drosophila protein which is required for general trans-
lation efficiency. In a certain molecular context, Belle can function as a
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Figure 46. Hypothetical model of Belle function in translational control
Belle interacts with translation initiation machinery (eIFs, PABP, ribosomal components)
and promotes general protein synthesis. In addition, Belle associates with proteins that
bind 3′ UTRs and repress translation (dFMR1, Imp) by mechanisms which are not com-
pletely clear. This repression is required for mRNP assembly, transport, and localized
translation on polysomes associated with cytoskeleton. At least in the case of Pumilio,
translational repression is dependent on mRNA deadenylation by the CCR4-CAF1-NOT
complex. Belle was also found to be associated with P body and stress granule com-
ponents (Me31B, decapping enhancers, RNA-binding proteins). These mRNP granules
contain aggregated mRNPs which are translationally inactivated by an unknown mecha-
nism. Finally, Belle interacts with the RISC complex components and may function in the
RNAi pathway. The grey dashed arrow corresponds to an activating signals; red blunted
lines correspond to inhibitory signals.
translational repressor and mediate the assembly of heavy mRNPs. Consis-
tent with its function in translation activation and repression, Belle associates
with various proteins involved in translational control and a subset of mR-
NAs in the cytoplasm, although a specific nuclear function for Belle cannot be
excluded. Several observations suggest that Belle may be involved in mRNP
assembly and transport as well as localized mRNA translation. Finally, Belle
may function as an auxiliary factor in the RNA interference pathway.
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6 Materials
6.1 Chemicals and reagents
Inorganic salts, acids and alkali, as well as organic buffers (HEPES, MOPS,
Tris), chelating agents (EDTA and EGTA), detergents (deoxycholate, NP-
40, Triton X-100, TWEEN 20, SDS) antibiotics (ampicillin, kanamycin,
cycloheximide, puromycin), DTT, β-mercaptoethanol, glyoxal, ammonium
persulfate, TEMED, heparin, Ficoll, and sucrose were supplied by Merck,
Fluka, SIGMA, and Carl Roth, Germany. Organic solvents (MeOH, EtOH,
iPrOH, CHCl3, formaldehyde) and acetic acid were obtained from Merck,
Germany. Phenol and an equilibrated mixture of phenol, CHCl3, isoamyl al-
cohol (25:24:1) was purchased from AppliChem, Germany. Formamide was
from Ambion, USA. peqGOLD TriFastTM reagent and deoxynucleotides were
supplied by PeqLab, Germany. IllustraTM NTP set (100 mM solutions) was
purchased from GE Healthcare, USA.
All reagents for cell culture, electrophoresis-grade agarose and pre-cast
gels for protein PAGE were purchased from Invitrogen, USA. Acrylamide/bis-
acrylamid (37.5:1) mixture for protein electrophoresis was obtained from Bio-
Rad, USA. Protein pre-stained and broad range markers, as well as DNA
size markers (100 bp and 1 kb ladder) were supplied by New England Bio-
labs. RNase inhibitor RNasin was purchased from Promega, USA. Complete
protease inhibitor cocktail, EDTA-free, was obtained from Roche Applied
Science, Germany.
Kits for DNA isolation (QIAprep Spin Miniprep and QIAfilter Plasmid
Purification Kits, QIAquick Gel Extraction Kit and PCR Purification Kit)
and the transfection reagent Effectine were from QIAGEN . The TOPO-
cloning kit was from Invitrogen, USA. The kit for the Dual-luciferaseTM
assay was purchased from Promega. The chemiluminescence immunoblot
detection system was from TROPIX , USA.
Isotope-labeled compounds were supplied by Amersham BiosciencesTM
and Hartmann, Germany. Fluoromount-GTM was from Southern Biotech-
nologies, USA. Glycogen which was used to enhance RNA precipitation was
obtained from Fermentas, Germany.
6.2 Enzymes
All restriction enzymes, T4 DNA ligase and the Klenow fragment of DNA
polymerase I were purchased from New England Biolabs, USA. Shrimp AP
was supplied by Roche Applied Science, Germany. DNase I (RNA quality)
for the removal of DNA from total RNA preparations and AMV reverse
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transcriptase were obtained from Promega. In special cases, the TURBO
DNA-freeTM DNA removal system from Ambion was used. The reverse tran-
scriptase for the generation of cDNA libraries and for the semi-quantitative
RT-PCR, RevertAidTM H Minus M-MuLV, was purchased from Fermentas,
Germany. The enzyme mix used for the amplification of cDNA for the pur-
pose of cloning was part of the Expand High Fidelity PCR System, Roche
Applied Science, Germany. For PCR mutagenesis, PfuTurbo polymerase
(STRATAGENE, USA) was used. Routine PCR and asymmetrical PCR for
the generation of radiolabeled probes were carried out using Tag polymerase
that was produced and purified in our laboratory. T7 RNA polymerase for
the in vitro transcription was also produced in house.
6.3 DNA oligonucleotides
DNA oligonucleotides were ordered from SIGMA, Germany. Primers for
PCR purified with reverse phase cartridge were obtained in lyophilized form
and were dissolved in water.
6.4 Membranes and filter paper
The nylon-based membrane for Northern blotting (GeneScreen Plus) was
obtained from PerkinElmerTM Life Sciences, USA. Nitrocellulose membrane
for Western blotting (Protran BA) was supplied by Whatman (Schleicher &
Schuel), Germany. Blotting paper (3MM Chr) was obtained fromWhatman,
England.
6.5 Chromatography resins and columns
For the co-immunoprecipitation experiments Protein A-agarose was used,
purchased from Roche Applied Science, Germany. Recombinant GST-fusion
proteins were purified using glutathione-agarose from SIGMA, Germany.
His-tagged recombinant proteins were purified using Ni-NTA Superflow resin
from QIAGEN , Germany. Sephadex G-50 from SIGMA, Germany, was used
for purification of radiolabeled DNA. Tandem affinity purification was per-
formed using IgG SepharoseTM 6 Fast Flow and Calmodulin SepharoseTM
4B, purchased from GE Healthcare, Sweden. Ion-exchange resin AG-510-X8
for the de-ionization of glyoxal was purchased from BioRad, USA.
Columns for chromatography were supplied by BioRad, USA and Mo-
BiTec, Germany.
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6.6 Antibodies
Polyclonal rabbit anti-HA antibody and monoclonal anti-tubulin mouse anti-
body were purchased from SIGMA. Monoclonal mouse anti-V5 antibody was
supplied by Invitrogen, USA. Monoclonal mouse anti-HA.11 antibody, used
for immunofluorescence and for the co-immunoprecipitation experiments was
from COVANCE, USA.
The following antibodies were generated in house by Michaela Rode,
Daniel Schweizer, Andreas Lingel, Isao Kashima and Regina Bu¨ttner: poly-
clonal antibodies against GW182, Tral (Lsm14), EDC3 (Lsm16) and Ge-1
(EDC4) were raised in rats immunized with recombinant GST-fusion pro-
teins; polyclonal antibodies against AGO2, PABPC, Upf1, GFP and Belle
were raised in rabbits immunized with recombinant GST-fusion proteins.
Secondary antibodies coupled to AP (goat anti-rabbit and goat anti-
mouse) were supplied with the TROPIX chemiluminescence immunoblot de-
tection system, goat ant-rat antibody was from SIGMA.
6.7 DNA oligonucleotide microarrays
High-density DNA oligonucleotide microarrays that were used in this study
were purchased from Affymetrix. The GeneChip Drosophila Genome 2.0
Array was largely based on the content from the annotation (release 3.1) of
the Drosophila melanogaster genome by Flybase and the Berkeley Drosophila
Genome Project (BDGP). In addition, other published gene predictions from
the Drosophila Research community were included. In total, the array uses
over 500,000 data points (14 probe pairs per probe set) to measure the ex-
pression of 18,500 transcripts and variants. The array also contains control
sequences including:
• Hybridization controls: bioB, bioC, bioD from E. coli and cre from P1
bacteriophage
• Poly-A controls: dap, lys, phe, thr, trp from B. subtilis
• Housekeeping/Control genes: Actin (Actin 42A), GAPDH (Glyceralde-
hyde 3 phosphate dehydrogenase 2), Eif-4a (Eukaryotic translation ini-
tiation factor 4a)
6.8 Bacterial strains
For the propagation of plasmid DNA, the E.coli strains DH5-α or XL1-Blue
were used. For recombinant protein expression BL21-Gold and RosettaTM 2
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strains were used. The genotypes are as follows. DH5-α: endA1 glnV44
thi-1 recA1 relA1 gyrA96 deoR nupG ∆(lacZYA-argF)U169 ∆(lacZ)M15
nsdR17. XL1-Blue: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac
glnV44 F′[proAB+ lacIq ∆(lacZ)M15 ::Tn10 (TetR)]. BL21-Gold: ompT hsdS
(r−B m
−
B) dcm
+ TetR gal endA Hte. RosettaTM 2: ompT hsdS (r−B m
−
B) dcm
+
(DE3) pRARE2 (CamR).
7 Methods
7.1 DNA cloning
7.1.1 Generation of cDNA library
A D. melanogaster cDNA library was prepared for the amplification of genes
of interest, when plasmid templates were not available. For this, total RNA
was isolated from Drosophila Schneider 2 cells and treated with DNase I, as
described in § 7.3.1 and § 7.3.3. The RNA was reverse transcribed using an
oligo(dT)15 or random hexamer primer and M-MuLV reverse transcriptase,
engineered to lack RNase H activity. The reaction was performed under
RNase-free conditions. All reagents and plasticware were sterile and RNase-
free. Equipment and work surfaces were cleaned with 1% SDS prior to use
and gloves were worn throughout all manipulations.
4 µg of DNase treated total RNA was mixed with 0.5 µg of oligo(dT)15 or
random hexamer primer in a total volume of 11 µL. The RNA was denatured
for 5 min at 70◦C, and then chilled on ice for 2 min. Subsequently, 5 µL of
5× reaction buffer (250 mM Tris-HCl, pH 8.3, 250 mM KCl, 20 mM MgCl2,
50 mM DTT), 2.5 µL of dNTP mix (dATP, dCTP, dGTP and dTTP, 10 mM
each), 0.5 µL of RNase inhibitor RNasin (40 u/µL) and 6 µL of H2O were
added. The mixture was incubated for 5 min at 25◦C before addition of 1
µL of RevertAidTM H minus M-MuLV reverse transcriptase (200 U/µL). If
random hexamer was used, the reaction mixture was incubated for 10 min
more at 25◦C. Then the reaction was allowed to proceed for 1 hour at 42◦C,
and after that the enzyme was inactivated by heating the reaction mix for
10 min at 70◦C.
7.1.2 Amplification of DNA by PCR
For the purpose of cloning, genes or gene fragments of interest were amplified
from plasmid templates or from a Drosophila cDNA library. In both cases,
the Expand High Fidelity PCR System was employed, which makes use of
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an enzyme mix containing thermostable Taq polymerase and a proofreading
polymerase optimized to amplify DNA fragments up to 5 kb.
The following reaction mixture was used:
38 µL H2O
3 µL cDNA template or ca. 50 ng of plasmid
5 µL 10× reaction buffer
1 µL dNTP mix (dATP, dCTP, dGTP, dTTP, 10 mM each)
0.5 µL sense primer (10 µM)
0.5 µL anti-sense primer (10 µM)
1 µL Expand High Fidelity enzyme mix
50 µL Total
The reaction mix was prepared in thick-walled 0.5 mL PCR tubes on ice. The
dNTP mix contained 10 mM of each nucleotide, dissolved in H2O. The 10×
reaction buffer (unspecified composition, containing 15 mM MgCl2) and the
enzyme mix were part of the Expand High Fidelity PCR System. If cDNA
served as the template, 3 µL of the 25 µL reverse transcription reaction
described in § 7.1.1 was used. This corresponds to cDNA generated from ca.
0.48 µg of total Drosophila S2 cells RNA. A DNA Engine (PTC-200) Peltier
Thermal Cycler (BioRad) was used, employing the following programm:
01 2:00 94◦C denaturation
02 0:30 94◦C denaturation
03 0:30 56◦C primers annealing
04 0:30 72◦C elongation
05 GOTO 02 34 times
06 7:00 72◦C elongation
The extension time varied, depending on the length of the DNA fragment
being amplified: 30 s was used for fragments of ca. 500 bp; for each additional
1 kb, the extension time was increased by 1 min.
For the semi-quantitative RT-PCR, in-house produced and purified Taq
polymerase was used together with 10× AmpliTaq polymerase buffer (15 mM
MgCl2) from Applied Biosystems. The amounts of reaction components were
adjusted to the final volume of 25 µL and mixed on ice in thin-walled 0.2 mL
PCR tubes. A RoboCycler Gradient 96 thermal cycler from STRATAGENE
was used, employing appropriate cycling parameters. Extension time and
primer annealing temperature varied, depending on the primers and DNA
fragment being amplified.
Tables 12 and 10 specify the DNA templates and PCR primers used in
each amplification reaction.
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7.1.3 DNA agarose gel electrophoresis
DNA fragments generated by PCR or restriction digest were separated ac-
cording to size by agarose gel electrophoresis, using a minigel system pro-
duced in the EMBL mechanical workshop. Agarose was melted in 1× TBE
buffer (90 mM Tris base, pH 8.3, 90 mM boric acid, 1 mM EDTA), at a final
concentration of 1%. After cooling to 65◦C, ethidium bromide was added (0.5
µg/mL final concentration), and the gel was allowed to solidify in a minigel
chamber with an appropriate comb. Before loading, the samples were mixed
with 5× DNA dye (20% Ficoll, 1 mM EDTA, 0.1% SDS, 0.05% Bromophenol
Blue). A DNA size marker (100 bp or 1kb ladder) was loaded on a separate
lane. Gel electrophoresis was performed at 15 V/cm in 1× TBE buffer con-
taining 0.5 µg/mL of ethidium bromide. DNA fragments were visualized
under UV light and documented using the gel documentation system from
PeqLab.
7.1.4 Purification of DNA fragments
DNA fragments generated by PCR or by restriction digest were purified
using the QIAquick PCR Purification Kit or Gel Extraction Kit (QIAGEN)
according to the manufacturer’s instructions.
Restriction fragments were purified from an agarose gel. For this, slices
containing the fragment of interest were excised from the gel, and the agarose
slice was solubilized in an appropriate amount of buffer QG (unspecified com-
position). DNA fragments generated by PCR were purified directly from the
reaction mixture, after the addition of 5 volumes of binding buffer PB (un-
specified composition). In either case, the solutions containing the solubilized
gel slice or the PCR mixture were applied to the silica-based purification col-
umn. The DNA selectively adsorbs to the silica membrane in the presence
of high-salt while contaminants pass through the column during a centrifu-
gation step. After washing the column with EtOH-containing buffer PE
(unspecified composition), the pure DNA was eluted with 30 µL Tris buffer
EB or water.
7.1.5 Restriction endonuclease digest of DNA
Plasmids and DNA fragments generated by PCR were digested with appro-
priate enzymes supplied by New England Biolabs. Optimal reaction buffers,
as recommended by the supplier, were used. Reactions were typically carried
out in a total volume of 50 µL, using 10-20 units of each enzyme (1 µL), 5
µL of the appropriate 10× buffer and 5 µL of BSA (1 mg/mL). The reac-
tion was incubated from 45 min to 15 hours (overnight) at 37◦C. Restriction
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fragments were separated by agarose gel electrophoresis, visualized by UV
light and purified from the gel using the QIAquick Gel Extraction Kit from
QIAGEN as described in §§ 7.1.3 and 7.1.4.
7.1.6 Ligation of DNA fragments
A linearized plasmid and a gene fragment with compatible ends were ligated
using T4 DNA ligase, New England Biolabs. Generally, 5-6 µL of the gel-
purified digested PCR product and 50 ng of linearized plasmid vector were
ligated. Ligation reaction was performed in 10 µL containing 200 units of
T4 DNA ligase and 1 µL of 10× T4 DNA ligase buffer (500 mM Tris-HCl,
pH 7.5, 100 mM MgCl2, 100 mM DTT, 10 mM ATP, 250 µg/mL BSA). The
reactions were performed either at room temperature for 10-20 min or at
16◦C over night.
7.1.7 Preparation of transformation-competent E. coli cells
To allow high efficiency transformation with DNA, E.coli strains XL1-Blue
and DH5α were treated as described in [185].
Bacteria from a frozen glycerol stock were streaked out on LB agar (10 g/L
tryptone, 5 g/L yeast extract, 10 g/L NaCl, 15 g/L agarose), and incubated
overnight at 37◦C. A colony was used to inoculate 2 mL of LB medium (10
g/L trypton, 5 g/L yeast extract, 10 g/L NaCl), and bacteria were allowed
to grow for 9 hours at 37◦C with vigorous shaking. 1 mL of the bacterial
suspension was transferred to a 2 L Erlenmeyer flask containing 500 mL of LB
medium supplemented with 10 mM MgCl2. The bacteria were grown at 18
◦C
while shaking at 100 rpm, until they reached an OD of 0.3 units. This would
typically take about 48 hours. Once the desired OD was reached, the culture
was cooled on ice, and the bacterial cells were pelleted by centrifugation at
2500×g in a pre-cooled rotor. The subsequent steps were performed at 4◦C
in a cold room, using pre-cooled reagents. The pellet was resuspended in
150 mL of ice-cold transformation buffer (10mM PIPES, 250 mM KCl, 15
mM CaCl2, 55 mM MnCl2), pelleted again as above, and finally resuspended
again in 40 mL of transformation buffer. 3 mL DMSO was added, while
gently swirling the bacterial suspension. The transformation-competent cells
were dispensed in 200 µL aliquots and immediately frozen in liquid nitrogen
and stored at −80◦C. Aliquots were tested by transformation with serial
dilutions of plasmid DNA to ensure a transformation efficiency of at least
106 colonies per 1 µg of plasmid DNA.
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7.1.8 Transformation of E. coli cells
Transformation-competent bacteria (E. coli strains, prepared as described in
§ 7.1.7), were thawed on ice. The ligation reaction or 100 ng of a plasmid
were added to 50 µL of the competent bacteria, and incubated on ice for 30
min. The cells were then heat-shocked for 1 min at 42◦C and chilled on ice.
500 µL of LB medium was added, and the bacteria suspension was incubated
for 30 min at 37◦C to allow the expression of antibiotic resistance genes if
required. The bacteria were then pelleted by brief centrifugation in a table-
top centrifuge and resuspended in 100 µL of LB medium. The cells were
plated onto LB agar plates containing the appropriate selective antibiotic
(e.g. 25 µg/mL kanamycin or 100 µg/mL ampicillin), and were incubated
overnight at 37◦C.
7.1.9 Isolation of plasmid DNA from E. coli cells
Plasmids were propagated in E. coli XL1-Blue or DH5α strains. For the
evaluation of cloning results, a small-scale plasmid preparation (miniprep)
was used. For this, 2-4 colonies were picked from an agar plate, and each
was used to inoculate 3 mL of LB medium containing the appropriate selec-
tive antibiotic (e.g. 25 µg/mL kanamycin or 100 µg/mL ampicillin). After
incubation at 37◦C for at least 9 hours, bacteria were pelleted from 2 mL of
the suspension by centrifugation at 6800×g for 3 min. Plasmids were purified
from the bacterial pellet using QIAprep Spin Miniprep Plasmid Purification
Kit (QIAGEN) according to manufacturer’s instructions. The bacterial pel-
let was resuspended in 250 µL of ice-cold buffer P1 (50 mM Tris-HCl, pH
8.0, 10 mM EDTA, 100 µL/mL RNase A). Then, an equal amount of lysis
buffer P2 (200 mM NaOH, 1% SDS) was added and mixed gently by in-
verting the tubes. After lysing the cells for no more than 5 min, 350 µL
of neutralization buffer N3 (confidential composition) was added and mixed
immediately. The resulting lysate was cleared by centrifugation for 10 min
at 16100×g, and the clear supernatant was applied on the spin column by
decanting. Plasmid DNA was adsorbed on silica membrane, washed with
EtOH-containing buffer PE, and eluted with 50 µL of elution buffer EB (10
mM Tris-HCl, pH 8.5).The plasmids were analyzed by restriction digest and
agarose gel electrophoresis as described in §§ 7.1.5 and 7.1.3.
In order to produce larger amounts of plasmid, cultures of bacteria har-
bouring the desired plasmid were used to inoculate 100 mL of LB medium
containing the appropriate selective antibiotic in 300 mL Erlenmeyer flask.
The suspension was incubated with vigorous shaking overnight at 37◦C. The
cells were pelleted by centrifugation at 6800×g, 4◦C, for 15 min. To extract
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the plasmid from the bacterial cells, the QIAfilter Plasmid Purification Kit
from QIAGEN was used according to the manufacturer’s instructions. The
bacterial pellet was resuspended in 4 mL of buffer P1 (see above). Then,
4 mL lysis buffer P2 (see above) was added. The mixture was incubated
at room temperature for 5 min. The lysis was terminated by addition of 4
mL of ice-cold neutralization buffer P3 (3 M KOAc, pH 5.5). The lysate was
poured into the barrel of the QIAfilter Cartridge and incubated at room tem-
perature for 10 min. In the meantime, the purification column (QIAGEN-tip
100) was equilibrated with 4 mL of buffer QBT (50 mM MOPS, pH 7.0, 750
mM NaCl, 15% iPrOH, 0.15% Triton X-100). The lysate was cleared by
passing it through the Cartridge filter. The cleared lysate was applied to the
previously equilibrated column and was allowed to enter the resin by gravity
flow. The column was washed twice with 10 mL of wash buffer QC (50 mM
MOPS, pH 7.0, 1 M NaCl, 15% iPrOH). Plasmid DNA was finally eluted
with 5 mL of elution buffer QF (50 mM Tris-HCl, pH 8.5, 1.25 M NaCl, 15%
iPrOH), and precipitated by adding 3.5 mL of iPrOH followed by centrifuga-
tion at 15000×g, 4◦C, for 15 min. The pellet was washed with 1 mL of 70%
EtOH, and centrifuged again for 5 min at 16100×g. The air-dried pellet was
dissolved in 150 µL of water. The concentration of DNA in the solution was
determined by measuring its absorbance at 260 nm (A260). An A260 value of
1 unit corresponds to a concentration of 50 µg/mL of double-stranded DNA.
7.1.10 PCR mutagenesis
For the generation of point mutants and for the insertion or deletion of short
DNA fragments, PCR mutagenesis was performed. The mutagenesis strat-
egy involves the amplification of the target plasmid with sense and anti-sense
oligonucleotide primers that contain the desired mutation. PfuTurbo poly-
merase was used to replicate both plasmid strands without displacing the
mutant oligonucleotide primers. This generated a mutant plasmid with stag-
gered nicks. After amplification, the parental DNA template was digested
with the restriction endonuclease Dpn I, which is specific for methylated and
hemimethylated DNA (target sequence Gm6ATC). The remaining, newly
synthesised mutated plasmid was used to transform E. coli cells, which re-
paired the nicks and propagated the plasmid.
Oligonucleotide primers (30-45 nt long) were designed to contain the de-
sired mutation, flanked on both sides by 15-20 nt of gene-specific sequences.
Both sense and anti-sense primers contained the desired mutation and an-
nealed to the same sequence on opposite strands of the template plasmid.
Oligonucleotide sequences are listed in Table 10.
The following reaction mixture was prepared for the mutagenesis PCR:
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40 µL H2O
1 µL plasmid template (200 ng/µL)
5 µL 10× Pfu buffer
1 µL dNTP mix (dATP, dCTP, dGTP, dTTP, 10 mM each)
1 µL sense primer (2 µM)
1 µL anti-sense primer (2 µM)
1 µL PfuTurbo polymerase (2.5 U/µL)
50 µL Total
The amplification reaction was performed using the following PCR pro-
gramme:
01 5:00 94◦C denaturation
02 1:00 94◦C denaturation
03 1:00 56◦C primers annealing
04 16:00 68◦C elongation
05 GOTO 02 19 times
06 16:00 68◦C elongation
Following the amplification, 1 µL of Dpn I enzyme (20 U/µL) was added
to the PCR mixture, and incubated for 2 hours at 37◦C. 50 µL of transform-
ation-competent E. coli XL1-Blue or DH5α cells were transformed with 2
µL of the digestion reaction, as described in § 7.1.8. The cells were plated
on an LB agar plate containing the appropriate selective antibiotic, and the
plates were incubated at 37◦C overnight. Plasmids were purified as described
in § 7.1.9, and the presence of the desired mutation was verified by DNA
sequencing.
7.1.11 Genetic constructs
The plasmids used in this study are listed in Table 12; cloning restriction
sites and origins of the inserts are indicated. The sequences of primers used
for the amplification of the inserts are listed in Table 10.
7.2 Cell culture and transfection
All cell culture experiments in this study were performed on Drosophila
melanogaster Schneider 2 (S2 or SL2) cells. This line was established in
1969 by I. Schneider from several hundred Oregon R embryos on the verge
of hatching (20 to 24 hours) [369]. The cells are male, by the criterion of
MSL (male specific lethal) complex assembly. This versatile cell line grows
rapidly at room temperature without CO2 and is easily adapted to suspension
culture.
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7.2.1 Propagation of D. melanogaster S2 cells
Drosophila Schneider cells were grown in GIBCOTM Revised Schneider’s
Drosophila medium (with L-Glutamine), purchased from Invitrogen. The
medium was supplemented with 10% heat-inactivated fœtal bovine serum
(FBS), 50 U/mL penicillin and 50 µg/mL streptomycin (Invitrogen).
The cells were propagated under sterile conditions as a loose, semi-ad-
herent monolayer in tissue culture flasks and in suspension in spinners at
25◦C without CO2. For general maintenance, the cells were passed into fresh
flasks when the cell density was between 2 to 7×106 cells/mL, and split at a
1:2 to 1:5 dilution. Some conditioned medium (that in which the cells had
been growing) was carried over when transferring the cells. S2 cells do not
grow well when seeded at a density below 5×105 cells/mL, so the density was
kept above 1×106 cells/mL.
7.2.2 Transfection
Transfection of S2 cells was performed in 6-well dishes using Effectene non-
liposomal lipid transfection reagent (QIAGEN) according to the manufac-
turer’s instructions.
One hour before transfection, 2.5×106 cells per well were seeded in a 6-well
plate and incubated under normal growth conditions. In the meantime, the
plasmid DNA mixture was prepared. 1 µg of plasmid DNA, combined in the
desired ratio in a total volume of 10 µL, was diluted in DNA-condensation
buffer, buffer EC (unspecified composition), to a final volume of 150 µL.
Then, 8 µL of Enhancer was added and mixed by vortexing for 1 s. After
incubation of the mixture at room temperature for 5 min, 25 µL of Effectene
Reagent was added and mixed by pipetting up and down 5 times, or by
vortexing for 10 s. The samples were incubated at room temperature for 15
min to allow transfection-complex formation. During this incubation, the
adhered S2 cells were washed once with PBS, and then covered with 1.6 mL
of complete Schneider’s medium. 0.6 mL of the growth medium was also
added to the tube containing the transfection complexes, and then mixed by
pipetting up and down twice. The mixture was added drop-wise onto the
adhered S2 cells.
The cells were incubated with the transfection complexes under their
normal growth conditions for an appropriate amount of time for expression
of the transfected genes (48-72 hours).
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7.2.3 RNA interference
To deplete endogenous proteins from S2 cells, double dsRNA interference
was performed, essentially as described in [71]. DsRNA was synthesized and
prepared as described in § 7.3.4.
Drosophila S2 cells were pelleted by centrifugation at 210×g for 5 min,
washed once and resuspended in serum-free Schneider’s medium (without
FBS, penicillin and streptomycin). The cell density was adjusted to 2×106
cells/mL, and 1-3 mL was put into a sterile 25 mL screw-cap Sarsted tube.
Then, 10 µg of dsRNA (3 µg/µL) per 106 cells was added. The cells were
incubated at 25◦C on an orbital shaker for 1-2 hours. After the incubation,
equal volume of “2×” Schneider’s medium containing 20% FBS, 100 U/mL
penicillin and 100 µg/mL streptomycin was added. Cells treated with dsRNA
were incubated on the shaker at 25◦C until further analysis on day 6-9. In
most cases, a second dsRNA treatment was performed on day 3 to ensure
efficient depletion of the targeted protein.
7.2.4 Generation of stable cell lines
Stably transfected S2 cell lines were generated as follows. The cells were
transfected as described in § 7.2.2, using two wells of a 6-well dish per genetic
construct. The construct contained the gene of interest under an inducible
metallothionein promoter, and a hygromycin B-resistance gene. 72 hours
after transfection the cells were harvested, washed twice and diluted in 24
mL of selection medium (complete Schneider’s growth medium supplemented
with 300 µg/mL of hygromycin B). The cells were seeded in a 24-well plate (1
mL per well), and incubated for 14 days (after 7 days the selection medium
was placed). The wells were checked regularly to see if transfectants were
growing. After this initial selection stage, polyclonal populations of cells
resistant to hygromycin B were expanded and tested for expression of the
transgene by a Western blot, as described in § 7.5. To induce expression of
the transgene, cells were treated with 2.5 mM CuSO4 overnight.
The positive cell lines expressing the desired transgene were frozen as fol-
lows. 150×106 cells were pelleted and resuspended in 5 mL of ice-cold “freez-
ing media” (15% DMSO in selective media). Then, the cells were aliquoted
into sterile cryotubes (1 mL per tube) and frozen gradually by shifting the
tubes from 4◦C to −20◦C (2 hours), and finally to −80◦C (overnight). After
freezing, the cells were stored in liquid nitrogen.
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7.3 RNA isolation and analysis
All work involving RNA was performed under RNase-free conditions, using
specially prepared reagents, pipettes, plastic- and glassware. Gloves were
worn throughout all manipulations.
7.3.1 RNA extraction with TriFastTM reagent
Total RNA was extracted from Drosophila melanogaster Schneider 2 cells
using peqGOLD TriFastTM reagent (PeqLab) according to the manufacturer’s
instructions. The TriFast reagent, a mono-phasic solution of phenol and
guanidine isothiocyanate, is an improvement to the single-step RNA isolation
method, described in [67]. During sample homogenization and lysis, the
reagent maintains the stability of RNA, while disrupting cells and dissolving
cell components.
To isolate RNA, the suspension of cells in growth medium was centrifuged
at 210×g for 5 min and the cell pellet washed once with ice-cold PBS. The cell
suspension was distributed into 2 mL tubes, centrifuged once again, and 1 mL
of TriFast reagent was added (packed cell volume was equal or less than 10%
of the volume of TriFast reagent used for lysis). Cell were lysed by repetitive
pipetting or by vigourous shaking for 30 s, followed by incubation at room
temperature for 5 min to permit the complete dissociation of nucleoprotein
complexes. Then, 200 µL of chloroform was added. After vigorous shaking
for 15 s, the tubes were incubated at room temperature for 5 min. The
aqueous and the organic phases were separated by centrifugation for 15 min
at 12000×g, 4◦C. The upper aqueous phase was transferred to a fresh 1.5
mL tube, and the RNA was precipitated by mixing with 500 µL of iPrOH
followed by incubation at −20◦C for at least 20 min. The RNA was pelleted
by centrifugation for 20 min at 12000×g, 4◦C. The pellet was washed with 1
mL of 75% EtOH, centrifuged at 7500×g, 4◦C, and allowed to air-dry for 5
min. The RNA was dissolved in the appropriate volume of water.
The concentration of RNA in the solution was determined by measuring
its absorbance at 260 nm (A260). An A260 value of 1 unit corresponds to a
concentration of 40 µg/mL of single-stranded RNA.
7.3.2 RNA extraction with phenol-chloroform-isoamyl alcohol
To extract RNA from various protein solutions (e.g. sucrose gradient frac-
tions, in vitro transcription reaction mixtures), the phenol-chloroform-iso-
amyl alcohol method was used. For this, typically 200 µL of the RNA-
containing mixture was taken (or the volume was adjusted to 200 µL with
water). One volume of TE-saturated (pH 4.5) phenol-chloroform-isoamyl
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alcohol mixture (25:24:1) was added. The RNA was extracted by vigor-
ous shaking for 20 s, and the phases were separated by centrifugation for 5
min at 12000×g, 4◦C. The upper aqueous phase containing RNA was then
transferred to a fresh tube and an equal volume of chloroform was added, to
remove the residual phenol. After another shaking and centrifugation step
(same as above), the upper phase was transferred to a fresh tube and precip-
itated with 0.75 volumes of iPrOH or with 2.5 volumes of EtOH, 0.1 volume
of 3 M NaOAc (pH 5.2), 10 µg glycogen (NaOAc and glycogen were added
only if a low yield of the RNA was expected). The concentration of the RNA
solution was determined as described in § 7.3.1.
7.3.3 DNase treatment of RNA preparations
To remove the remnants of genomic and plasmid DNA from RNA prepara-
tions (e.g. before reverse transcription, or to reduce background signal in
Northern blots), the RNA solutions were treated with RNase-free DNase.
Routinely, RQ1 RNase-free DNase (Promega) was used in the following re-
action:
37.5 µL RNA (10-50 µg) in H2O
10 µL 5× transcription buffer
0.5 µL RNasin (40 U/µL)
2 µL RNase-free DNase I
50 µL Total
5× transcription buffer contained 400 mM HEPES-KOH, 120 mMMgCl2,
10 mM spermidine, 200 mM DTT. The reaction mixture was incubated for 30
min at 37◦C. After incubation, the RNA was purified as described in § 7.3.2.
For semi-quantitative RT-PCR, RNA samples were treated with TURBO
DNase (Ambion). For this, the RNA pellet was dissolved in 21.5 µL of H2O.
2.5 µL of 10× reaction buffer (unspecified composition) and 1 µL of TURBO
DNase (2 U/µL) were added. The mixture was incubated at 37◦C for 30
min, and then 2.5 µL of DNase Inactivation Reagent was added followed
by incubation with occasional mixing for 2 min at room temperature. The
DNase Inactivation Reagent was removed by centrifugation for 1.5 min at
10000×g, room temperature. The supernatant, containing DNA-free RNA
ready for downstream applications, was transferred to a fresh tube and used
directly for reverse transcription.
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7.3.4 Preparation of double-stranded RNA
Depletion of endogenous proteins was performed by RNA interference (RNAi)
as described in § 7.2.3. For this, long double-stranded RNA (dsRNA) was
used. DsRNAs corresponding to Drosophila genes were transcribed in vitro
from DNA templates about 700 base pairs long. To generate the templates
for dsRNA synthesis, fragments of cDNA were amplified by PCR as described
in § 7.1.2 from a Schneider cell cDNA library. The primers which were used
for the amplification carried a 24 nt T7 polymerase promoter sequence on its
5′-end. The sequences of the primers are listed in Table 11. The PCR prod-
ucts were purified from an agarose gel as described in § 7.1.4. The purified
DNA was examined by agarose gel electrophoresis prior to transcription to
ensure the presence of a clean (nondegraded) DNA fragment of the expected
size. In vitro transcription was performed in the following reaction mixture:
10 µL H2O
30 µL DNA template (≥50 ng/µL)
20 µL 5× transcription buffer (see § 7.3.3)
30 µL NTP mix (ATP, CTP, GTP, UTP, 25 mM each)
10 µL T7 polymerase (in-house produced)
100 µL Total
The reaction mixture was incubated overnight at 37◦C. The DNA template
was removed by digestion with DNase following the transcription reaction.
2 µL of RQ1 RNase-free DNase from Promega was added to the transcription
reaction, and the tube was incubated for another 30 min at 37◦C. After that,
in vitro transcripts were extracted with phenol-chloroform-isoamyl alcohol
as described in § 7.3.2. The RNA pellet was dissolved in 150 µL of water by
vigorous shaking at 30◦C. To anneal the opposite RNA strands and obtain
dsRNA, the RNA from the transcription reaction was denatured at 80◦C for
10 min and then the tube was placed into a beaker containing 500 mL of water
heated to 80◦C. The RNA solution was allowed to cool down gradually to
the room temperature with the water bath. The concentration of the RNA
solution was determined as described in § 7.3.1. An A260 value of 1 unit
corresponds to a concentration of 45 µg/mL of dsRNA. The concentration
was adjusted to 3 µg/µL and 0.3 µg was mixed with DNA dye and loaded
on a 1% agarose gel to assess the quality of the preparation.
7.3.5 Northern blot
Denaturing agarose gel electrophoresis Total RNA isolated from S2
cells was separated according to size by denaturing agarose gel electrophoresis
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in the presence of glyoxal. For a 1.2% agarose gel (size: 20 cm×20 cm), 3.6 g
of agarose was melted in 270 mL of RNase-free water, and the solution was
allowed to cool down to 65◦C. Then, 30 mL of 10× MOPS running buffer
(200 mM MOPS, 80 mM NaOAc, 10 mM EDTA, pH 7.0) was added. The
gel was allowed to solidify in a gel tray with an appropriate comb (19 or 21
wells). 6 to 14 µg of RNA was loaded per lane.
To start the glyoxal denaturing reaction, 6.75 µL of RNA in H2O was
combined with 23.25 µL of glyoxal reaction mixture. The glyoxal reaction
mixture was prepared beforehand according to the following recipe:
1.2 mL DMSO
0.4 mL deionized glyoxal
0.24 mL 10× MOPS running buffer
0.12 mL 80% glycerol
40 µL H2O
2 mL Total
The RNA samples were incubated at 74◦C for 10 min, and chilled on ice.
Then, 3 µL of RNA gel loading dye (95% formamide, 0.05% SDS, 0.05%
xylene cyanol FF, 0.05% Bromphenol Blue, 0.5 mg/mL ethidium bromide)
was added. The gel was pre-run for 10 min at 2 V/cm in 1× MOPS running
buffer (see above), before the samples were loaded. Gel electrophoresis was
performed over 12-16 hours at 2 V/cm, 4◦C.
Transfer of RNA to membranes After electrophoresis, the agarose gel
was rinsed once with water. The RNA was blotted onto a positively charged
nylon membrane (GeneScreen Plus) by upward capillary transfer. The trans-
fer setup was assembled as follows:
The gel was placed on a large strip of filter paper (Whatman, 3MM)
situated on a glass plate, with the ends of the filter paper in a reservoir with
10× SSC buffer (1.5 M NaCl, 0.15 M tri-sodium citrate dihydrate, pH 7.0).
The nylon membrane was soaked in 10× SSC buffer and placed on top of
the gel, surrounded by plastic film to prevent the buffer from bypassing the
membrane. Two pieces of Whatman filter paper soaked in 2× SSC buffer
were then placed on top, followed by an assembly of dry filter paper to
create the upward capillary action. The transfer was allowed to proceed for
5-6 hours.
After transfer, the membrane was rinsed in 2× SSC buffer, and the RNA
cross-linked to the membrane by UV light using a Stratalinker 2400 (Strata-
gene). The ethidium bromide-stained ribosomal RNA was visualized under
UV light, and the membrane was marked and cut at the 18S rRNA band, so
that the two halves could be hybridized independently.
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Preparation of [32P]-labeled DNA probes Labeled DNA probes for
Northern hybridization were prepared by asymmetric PCR or by random
priming. The template for asymmetric PCR, as well as for random priming,
was produced by PCR or restriction digest, followed by purification of the
product from an agarose gel as described in § 7.1.4. Linear PCR was per-
formed in the presence of [32P]-dATP and [32P]-dCTP (Hartmann), using the
anti-sense primer to initiate the synthesis of single-stranded DNA molecules
which were complementary to the mRNA of interest. The following reaction
mixture was used:
30 µL H2O
2 µL DNA template (50-100 ng)
5 µL 10× reaction buffer
1 µL dNTP mix (0.1 mM dATP, dCTP; 10 mM dGTP, dTTP)
1 µL anti-sense primer (10 µM)
1 µL Taq polymerase (in-house produced)
5 µL [32P]-dATP (10 Ci/µL)
5 µL [32P]-dCTP (10 Ci/µL)
50 µL Total
The reaction mix was prepared in thin-walled 0.2 mL PCR tubes on
ice. A DNA Engine (PTC-200) Peltier Thermal Cycler (BioRad) was used,
employing the following programm:
01 2:00 94◦C denaturation
02 0:30 94◦C denaturation
03 0:30 56◦C primers annealing
04 0:45 72◦C elongation
05 GOTO 02 39 times
06 7:00 72◦C elongation
To label DNA fragments by random priming (as described in [116]), at
least 30 ng of DNA template was taken and combined with 2 µg of random
nonamer in a total of 13 µL of water. The mixture was denatured for 5 min
at 94◦C and chilled on ice. Then, the following reagents were added:
5 µL N9 buffer
1 µL BSA (10 µg/µL)
1 µL Klenow polymerase (5 U/µL)
5 µL [32P]-dCTP (10 Ci/µL)
25 µL Total
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The composition of N9 buffer was as follows: 1 M HEPES, pH 6.6, 250
mM Tris-HCl, pH 8.0, 25 mM MgCl2, 5 mM β-mercaptoethanol, dATP,
dCTP, dGTP, dTTP, 2 mM each. The reaction mixture was incubated for
30 min at 37◦C.
The [32P]-labeled probes were purified by size-exclusion chromatography,
using a Sephadex G50 column. To prepare the G50 column, the plunger
was removed from a 2 mL syringe, and a small amount of siliconized glass
wool was inserted at the tip of the syringe. The syringe was then filled with
Sephadex G50 slurry (1:1) in water, and centrifuged for 5 min at 840×g in
a 15 mL polypropylene Falcon tube. The flow-through was discarded, and
a 1.5 mL reaction tube with the cap removed was placed below the tip of
the syringe. Then, the the labeling reaction, diluted in 100 µL of water,
was applied to the column. After centrifugation for 5 min at 840×g, the
flow-through containing the radiolabeled probe was collected, while any un-
incorporated nucleotides were retained on the column. The specific activity
of 1 µL of the probe solution was measured using a scintillation counter, and
106 cpm were used per 1 mL of hybridization buffer.
Northern hybridization Reporter transcripts and endogenous mRNAs
were detected by hybridization of [32P]-labeled probes, generated as de-
scribed in above. Membranes were placed in glass hybridization tubes, rinsed
once with 2× SSC buffer, and pre-hybridized at 65◦C in 12.5 mL of Church
hybridization buffer (500 mM sodium phosphate, pH 7.0, 7% SDS, 1 mM
EDTA) containing 100 µg/mL salmon testis DNA. The salmon testis DNA
was denatured for 5 min at 96◦C and chilled on ice before it was added to
the hybridization buffer. After one hour of pre-hybridization, the purified
[32P]-labeled probe was added (106 cpm per 1 mL of Church buffer). Hy-
bridization was carried out overnight at 65◦C. Membranes were washed 5
times for 20 min at 65◦C with 20 mL of Church wash buffer (40 mM sodium
phosphate, pH 7.0, 1% SDS, 1 mM EDTA), and sealed between two trans-
parent films. Radioactive bands were visualized using BioMax MS and MR
films (KodakTM), and their intensity was quantified using the StormTM 820
Gel and Blot Imaging system (GE Healthcare, USA).
7.3.6 Preparation of RNA for microarray analysis
Total RNA from 18×106 Drosophila Schneider 2 cells transfected with dsRNA
(see § 7.2.3) was extracted as described in § 7.3.1. Two RNA preparations for
each type of knock down were performed in parallel. The RNA preparations
were treated with DNase (see § 7.3.3). After that, the RNA was precipitated,
dissolved in 20 µL of water and concentrations and A260/A280 ratios were de-
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termined. Ratios between 1.9 and 2.1 were considered to be acceptable. The
concentrations were adjusted to 2 µg/µL. 2 µg from each RNA sample were
analyzed by agarose gel electrophoresis (see § 7.1.3) to ensure the presence of
two bands of nondegraded ribosomal RNA. For this, 1 µL of RNA solution
was mixed with 19 µL of RNA gel loading dye, and loaded on a 1% agarose
gel. Then equal amounts of RNA from two separate preparations of each
knock down were combined (“Pool I”) and the concentration of this pooled
RNA sample was adjusted to 1.5 µg/µL.
Each type of knock down experiment was repeated again. Two RNA
preparations for each type of knock down were performed and processed
in parallel, in essentially the same way, to obtain “Pool II”. RNA from each
pool was tested separately by RT-PCR, using random hexamer and AMV re-
verse transcriptase (Promega) for reverse transcription (§ 7.1.1) and primers
specific for RpL49 mRNA during 18 cycles of PCR (§ 7.1.2).
Equal amounts of RNA from “Pool I” and “Pool II” were combined in
the final RNA sample, and the concentration was adjusted to 1 µg/µL. RNA
integrity was tested as described above by measuring the A260/A280 ratios
and running an agarose gel electrophoresis.
10 µg of total RNA obtained from each type of knock down experiment
were sent to Affymetrix GeneChip Array Services at the European Molecular
Biology Laboratory CeneCore facility. The samples were processed according
to Affymetrix protocols and the cRNAs thus obtained were hybridized to the
GeneChip Drosophila Genome 2.0 Array.
7.4 Immunoprecipitation
For immunoprecipitations of tagged proteins, transfections of Drosophila
Scheinder 2 cells were performed in 6-well dishes as described in § 7.2.2.
Cells were collected 3 days after transfection, washed with PBS, and resus-
pended in ice-cold lysis buffer (50 mM HEPES-KOH, pH 7.6, 150 mM KCl,
1 mM EDTA and 0.1% Triton X-100), supplemented with Complete pro-
tease inhibitor cocktail (Roche Applied Science). The cells were lysed for
15 min on ice in 200 µL of buffer per 5×106 cells. Cell lysate was spun at
16000×g for 15 min at 4◦C, and the supernatant was transferred to a fresh
tube. 10% of the lysate was taken aside and mixed with an equal volume
of 2× SDS sample buffer (10% input). Mouse monoclonal anti-HA antibody
(COVANCE) was added to the supernatant (2.5 µL/5×106 cells), and the
tube was rotated for one hour at 4◦C. After that, 25 µL of Protein G-agarose
(Roche Applied Science) were added and the mixture was rotated for another
hour at 4◦C. Protein G-agarose beads were pelleted by centrifugation for 2
min at 500×g, 4◦C, washed three times with lysis buffer and once with lysis
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Table 7. Resolving gels for denaturing SDS-PAGE
Volume of components (mL) per gel mould volume of 40 mL
8% 10% 12% Components
18.5 15.9 13.2 H2O
10.7 13.3 16 30% acrylamide/bis-acrylamide (37.5:1)
10 10 10 1.5 M Tris-HCl, pH 8.7
0.4 0.4 0.4 10% SDS
0.4 0.4 0.4 10% APS
0.024 0.016 0.016 TEMED
buffer without Triton X-100. Bound proteins were eluted by incubating the
beads in 100 µL of 2× SDS sample buffer at 96◦C for 5 min with occasional
vigorous mixing.
7.5 Protein gel electrophoresis and Western blot
Total-cell extracts for Western blot were prepared as follows. Drosophila
Schneider 2 cells grown as a layer or in suspension were collected, washed
once with ice-cold PBS, and lysates obtained by re-suspending the cell pellet
in 2× SDS sample buffer (41.6 mM Tris-HCl, pH 6.8, 6% SDS, 30% glycerol,
100 mM DTT, 0.05% Bromophenol Blue) at a concentration of 30000 cells
per 1 µL.
7.5.1 Polyacrylamide gel electrophoresis
Proteins were separated according to size by SDS-polyacrylamide gel elec-
trophoresis (SDS-PAGE). Polyacrylamide gels contained an upper stacking
gel to ensure that all proteins in the sample entered the lower separating gel
simultaneously. In the lower gel, the proteins were separated according to
molecular weight, as the amino acid chains were denatured in the presence
of SDS. Separating gels were prepared according to the recipes summarized
in Table 7.
APS and TEMED were the last reagents to be added to the mixture, just
before pouring the gel. The lower separating gel was overlaid with iPrOH,
and allowed to solidify for 15 min. The upper stacking gel had the following
composition:
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6.8 mL H2O
1.7 mL 30% acrylamide/bis-acrylamide (37.5:1)
1.25 mL 1.5 M Tris-HCl (pH 6.8)
0.1 mL 10% SDS
0.1 mL 10% APS
0.01 mL TEMED
10 mL Total
The iPrOH was aspirated from the lower gel, and a layer of stacking gel
was poured on top. A comb was inserted, and the gel was allowed to solidify
for 10 min. Gel electrophoresis was performed in Læmmli buffer (25 mM
Tris base, 192 mM glycin, 1% SDS). The gel was run at 15 V/cm until the
Bromophenol Blue dye front had migrated out of the gel.
7.5.2 Transfer of proteins to nitrocellulose membranes
To transfer proteins from the polyacrylamide gel onto a nitrocellulose mem-
brane (Protran BA), a wet transfer system (BioRad) was used. The mem-
brane, the gel and 4 pieces of Whatman 3MM filter paper were soaked in
transfer buffer (20 mM Tris base, 150 mM glycine, 20% MeOH, 0.1% SDS).
A transfer sandwich was assembled as follows (from the side of the cathode—
the negative electrode): a porous pad, two pieces of filter paper and the gel.
The nitrocellulose membrane was placed on top of the gel, and air bubbles
between the membrane and the gel were removed. Two pieces of filter pa-
per and the second porous pad completed the transfer assembly. The wet
transfer was performed in the transfer buffer (see above) for 2 hours at 50 V,
4◦C.
7.5.3 Western blot
After transfer, the membrane was rinsed with water and stained with 0.05%
Ponceau Red to assess the efficiency of the transfer, washed in water, and
blocked overnight at 4◦C in blocking buffer (PBS, 0.3% TWEEN 20, 5%
desiccated milk). Immunoblotting was performed using the Western-StarTM
chemiluminescent immunoblot detection system (TROPIX). The system uti-
lizes enzyme-linked immunodetection of antigen-specific antibodies with sec-
ondary antibodies conjugated to alkaline phosphatase (AP). The immobilized
AP enzyme dephosphorylates the CDP-StarTM substrate. Upon dephospho-
rylation, the substrate decomposes, producing a prolonged emission of light
that is imaged on X-ray or instant photographic film.
For the Western blot, the blocked membrane was incubated for 1 hour
with primary antibody diluted in the blocking buffer on a rocking platform at
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room temperature. Antibodies and working antibody dilutions are listed in
Table 8. The membrane was washed three times for 5 min in washing buffer
(PBS, 0.3% TWEEN 20), and then incubated for 1 hour with a secondary
antibody coupled to alkaline phosphatase, diluted in the blocking buffer.
After four washes for 15 min in the washing buffer, the membrane was washed
twice for 2 min in assay buffer (20 mM Tris-HCl, pH 9.8, 1 mM MgCl2), then
the excess buffer removed. The membrane was placed on a glass plate and
covered with a thin layer of CDP-StarTM substrate solution followed by 5
min incubation at room temperature. Then the substrate was removed and
the blot was sealed between two transparent films and exposed to BioMax
MR film (KodakTM).
Table 8. Antibodies used for Western blot
Antigen Properties Source Dilution
Belle Rabbit polyclonal Our laboratory 1:50000
UPF1 Rabbit polyclonal Our laboratory 1:1000
AGO2 Rabbit polyclonal Our laboratory 1:1000
GW182 Rat polyclonal Our laboratory 1:1000
Tral/Lsm14 Rat polyclonal Our laboratory 1:2000
EDC3/Lsm16 Rat polyclonal Our laboratory 1:1000
EDC4/Ge-1 Rat polyclonal Our laboratory 1:1000
EGFP Rabbit polyclonal Our laboratory 1:2000
Tubulin Mouse polyclonal SIGMA 1:10000
HA tag Rabbit polyclonal SIGMA 1:1000
V5 tag Mouse monoclonal Invitrogen 1:5000
Rabbit IgG Goat polyclonal, AP-coupled TROPIX 1:50000
Mouse IgG Goat polyclonal, AP-coupled TROPIX 1:20000
Rat IgG Goat polyclonal, AP-coupled SIGMA 1:20000
7.6 In vivo metabolic labeling of cells
Drosophila Schneider 2 cells, transfected with dsRNA as described in § 7.2.3,
were transferred to 15-mL Falcon tubes, washed once with serum-free Sf-900
II SFM Drosophila medium lacking methionine and cystine (Invitrogen), and
incubated in 200 µL of this medium for 20 min at 25◦C. After this prein-
cubation period, 200 µL of Sf-900 II SFM medium, supplemented with 125
mCi/mL of [35S]-labeled methionine and cysteine (RedivueTM PRO-MIX TM
in vitro cell labeling mix; Amersham BiosciencesTM), were added. Cells were
either kept at 25◦C or immediately shifted to 37◦C by immersing the tubes
in a water bath. After 1 hour, cells were washed twice with ice-cold PBS
and directly resuspended in 100 µL of 2× SDS sample buffer (see above).
Aliquots of 25 mL were analyzed by SDS-PAGE (see § 7.5.1). The gel was
stained with Coomassie solution (45% MeOH, 10% AcOH, 1 g/L Brilliant
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Blue R-250) for 15 min, and destained with destaining solution (25% iPrOH,
10% AcOH). Then, the gel was photographed using gel documentation sys-
tem (PeqLab), and dried in a BioRad gel dryer for 45 min at 65◦C. The dried
gel was exposed to BioMax MR film (KodakTM).
7.7 Analysis of polysomes by sedimentation in sucrose
gradients
The following protocol for the analysis of polysome profiles of Drosophila S2
cells in sucrose gradients was developed in our laboratory based on similar
protocols for yeast and mammalian cells.
Cells intended for polysome profile analysis were harvested at a cell den-
sity of 3-4×106 cells/mL. It was important to keep the cell population in
the logarithmic phase (cell density below 5×106 cells/mL), since translation
is most efficient at this stage. Approximately, 30×106 cells were taken per
gradient.
To stabilize the polysomes, cycloheximide5 was added to the growth
medium at 0.1 mg/mL final concentration, and the cells were incubated at
25◦C for 20-30 min. During the incubation with cycloheximide, lysis buffer
and sucrose gradients6 were prepared.
Hypertonic buffer7 was used for lysing the cells. The buffer composition
was as follows: 40 mM HEPES-KOH, pH 7.6, 300 mM KCl, 5 mMMg(OAc)2,
2 mM DTT, 1% NP-40, 1% sodium deoxycholate, 1× Complete protease
inhibitor cocktail (Roche Applied Science), 0.5 U/µL RNasin, 0.1 mg/mL
cycloheximide.
11×60 mm ultracentrifuge tubes were used in conjunction with an SW
60 Ti rotor. Pairs of tubes were selected that differed in mass by less than
50 mg. The tubes were rinsed once with 0.1% DEPC and twice with H2O.
2 mL of 15% sucrose in gradient buffer (40 mM HEPES-KOH, pH 7.6, 150
mM KCl, 5 mM Mg(OAc)2, 2 mM DTT, 0.1 mg/mL cycloheximide) was
underlaid with 2 mL of 45% sucrose, without disturbing the interface. This
was done by gently inserting the tip of a blunt stainless steel needle to the
5Cycloheximide inhibits the peptidyl transferase reaction on the 60S ribosomal subunit
preventing ribosomes from completing the translation cycle and falling off the mRNA
during extraction.
6The sucrose concentration range for the gradient is determined by the goals of the
experiment. 15%-45% gradient gives fairly good resolution of free mRNPs, ribosome
subunits, monosome and polysome peaks.
7The choice of the lysis buffer is determined by the mRNA of interest, since some
mRNAs get extracted more efficiently with hypotonic buffer, some with hypertonic, etc.
This has to be tested for each particular mRNA.
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bottom of the tube and slowly releasing the 45% sucrose solution from the
syringe to displace the 15% sucrose solution upwards. The tubes were finally
equilibrated by adding 15% sucrose on top.
To form a linear gradient of sucrose concentration, the tubes with two
layers (15% and 45%) of sucrose were capped and placed in the BioComp
Gradient Master. The instrument was run according to the manufacturer’s
programme, so the gradient was formed and stored at 4◦C.
After incubation with cycloheximide, the cells were pelleted by centrifu-
gation at 210×g for 5 min. After centrifugation, the cells were placed on ice
and all further manipulations were performed at 4◦C. The pellet was resus-
pended in ice-cold PBS, containing 0.1 mg/mL cycloheximide, and the cells
were transferred to 1.5 mL tube. The cells were pelleted again, resuspended
in the lysis buffer (200 µL per 30×106 cells) by pipetting up and down, and
lysed on ice for 10 min. The cell lysate was cleared by centrifugation at
10,000×g for 10 min, 4◦C. The supernatant was transferred to a fresh tube
and EDTA was added (30 mM final concentration) to a control sample to
disrupt the polysomes.
The cleared lysate was carefully layered on top of the sucrose gradient
and centrifuged for 55 min at 45,000 rpm in a Beckman SW 60 Ti rotor, 4◦C.
The gradient was fractionated using an ISCO Teledyne gradient fraction-
ator. The gradient’s A260 profile was recorded during the fractionation. 12
fractions were collected and kept at −80◦C.
One half of each fraction was used to precipitate proteins with MeOH-
chloroform (see below), and the other to extract total RNA with phenol-
chloroform-isoamyl alcohol (§ 7.3.2). Samples for RNA isolation were treated
with Proteinase K (stock solution: 10 mg/mL in 50 mM Tris-HCl, pH 8, 10
mM CaCl2) prior to RNA extraction. For this, the samples were mixed with
0.1 volume of 10× digestion buffer (100 mM Tris-HCl, pH 7.5, 50 mM EDTA,
5% SDS) and Proteinase K up to 100 µg/mL. The tubes were incubated with
vigourous shaking for 45 min at 37◦C, and then total RNA was extracted as
described in § 7.3.2 (phenol-chloroform-isoamyl alcohol extraction was per-
formed twice). The RNA content of different gradient fractions was analyzed
by Northern blot, as described in § 7.3.5.
Proteins contained in gradient fractions were extracted as follows. Sam-
ples were mixed with 4 volumes of MeOH by vortexing for 20 s. Then, one
sample volume of chloroform was added, followed by vortexing for 20 s. To
separate the organic and the aqueous phases, 3 sample volumes of water
were added, followed by vortexing for 20 s and centrifugation for 5 min at
16,100×g, room temperature. The upper phase was carefully removed, leav-
ing the lower phase and the interphase intact. To precipitate the proteins, 3
sample volumes of MeOH were added to the lower phase and the interphase.
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After vortexing for 20 s, the proteins were pelleted by centrifugation for 10
min at 16,100×g, room temperature. The pellet was air-dried and resus-
pended directly in 2× SDS sample buffer. The protein content of different
gradient fractions was analyzed by Western blot, as described in § 7.5.
7.8 Tandem affinity purification and mass spectrome-
try analysis of protein complexes
Stably transfected Drosophila S2 cell lines, expressing TAP-tagged proteins,
were used for tandem affinity purification. The expression of the transgene
was induced overnight by addition of CuSO2 to the growth media
8.
7.8.1 Tandem affinity purification
For each purification, 450 mL of culture was used with cell density of 4-5×106
cells/mL. The cells were harvested in 50 mL FalconTM tubes and pelleted by
centrifugation for 5 min at 210×g, room temperature. All further work was
performed at 4◦C (in a cold room), using ice-cold reagents. The cells were
washed twice with 10 pcv (packed cell volume) of PBS. Then, the pellet was
resuspended in 7 mL of buffer A (10 mM HEPES-KOH, pH 7.9, 10 mM KCl,
1.5 mM MgCl2, 0.5 mM DTT, 0.5 mM EDTA, 2 mM EGTA, 1× Complete
protease inhibitor cocktail) and allowed to swell for 10-15 min on ice. After
that, the cells were disrupted with 40 strokes in a Dounce “B” homogenizer.
The lysate was centrifuged for 20 min at 740×g, 4◦C, to remove nuclei and
cell debris. The supernatant was transferred to a fresh tube and KCl was
added to a final concentration of 200 mM. To increase the stringency of the
purification, NP-40 was added at this stage up to 0.5%. Then, the extract was
centrifuged for 15 min at 15,700×g, 4◦C. The supernatant was collected and
cytochalasin B was added up to 5 µg/mL to avoid actin unspecific binding.
To disrupt RNA-mediated interactions in some experiments, RNase A was
added to the final concentration of 200 µg/mL.
100 µL of cross-linked IgG Sepharose 6 Fast Flow beads (GE Healthcare)
was added to the extract. Proteins were bound to the beads for 2 hours on a
rotating wheel at 4◦C. Then the beads were pelleted by centrifugation for 2
min at 300×g, resuspended in 800 µL of buffer B (20 mM HEPES-KOH, pH
7.9, 200 mM KCl, 2 mM EGTA, 0.5 mM DTT, 0.5 mM EDTA, 1× Complete
protease inhibitor cocktail, 0.5% NP-40, 20% glycerol), and transferred into
a fresh 1.5 mL tube. After that, the beads were washed four times with 800
8The amount of CuSO2 was determined experimentally to ensure that the transgene
protein level was similar to the endogenous protein level.
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µL of buffer B, four times with 800 µL of buffer C (20 mM HEPES-KOH, pH
7.9, 200 mM KCl, 0.5 mM DTT, 0.5 mM EDTA, 0.1% NP-40, 20% glycerol),
and finally two times with TEV cleavage buffer (10 mM Tris-HCl, pH 8, 150
mM NaCl, 0.5 mM DTT, 0.5 mM EDTA, 0.1% NP-40).
The beads were pelleted (2 min at 300×g, 4◦C), resuspended in 200 µL of
TEV cleavage buffer, and 3 µg of TEV protease was added (1 mg/mL stock
solution) to cleave off the protein complexes that were bound to the IgG
beads. The cleavage was carried out overnight at 4◦C, on a rotating wheel.
Next day the beads were pelleted and washed twice with 50 µL of TEV
cleavage buffer. The supernatant was transferred to a fresh tube, combined
with the two washes (ca. 300 µL in total), and CaCl2 was added up to 2
mM. The supernatant was mixed with 900 µL of calmodulin binding buffer
(10 mM Tris-HCl, pH 8, 150 mM NaCl, 1 mM Mg(OAc)2, 2 mM CaCl2,
0.5 mM EDTA, 1 mM imidazole, 10 mM β-mercaptoethanol, 0.1% NP-40),
and applied to 70 µL of calmodulin beads (equilibrated beforehand with
calmodulin binding buffer). Protein binding to calmodulin beads was carried
out for 2 hours at 4◦C, on a rotating wheel. The beads were next washed
seven times with 800 µL of calmodulin binding buffer, and transferred into
precleaned (with 1× LDS sample buffer9 and calmodulin binding buffer)
micro-columns (MoBiTec, 35 µm pores, No. M2135). The remaining buffer
was removed by brief centrifugation of the column. Then, the proteins were
eluted from the beads with 40 µL of 1× LDS sample buffer after 20 min of
shaking at room temperature. This step was repeated once with additional
15 µL of 1× LDS sample buffer and a further 10 min of shaking at room
temperature. The eluate was collected by centrifugation for 30 s at 16,000×g,
room temperature.
The proteins were separated by PAGE, using NuPAGE Novex Bis-Tris
precast 4-12% gradient gels from Invitrogen with MOPS buffer, according to
the manufacturer’s instructions.
7.8.2 Silver staining of protein gels
The staining of the gel was performed using the SilverQuestTM Silver Staining
Kit from Invitrogen according to the manufacturer’s instructions.
After electrophoresis, the gel was removed from the cassette and placed
in a clean staining tray of the appropriate size. The gel was rinsed briefly
with ultrapure water and fixed in 100 mL of fixative (40% EtOH, 10% AcOH
in ultrapure) for 20 min with gentle rotation. The fixative solution was
decanted and the gel washed in 30% EtOH for 10 min. The EtOH was
9Provided with NuPAGE Novex Bis-Tris precast gels from Invitrogen.
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decanted and 100 mL of Sensitizing solution (30% EtOH, 10% Sensitizer
of unspecified composition in ultrapure water) added to the washed gel in
the staining container. The gel was incubated in the Sensitizing solution
for 10 min. The Sensitizing solution was decanted and the gel washed for
10 min each in 100 mL of 30% EtOH, then in 100 mL of ultrapure water.
The gel was next incubated in 100 mL of Staining solution (1% Stainer of
unspecified composition in ultrapure water) for 15 minutes. After staining
was complete, the Staining solution was decanted and the gel washed with
100 mL of ultrapure water for 20-60 s. Then, the gel was incubated in 100
mL of Developing solution (10% Developer, 0.05% Development enhancer in
ultrapure water) for 4-8 min until bands started to appear and the desired
band intensity was reached. Once the appropriate staining intensity was
achieved, 10 mL of Stopper (unspecified composition) was added directly to
the gel still immersed in Developing solution, and the gel gently agitated for
10 min. The Stopper solution was decanted and the gel was finally washed
with 100 mL of ultrapure water for 10 min.
The gel was photographed using a digital gel documentation system from
PeqLab.
7.8.3 Destaining the gel and preparing samples for mass spec-
trometry analysis
All manipulations for preparing the samples for mass spectrometry analysis
and the analysis itself were performed by Guido Sauer in our laboratory.
The gel was thoroughly washed with ultrapure water. The bands of in-
terest were carefully excised using a clean scalpel and placed into a 1.5 mL
sterile tube. 50 µL of Destainer A and 50 µL of Destainer B (provided with
the SilverQuestTM Kit) were added to the tube. The contents of the tube
were thoroughly mixed and incubated for 15 min at room temperature. The
supernatant was removed, 200 µL of ultrapure water was added to the tube,
mixed, and incubated for 10 min at room temperature. The last washing
step was repeated 3 times.
After destaining, the bands of interest were in-gel digested with trypsin
(Promega) and extracted essentially as described in [377].
7.8.4 Mass spectrometry analysis of purified proteins
The extracted peptides were separated by reversed-phase HPLC (NanoLC-
2DTM, Eksigent) using SilicaTipTM (PicoTips, New Objective) capillary col-
umn with 15 cm length and 75 µm inner diameter, self-packed with ReproSil-
Pur C18-AQ, 3 µm (Dr. Maisch GmbH).
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A stepwise gradient with buffer A (0.1% formamide in ultrapure water)
and buffer B (0.1% formamide in acetonitrile) was applied in a run time of
90 min:
• 6 min at 5% of buffer B
• 67 min linear gradient from 5% to 30% of buffer B
• 6 min linear gradient from 30% to 80% of buffer B
• 5 min at 80% of buffer B
• 6 min linear gradient from 80% to 4% of buffer B
Mass spectrometric analysis was performed on an ion trap (HCTultra
TM,
Bruker Daltonics) equipped with a nano-electrospray ion source from Pro-
xeon. 4-8 scans were acquired for precursor ion scans in Standard Enhanced
scan mode and Ultrascan mode for MS/MS fragmentation, respectively. Scan
range was 300 to 1100 m/z in MS mode. Up to 4 precursors were fragmented
per parent ion scanning with active exclusion activated for 30 sec.
A Mascot generic data file was generated using DataAnalysis software
(Bruker) and peptides were searched against the NCBInr protein database
using an in-house Mascot Server (V2.2). The following settings were used:
digestion with trypsin allowing 1 miss cleavage, carbamylation of cysteine as
fixed modification, oxidation of methionine as variable, 0.6 Da peptide mass
accuracy and 0.3 Da for fragmentation masses. Proteins with a score of > 50
and at least two unique peptides were regarded as identified.
7.9 Immunofluorescence and confocal microscopy
7.9.1 Immunofluorescence
For localization studies, S2 cells were transfected with HA- and EGFP-tagged
proteins as described in § 7.2.2. 24 hours after transfection the cells were
collected, washed once and resuspended in serum-free Schneider’s medium
(without FBS, penicillin and streptomycin). The suspension was pipetted
on poly-Lysine coated glass coverslips placed in a 24-well plate and cells
were allowed to adhere for 10 min. After that, the cells were washed once
with serum-free medium and fixed in 4% paraformaldehyde, 4% sucrose in
PBS for 10 min. Then, the coverslips were washed once with PBS for 5
min, incubated for 5 min in MeOH at −20◦C, and washed again three times
with PBS for 5 min. To detect HA-tagged or endogenous proteins, the cells
were permeabilized with 0.1% Triton X-100 in PBS for 10 min, followed
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by three washes in PBS for 5 min. To avoid unspecific signal, the cells
were blocked for 30 min in 1% BSA (w/v) in PBS, then incubated with
an appropriate antibody (see Table 9) diluted in PBS containing 1% BSA
for 1 hour. Antibody incubation was carried out at room temperature in a
humidified chamber. The cells were washed three times in PBS and incubated
with secondary antibody in PBS containing 1% BSA as described above. To
stain nuclear envelope, 2 µg/mL Alexa Fluor 488 conjugated to the lectin
wheat germ agglutinin (Molecular ProbesTM) was also applied to the the cells
together with the secondary antibody solution. After two washes with PBS,
the coverslips were incubated for 3 min in 10 µg/mL Hoechst 33342 in PBS
(Molecular ProbesTM) to stain the DNA, washed again twice and mounted
on a glass slide using Fluoromount-GTM(Southern Biotechnologies).
Table 9. Antibodies used for immunofluorescence
Antigen Properties Source Dilution
Belle Rabbit polyclonal Our laboratory 1:100
HA tag Mouse monoclonal COVANCE 1:1000
Mouse IgG Goat polyclonal, TRITC-coupled Southern Biotech 1:250
Rabbit IgG Goat polyclonal, TRITC-coupled Southern Biotech 1:250
7.9.2 Confocal fluorescence microscopy
Confocal images were accquired using a Carl Zeiss LSM510 confocal scan-
ning microscope fitted with a 63× oil immersion objective (Carl Zeiss Plan-
Apochromat). A UV laser was used at 405 nm for excitation of Hoechst
33342 dye (excitation maximum 346 nm), an Ar laser at 488 nm for excita-
tion of EGFP (excitation maximum 488 nm), and HeNe laser at 543 nm for
excitation of TRITC (excitation maximum 554 nm). In co-localization exper-
iments, an emission filter set was used to collect emissions at non-overlapping
frequency intervals, surrounding each fluorophore’s emission maximum to
minimize the crosstalk between channels: 420-280 nm for Hoechst 33342,
505-550 nm for EGFP, 560-657 nm for TRITC.
The LSM-FCS software (Carl Zeiss in collaboration with the Advanced
Light Microscopy Facility, EMBL) was used for image acquisition. Confocal
sections were obtained as optical slices of < 1 µm, with pixel time 1.6 µs and
stack size 512× 512 pixels (16.2 µm×16.2 µm). Images were generated as a
mean of four linear scans to improve the signal-to-noise ratio.
Table 10. Oligonucleotide sequences used for cloning, mutagenesis and RT-PCR
No. Primer name Sequence Transcript ID
9 HMGzLBamHI CGGGATCCCAAGGCGGTAAAGGAGTACG CG17921-RB
10 HMGzREcoRI CGGAATTCACTTGACGCGATCGAAAGTT CG17921-RB
41 CG15861XbaL CTCTAGATACGAAATGCTGGTGGTCAA CG1586-RA
42 CG15861NcoR TACCATGGCCGTTGTGAGCATAATGGTG CG1586-RA
45 CG15825BamL CGGGATCCTGGAAGTTCCTTCGGCTCTA CG15825-RB
46 CG15825EcoR CGGAATTCGGTGGTCACCTTTCGTTGAT CG15825-RB
47 CG18522BamL CGGGATCCATGTACGGCCTGCTGAAGTC CG18522-RA
48 CG18522EcoR CGGAATTCGACACAGCTCCATGGTTTCA CG18522-RA
71 17.6L GCCGCATACGTCAACAATAA X01472
72 17.6R GAGAAGCCTCTGTGCTTGCT X01472
75 TranspacL ACACATGGCGCTAAGCTTTT AF222049
76 TranspacR AAGATCGTTGCCTCCAGAAA AF222049
77 JuanL CTGTAAAGGCGACCATCCAT AY180919
78 JuanR TGCTTTGGGATTAGGCAAAG AY180919
100 CG31642L ACCAAGGAATTGATGGAACG CG31642-RA
101 CG31642R CCGAGGCTTATTTCCTACAAA CG31642-RA
110 CG15861Int1L TGATTCTTGCTCCTCACCTT CG15861-RA
111 CG15861Int1R TGAGAAAGGGCACATAAACG CG15861-RA
112 CG15861Int2L CGCTATATCTTTTCGCCACA CG15861-RA
113 CG31642Int1L GCCGCTCACATTTCAATTTT CG31642-RA
114 CG31642Ex2R TTGCCGCACAAAGTGTATTC CG31642-RA
121 CG31641IntL GACCTTTAACGCGAGCCATA CG31641
122 CG31641IntR TCCCGCACTTTAGGTGAAAC CG31641
125 Dm-miR-7-s TGGAAGACTAGTGATTTTGTTGT AJ421767
126 Dm-miR-7-as ACAACAAAATCACTAGTCTTC AJ421767
127 Dm-miR-9b-as CATACAGCTAAAATCACCAAAGA CG31782-RA
128 Dm-miR-14-as TAGGAGAGAGAAAAAGACTGA AJ421776
129 Dm-miR-bantam-as AATCAGCTTTCAAAATGATCTCA AJ550546
130 18-S-157-S TCTTTCAAATGTCTGCCCTATCAAC FBgn0061475
131 18-S-329-AS GAGTCCTGTATTGTTATTTTTCGTCAC FBgn0061475
231 belleFL-HindIII-L CGCAAGCTTGATGAGTAATGCTATTAACCAA CG9748-RA
232 belleFL-NotI-R ATGCGGCCGCTCATTGAGCCCACCAGTCGGG CG9748-RA
244 AGO2-FL-NotI-R ATGCGGCCGCTCAGACAAAGTACATGGGGTT CG7439-RB/C
246 AGO1-RB-FL-EcoRI-L CGGAATTCCATGTATCCAGTTGGACAACAGTC CG6671-RB
247 AGO1-FL-NotI-R ATGCGGCCGCTTAGGCAAAGTACATGACCTTCTTGG CG6671
250 CG10077-RA-FL-HindIII-L CGCAAGCTTAATGAACATGTACAACGGACAGATG CG10077-RA
251 CG10077-RA-FL-NotI-R ATGCGGCCGCCTAGTTCTGCACAGGCAGCG CG10077-RA
256 Dmp68FL-NotI-R ATGCGGCCGCCTAGTCGAAGCGCGAGTGTC CG10279-RD
257 Dmp68FL-HindIII-L CGCAAGCTTAATGGCACCACACGATCG CG10279-RD
259 MBP-FL-HindIII-L CGCAAGCTTCATGAAAATCGAAGAAGGTAAAC pETM-41
260 MBP-FL-NotI-R ATGCGGCCGCCTAGTCTTTCAGGGCTTCATCG pETM-41
265 CG10686-FL-HindIII-L CGCAAGCTTGATGAGCGGGGGATTACC CG10686-RA
266 CG10686-FL-NotI-R ATGCGGCCGCCTATTGTGAAACTGCCGCC CG10686-RA
267 AGO2-RC-FL-EcoRV-L GCGATATCATGCACTTTCCAATTACCACCCCAG CG7439-RC
272 bel-K345N-L CCCAGACTGGATCAGGCAACACGGCCGCCTTCCT CG9748-RA
273 bel-K345N-R AGGAAGGCGGCCGTGTTGCCTGATCCAGTCTGGG CG9748-RA
274 bel-E459Q-L TTCCTTGTACTGGATCAGGCTGATCGTATGT CG9748-RA
275 bel-E459Q-R ACATACGATCAGCCTGATCCAGTACAAGGAA CG9748-RA
276 bel-H645Q-L GGAGGAGTATGTCCAGCGTATCGGGCGTACC CG9748-RA
277 bel-H645Q-R GGTACGCCCGATACGCTGGACATACTCCTCC CG9748-RA
284 belle-FL-NcoI-L ATCCATGGCAATGAGTAATGCTATTAACCAA CG9748-RA
286 Dmp68FL-NcoI-L TATCCATGGCACCACACGATCG CG10279-RD
287 Dmp68FL-KpnI-R ATGGTACCCTAGTCGAAGCGCGAGTGTC CG10279-RA
295 Act-5C-L AAATGTGTGACGAAGAAGTTGC CG4027-RA
296 Act-5C-R TCTTCATCAGGTAGTCGGTCAA CG4027-RA
310 Pum-RA-FL-XbaI-R TATCTAGATTACAGCACAACGTTGCCG CG9755-RA
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No. Primer name Sequence Transcript ID
317 cycB-RA-3’UTR-EcoRI-L TAGAATTCTGCGGTCCAAGGCGGACTG CG3510-RA
318 cycB-RA-3’UTR-SalI-R GACGTCGACCTATGTATTGTTCAGAGAC CG3510-RA
321 bel-230-KpnI-R ATGGTACCTTAGCCGCGATTGTTGTAGCTTC CG9748-RA
327 Pum-RE-extraFL-HindIII-L TAGAAGCTTGATGGTGGTTTTAGAAACTG CG9755-RE
330 belle-FL-XhoI-L GCCTCGAGATGAGTAATGCTATTAACCAA CG9748-RA
331 belle-FL-EcoRV-R ATGATATCTTGAGCCCACCAGTCGGGT CG9748-RA
368 yps-RA-HindIII-L TATAAGCTTGATGGCTGATGCCGCGGAGAG CG5654-RA
369 yps-RA-NotI-R ATGCGGCCGCCTATGCAGTGCTCTCTGTGG CG5654-RA
374 exu-RA-EcoRI-L CGGAATTCAATGGTTGCCGATAACATCGATG CG8994-RA
375 exu-RA-XbaI-R GCTCTAGATTAGTTGGAGGCCGTGATGGC CG8994-RA
386 Belle-Y46A-L CTCGGTCACCGGTGGTGTGGCTGTGCCCCCGCACCTTCGTG CG9748-RA
387 Belle-Y46A-R CACGAAGGTGCGGGGGCACAGCCACACCACCGGTGACCGAG CG9748-RA
388 Belle-L51A-L TGTGTATGTGCCCCCGCACGCTCGTGGTGGTGGTGGCAATAAC CG9748-RA
389 Belle-L51A-R GTTATTGCCACCACCACCACGAGCGTGCGGGGGCACATACACA CG9748-RA
390 Pasilla-RD-EcoRI-L TAGAATTCAATGTTGTTCGCCAGAACCAC CG8144-RD
391 Pasilla-RD-XbaI-R GCTCTAGATTAATTCACAACAGTGGTTAATG CG8144-RD
392 Imp-RA-EcoRI-L CAGAATTCAATGCACAGCAACAATAATAG CG1619-RA
393 Imp-RA-XbaI-R GCTCTAGATTACTGTTGTGAGCTCGCCAG CG1619-RA
394 dFMR-RA-HindIII-L TATAAGCTTGATGGAAGATCTCCTCGTGG CG6203-RA
395 dFMR-RA-XhoI-R GCCTCGAGTTAGGACGTGCCATTGACCAG CG6203-RA
396 Penguin-HindII-L TATAAGCTTGATGGTTAGCTCGGAGCCGAAAG CG1685-RA
397 Penguin-XhoI-R GCCTCGAGTCATTTGCCAATGTCCAG CG1685-RA
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Table 11. Oligonucleotide sequences used for dsRNA preparation
No. Primer name Sequence ID/Source
1 T7Ago1Left ttaatacgactcactatagggagaCATTAAAAAGCTGACCGATATGC CG6671-RA
2 T7Ago1Right ttaatacgactcactatagggagaTTGACGTTGATCTTCAGACACAG CG6671-RA
3 T7AubLeft ttaatacgactcactatagggagaGTGGGTCCCTCGATAGAGAAAT CG6137-RA
4 T7AubRight ttaatacgactcactatagggagaGTGGCATATCTCGGAACAAAGT CG6137-RA
5 T7PiwiLeft ttaatacgactcactatagggagaCGAACTTTTTCCGATTAAAAACC CG6122-RA
6 T7PiwiRight ttaatacgactcactatagggagaAGTTTGTCCAAAGTCGACATCAT CG6122-RA
31 T7Ago1L ttaatacgactcactatagggagaCCCAAGTGCCCAGAATGT CG6671-RA
32 T7Ago1R ttaatacgactcactatagggagaAACTGAAGAAGCTACGTCCCACT CG6671-RA
33 T7Ago2L ttaatacgactcactatagggagaAGGGTGGACTAAACAAGGTCAAC CG7439-RB
34 T7Ago2R ttaatacgactcactatagggagaGCTGTTGGTAGCCACCTTCTT CG7439-RB
35 T7AubL ttaatacgactcactatagggagaCAGAAGGAGTCTTTCCGCTACTT CG6137-RA
36 T7AubR ttaatacgactcactatagggagaACTCGTATGGTTCCGCTGTAAT CG6137-RA
37 T7PiwiL ttaatacgactcactatagggagaTATGCGTGCCATGAGCAGTTA CG6122-RA
38 T7PiwiR ttaatacgactcactatagggagaTTTCGGCGTTATCATTGGGTA CG6122-RA
39 T7Ago2cL ttaatacgactcactatagggagaAAAGAGTACCGTAACGCCTATCC CG7439-RB
40 T7Ago2cR ttaatacgactcactatagggagaACTCCTTCTTCAAATCCAGGAAC CG7439-RB
360 T7belle-Boutros-L ttaatacgactcactatagggagaTTTGACGGTAATCCCTGGAG CG9748-RA
361 T7belle-Boutros-R ttaatacgactcactatagggagaATCCCGTCACTAGCATCCAC CG9748-RA
Oligonucleotides from other sources
GFP-UT7 ttaatacgactcactatagggaggATGGTGAGCAAGGGCGAGGAG E. Izaurralde
GFP-LT7 ttaatacgactcactatagggaggCTTGTACAGCTCGTCCATGCCG E. Izaurralde
T7U-Drosha taatacgactcactatagggaggATGTACCAGCCGCCTTTGCCACCG E. Izaurralde
T7L741-Dros taatacgactcactatagggaggGCAGAAGTTAGAACACCACTGTCTC E. Izaurralde
Me31B-T7U taatacgactcactatagggaggATGATGACTGAAAAGTTAAATTCTGGG E. Izaurralde
Me31B-T7L taatacgactcactatagggaggCTTGACTGTTAGTGGAAATGTTGCGG E. Izaurralde
eIF4E-UT7-171 ttaatacgactcactatagggaggAGCAGGCAACACTGCAAC A. Eula´lio
eIF4E-T7L650 ttaatacgactcactatagggaggGCTTCCTCGTTGTTTCCG A. Eula´lio
eIF4A-UT7 ttaatacgactcactatagggaggATGGATGACCGAAATGAGATACC A. Eula´lio
eIF4A-T7Low700 ttaatacgactcactatagggaggGACGGGATCACGCATGAAGC A. Eula´lio
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